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SS 1.03
Differential diagnosis of cystic pancreatic lesions: 
usefulness of diffusion-weighted 3T MR imaging with 
b-multiple SE-EPI
P. Boraschi, F. Donati, R. Gigoni, G. Gherarducci, 
F. Pacciardi, U. Boggi, F. Falaschi, C. Bartolozzi; Pisa/IT
Purpose: To evaluate the usefulness of diffusion-weighted 3T MR imaging 
with b-multiple SE-EPI in providing an objective value for the differentiation of 
cystic pancreatic lesions.
Material and Methods: A series of 103 patients with cystic pancreatic lesions 
of at least 1 cm in size identified at US and/or CT and 20 normal subjects 
underwent MR imaging at 3T-device (GE DISCOVERY MR750; GE Healthcare). 
After the acquisition of axial T1w and T2w sequences and coronal MRCP, 
diffusion-weighted MRI was performed using an axial respiratory-triggered 
spin-echo echo-planar sequence with multiple b values (150, 500, 1000, 1500 
s/mm2) in all diffusion directions. ADC value was calculated by using a 
dedicated software fitting the curve obtained from the corresponding ADC for 
each b value. Fitted ADC values were calculated by two observers in 
conference for each cystic pancreatic lesion and for normal pancreatic 
parenchyma. Imaging results were correlated with surgery, ERCP, and/or 
imaging follow up.
Results: Final diagnoses included intraductal papillary mucinous tumor (IPMT) 
(n=70), serous cystoadenoma (n=21), and mucinous cystoadenoma (n=12). 
Fitted ADC value was 1.33x10-3 mm2/s for normal pancreatic parenchyma, 
3.11x10-3 mm2/s for IPMT, 2.55x10-3 mm2/s for serous cystoadenoma, 
2.95x10-3 mm2/s for mucinous cystoadenoma. Fitted ADC values were 
significantly higher in mucinous neoplasms than in serous cystoadenomas 
(p<0.05).
Conclusion: Our results suggest that diffusion-weighted 3T MR imaging with 
b-multiple SE-EPI may be helpful to differentiate mucinous from serous cystic 
pancreatic lesions.
SS 1.04
Prediction of benign neuroendocrine tumors for 
determination of parenchyma-preserving resection: the 
value of gadoxetic acid-enhanced and diffusion-
weighted MR imaging
S. Lim, S.H. Kim, K.M. Jang, M.J. Park, H.J. Park, D. Choi; 
Seoul/KR
Purpose: The purpose of this study was to evaluate the value of gadoxetic 
acid-enhanced and diffusion-weighted MR imaging (DWI) in predicting benign 
pancreatic neuroendocrine tumors (NETs) for determination of parenchyma-
preserving resection.
Material and Methods: We searched radiology and pathology databases from 
November 2010 to July 2012 to identify patients who underwent surgery for 
pancreatic NETs (<4 cm). Twenty patients in the benign group and 14 patients 
in the non-benign group were included. Two radiologists analyzed the 
morphologic features, signal intensity on MR images including DWI (b=800), 
and dynamic enhancement pattern of the tumors with consensus. The tumor-
to-parenchyma ratio and tumor apparent diffusion coefficients (ADCs) were 
quantitatively assessed.
Results: The benign pancreatic NETs were more often round (7/20, 35%) or 
ovoid (13/20, 65%) in shape and less hypovascular on the arterial phase (3/20, 
15%) than were the non-benign pancreatic NETs (1/14, 7.1% and 5/14, 35.8%; 
7/14, 50% respectively; P < 0.05). Main pancreatic duct dilatation by tumors 
was demonstrated only in non-benign pancreatic NETs (4/14, 28.4%; P=0.021). 
ADC values and ratios were significantly different between benign pancreatic 
NETs (mean, 1.48 x 10-3 mm2/s, 1.11+0.25, each) and non-benign pancreatic 
NETs (mean, 1.04 x 10-3 mm2/s, 0.74+0.13, each) (P <0.01). Other qualitative 
and quantitative analyses were not significantly different.
Conclusion: Abdominal MR imaging with DWI may be useful for differentiating 
benign pancreatic NETs from non-benign pancreatic NETs, which might be 
helpful for determination of parenchyma-preserving resection.




Does Electroencephalography Bispectral Index 
monitoring allow interventional nurses to administer 
conscious sedation safely and effectively?
J.H. Chuah, P. Puro, S. Vasileuskaya, N. Kibriya, D. Mullan, 
J.A. Lawrance, S.M. Stivaros, H. Laasch; Manchester/UK
Purpose: UK guidelines suggest that the interventionist should not be the 
person administering sedation for interventional procedures. The aim of this 
study was to review whether sedo-analgesia can be administered by nursing 
staff guided by an Electroencephalography (EEG) Bispectral Index monitor 
(BIS Vista, Aspect Medical Systems, Leiden, The Netherlands).
Material and Methods: 103 patients requiring sedo-analgesia for a variety of 
radiological procedures were evaluated. All patients received increments of 
fentanyl and midazolam to maintain a BIS level of 80-85. Full cardio-respiratory 
monitoring and nasal oxygen were given routinely. Data evaluated were 
Ramsay Sedation Score (RSS), tolerance, duration of the procedure and 
oxygen saturation.
Results: Median procedure duration was 30 min (range 7-150 min). The 
median BIS score was 84 (range 73-97), with a median RSS of 2 (=drowsy and 
anxiety free; range 1-3). In 15 of 103 patients, the BIS monitor could not record 
a reading. The median tolerance level was 1 (no discomfort/pain, range 1-2), 
median oxygen saturation was 100% (range 90-100%), none of the patients 
needed airway management or reversal of sedation. Median drug doses 
administered were 3 mg Midazolam (1-15 mg) and 50 μg Fentanyl (25-300 μg). 
Doses were correlated strongly with length of procedure (Pearson's correlation 
coefficient +0.82).
Conclusion: EEG BIS monitoring is a simple tool to allow very accurate and 
safe administration of conscious sedation by nursing staff, but readings can be 
difficult to obtain in up to 15% of patients.
SS 1.02
Is CT-assessed sarcopenia predictive of post-Whipple 
complications?
E. Kasatkina, V. Lyadov, V. Sinitsyn; Moscow/RU
Purpose: To find if CT-assessed sarcopenia (muscle depletion) is predictive of 
postoperative complications and mortality in patients with pancreatic cancer 
(PC).
Material and Methods: CT-images/clinical history of 51 patients with 
resectable PC who undergone Whipple-procedure in 2009-2012 (25 male/26 
female) were selected from hospital-database. Mean age of patients was 
64.5±10.2 years, mean value of BMI was 25.1±3.9 kg/m2. Body composition 
was analyzed using commercially available software (Silce-O-Matic). For 
sarcopenia evaluation, single CT-scan on level of L3 was used to measure 
cross-sectional area of skeletal muscle (cm2). Values were normalized for 
stature to get L3-skeletal-muscle index (cm2/m2). We used sarcopenia 
thresholds of 52.4 cm2/m2 for male and 38,5 cm2/m2 for female defined 
elsewhere (Prado et al.). Surgical complications were stratified using Clavien-
Dindo-Classification.
Results: There were 34/51 patients diagnosed with sarcopenia (66.7%), 20/25 
male and 14/26 female. Mean value of L3 SMI was 46.7±6.9 cm2/m2 for male 
and 38.3±6.1 cm2/m2 for female. 43.1% of patients had severe post-operative 
complications. Grade V complications (death of a patient) were found only in 
sarcopenic patients: 6 cases – 11.7% of total and of 17.6% sarcopenic 
patients. Relationship between sarcopenia and fatal outcomes was revealed 
(p=0.065, chi-square test (Χ2)). No correlation was found between IIIA-IVB 
complications and sarcopenia. Mean time spent for body composition 
assessment was 3.7±1.4min.
Conclusion: Pre-operative CT-assessment of sarcopenia can be used as 
additional prognostic factor in patients with resectable PC. It does not add 
much time to study and these results can be used in metabolic disorders 
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SS 1.07
Gadodiamide versus gadoteric acid in the evaluation of 
intraductal papillary mucinous neoplasms with magnetic 
resonance
G. Morana1, A. Dorigo1, V. Tavano2, F. De Leo1; 1Treviso/IT, 
2Padua/IT
Purpose: In the last decade, the detection rate of the intraductal papillary 
mucinous tumor (IPMN) has been increased due to an improvement in imaging 
modalities such as MR. MR contrast media (CM) administration allows a better 
definition of IPMN on T1 and T2, lowering the signal from parenchyma, thus 
increasing the C/N (contrast noise) between the lesion and the surrounding 
structures. Due to different relaxivities in CM, aim of this study was to compare 
the paramagnetic (T1) and superparamagnetic (T2) effect of two different CM, 
Gadodiamide (Omniscan@GE) and Gadoterate Meglumina (Dotarem@
Guerbet) to identify and assess IPMN.
Material and Methods: Fifty patients (mean age 67.9 years) with small branch 
duct IPMN were studied by using alternatively the two CM with a time gap of 
6 months. MR examinations were performed on a 1.5-T scanner (Siemens 
Avanto): 2D HASTE, coronal 2D and 3D MCRP, axial VIBE-T1w before and 
during injection of CM. Statistical analysis (Matlab2010): Pearson, box plots, t 
test, Wilcoxon-test, Kruskal-Wallis
Results: The Wilcoxon test showed significant differences between the two 
groups (p=0.0001). The percentage of gadodiamide-enhancement resulted 
greater than gadoteric acid in each phase: T1_art (p=0.0058); T1_ven 
(p=0.001); T1_delayed (p=0.0018). The contrast noise-T2w (pre-post CM) was 
greater for gadodiamide than gadoteric acid in the IPMN (p=0.008) than in the 
Wirsung’s duct (p=0.0001)
Conclusion: Our study showed that gadodiamide could provide a stronger T1 
and T2 effects than gadoteric acid, which are needed for a better definition of 
IPMT and to assess morphological signs of malignant degeneration.
SS 1.08
Value of diffusion-weighted MR imaging in the diagnosis 
of lymph node metastases in patients with extrahepatic 
cholangiocarcinoma
K. Holzapfel, M. Loos, M. Eiber, E.J. Rummeny, J. Gaa; 
Munich/DE
Purpose: To evaluate diffusion-weighted MR imaging (DWI) in the diagnosis of 
lymph node metastases in patients with extrahepatic cholangiocarcinoma.
Material and Methods: In 24 patients with extrahepatic cholangiocarcinoma, 
MR imaging of the upper abdomen was performed prior to surgery (1.5T, 
Avanto, Siemens). DWI was performed using a respiratory-triggered single-
shot echo-planar imaging (SSEPI) sequence (b-values 50/300/600s/mm2). 
Apparent diffusion coefficient (ADC)-values and diameters of regional lymph 
nodes (LN) were determined. Subsequently, in all patients, surgical resection 
of the primary tumor and regional LN dissection were performed. Imaging 
results were correlated with results of histopathologic analysis. ADC-values 
and diameters of benign and malignant LN were compared using the Mann-
Whitney U test. In addition, a receiver operating characteristic (ROC) curve 
analysis was performed.
Results: The mean ADC-value (x10-3mm2/s) of metastatic LN (1.21±0.15) was 
significantly lower than that of benign LN (1.62±0.33, p<0.001) while there was 
no significant difference in the mean diameter of malignant (16.8±5.4 mm) and 
benign LN (14.1±4.0 mm; p=0.09). Using an ADC-value of 1.25x10-3mm2/s as 
threshold, 91.4% of LN were correctly classified as benign or malignant with a 
sensitivity/specificity of 83.3%/92.8% and a positive/negative predictive value 
of 66.7%/96.7%. The area under the ROC-curve was 0.93.
Conclusion: DWI using a respiratory-triggered SSEPI sequence is a promising 
imaging modality in the differentiation of benign and malignant LN in patients 
with extrahepatic cholangiocarcinomas.
SS 1.05
Reliable differentiation of malignant and benign 
intraductal papillary mucinous neoplasm – not an easy 
task
T.C. Walter, T. Denecke, L. Stelter, I.G. Steffen, C.M. Perez 
Fernandez, M. Bahra, B. Hamm, C. Grieser; Berlin/DE
Purpose: Retrospective evaluation of morphologic characteristics and 
differentiation of benign from malignant intraductal papillary mucinous 
neoplasm (IPMN) using CT and MRI.
Material and Methods: 42 patients (mean age, 63 years) with 61 imaging 
studies (CT, 14; MRI, 9; both, 19) were retrospectively evaluated. Three 
independent blinded observers (O1-3) were asked to evaluate each study with 
respect to previously published diagnostic imaging criteria (Sendai criteria – 
nodules, size, main duct involvement) and to grade the identified lesion or 
lesions as either benign or malignant. The diagnostic predictions were 
compared and correlated with the histological diagnoses (benign – IPMN/
Borderline, malignant – CIS/IPMC/solid tumors).
Results: Histology revealed 26 benign and 16 malignant lesions. The overall 
averaged accuracy of differentiation between benign IPMN and malignant 
IPMN was 82% for CT and 85% for MRI for all 3 observers (interobserver 
agreement: range 79-94% and 78-100%, respectively; p<0.05). Exclusion of 
cases with highly likely benign IPMN or solid tumors resulted in an overall 
averaged accuracy of 71% for CT and 68% for MRI (interobserver agreement: 
range 71-83% and 78-87%, respectively; p<0.05). Mural nodules and lesion 
size (>2.5 cm) were significant for malignant lesions (p=0.017 and p=0.02, 
respectively) whereas all other parameters were not found to be significant 
(p>0.05).
Conclusion: Differentiation of benign from malignant IPMN is possible with CT 
and MRI. However, if findings are equivocal, additional diagnostic measures 
are desirable before treatment decisions are made.
SS 1.06
The efficacy of diffusion weighted imaging for detection 
of acute pancreatitis and comparison of subgroups 
according to Balthazar classification
E. Yencilek1, S. Telli1, K. Meric1, A. Ozgur2, O. Cakir1, 
M. Simsek1; 1Istanbul/TR, 2Mersin/TR
Purpose: To measure pancreatic apparent diffusion coefficient (ADC) values in 
acute pancreatitis and compare with CT findings based on Balthazar 
classification.
Material and Methods: Fifty patients with the diagnosis of clinical pancreatitis 
were evaluated both with multidetector CT and MRI in 24 h of presentation. We 
calculated pancreatic ADC values with diffusion weighted imaging (b=0 and 
b=1000 mm2/sn). These values were compared with their normal counterparts 
(n=24). The patients with acute pancreatitis were subgrouped according to the 
Balthazar classification. The mean ADC values were calculated in each 
subgroup and they were compared with control group’s ADC values.
Results: The mean pancreatic ADC values in acute pancreatitis (1.19 x 10-3 
mm2/sn ± 0.32) was significantly lower than in the normal group (1.78 x 10-3 
mm2/sn ± 0.29) (p<0.001). In subgroup analysis, ADC values in each group 
were significantly lower than normal group (p<0,001). In addition, according to 
Balthazar classification, as severity of pancreatitis increases, lower ADC 
values were noted.
Conclusion: DWI with MRI and ADC values are helpful in diagnosis of all 
subgroups of acute pancreatitis. Due to lack of CT findings in grade A patients, 
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11:00 - 12:30 Room J
Scientific Session 2
Imaging of the rectum
SS 2.01
Comparison between air-balloon and gel defeco MRI
F. Mazzamurro, N. Al Ansari, V. Buonocore, V. De Marco, 
F. Maccioni; Rome/IT
Purpose: To prospectively compare two different techniques of rectal filling for 
Dynamic Pelvic Floor MRI (DPF-MRI) in 22 patients affected by pelvic floor 
disorders. In the first technique, the rectum was inflated with air using a Foley 
catheter, in the second one an echographic gel was used to fill the rectum.
Material and Methods: 22 consecutive patients (22 females), mean age 57 
years, with pelvic floor dysfunction underwent both rectal filling techniques 
during the same procedure. The two examinations were compared with regard 
to the evidence of rectocele, rectal invagination, cystocele, anorectal junction 
descent, enterocele and other pathologic findings.
Results: DPF MRI performed using gel detected 22 rectoceles, 18 invagination, 
6 enteroceles, 16 cystoceles, 2 pelvic diskinesia and 0 urethral hyperpermobility. 
DPF MRI performed using air filling detected 19 rectoceles, 16 invagination, 10 
enteroceles, 20 cystoceles, 0 pelvic diskinesia and 4 urethral hyperpermobility. 
Associated pelvic floor disorders of the urogenital and posterior compartment 
were detected in 60% patients with air and 50% of patients with gel.
Conclusion: Rectal filling with gel better evaluated pelvic diskinesia and 
rectocele, but it caused patient discomfort. The use of air depicted a larger 
number of cystoceles and urethral hypermobility, of enteroceles and of 
rectocele (19/22) most likely because it does not have a real evacuation phase. 
Although both techniques were able to detect three-compartment pelvic floor 
disorders, a higher sensitivity of air filling techniques was observed.
SS 2.02
Does quantitative diffusion-weighted and dynamic 
contrast-enhanced MRI predict pathological complete 
response after neoadjuvant chemoradiation therapy in 
rectal cancer patients?
A. Alconchel1, I. Sosnovskikh1, J. Garcia Bennett2, 
P. Summers1, G. Petralia1, M. Bellomi1; 1Milan/IT, 2Reus/ES
Purpose: To evaluate the potential of quantitative diffusion-weighted MRI 
(DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) to predict 
pathologic complete response (pCR) after neoadjuvant chemoradiation 
therapy (NACRT) in rectal cancer patients.
Material and Methods: 43 patients (mean age 61.7 years, range 40-81) with 
locally advanced rectal adenocarcinoma (T stage≥ T3, or N1-2) underwent T2-
weighted, DW-MRI and DCE-MRI on a 1.5T scanner, before and after NACRT 
before surgery. Regions of interest (ROIs) were manually drawn on rectal 
cancer by a radiologist on DW and DCE images in all slices where tumour was 
visible. For each ROI, mean transfer constant (Ktrans), rate constant (Kep) and 
leakage space (Ve), or apparent diffusion coefficient (ADC) values were 
calculated. Based on the pathologic stage on surgical specimen, patients were 
grouped into those who achieved pCR (ypT0ypN0) and non-responders (nR) 
(including local downstaging, no local downstaging or increase in local stage).
Results: Six patients (14%) were pCR and 37 (86%) nR at final histology. 
Baseline and post-therapy KTrans, Kep, Ve and ADC were not significantly 
different between pCR and nR patients. Overall KTrans and Kep significantly 
decreased and Ve and ADC increased after therapy, but no difference in 
percentage changes of these values were observed between pCR and nR 
patients.
Conclusion: In our cohort, quantitative DW-MRI and DCE-MRI did not identify 
patients who achieved pCR after NACRT in rectal cancer patients.
SS 1.09
Percutaneous cholecystostomy: single centre 
experience in 111 patients with an acute cholecystitis
R. Peters1, S. Braak1, S. Rakic1, M. Simoens1, 
S. Kolderman2; 1Almelo/NL, 2Veendam/NL
Purpose: To evaluate the safety and long-term outcome of percutaneous 
cholecystostomy (PC) under radiologic guidance for acute calculeous (ACC) 
and acalculeous cholecystitis (AAC).
Material and Methods: We performed a retrospective analysis of 111 patients 
who underwent PC from 2002 to 2011. Patients were divided into two groups: 
AAC and ACC. For all patients, comorbidity and American Society of 
Anesthesiologists (ASA) classification were determined. The indications, 
complications, recurrence rate and long-term outcome for both groups were 
analyzed.
Results: Twenty-four patients with AAC and 87 patients with ACC underwent 
PC. The procedure failed in 2 (1.8%) patients. There were 4 abscesses and 2 
fistulas post-PC. Drain dislodgment was found without sequelae in 8 patients. 
Elective cholecystectomy was performed in 35/111 (31.5%). 51 of 87 (58.6%) 
patients with gallstones underwent cholecystectomy; 36/87 (41.3%) did not 
undergo surgery either due to a too short follow-up or they died of non-biliary 
disease. In the AAC group, there was no recurrent cholecystitis in 17/24 
(70.8%) patients; 3/24 (12.5%) needed surgery later on and 4/24 (16.6%) 
patients died.
Conclusion: PC is a treatment with a low complication rate for patients with 
acute cholecystits who are considered to be at a high-risk for cholecystectomy. 
In patients with ACC, PC seems to be a valuable bridge to surgery, which will 
be required in the majority later on. In most of AAC-patients, no further 
treatment seems to be needed.
SS 1.10
ARFI of pancreatic cystic lesions
M. D’Onofrio, R. De Robertis, S. Canestrini, S. Crosara,  
E. Demozzi, R. Pozzi Mucelli; Verona/IT 
Purpose: To prospectively evaluate the results of ARFI (Acoustic Radiation 
Force Impulse) ultrasound in the study of pancreatic cystic lesions using 
different analysis methods, compared with the final diagnosis (pathological or 
by MRI/EUS findings).
Material and Methods: 38 patients with pancreatic cystic focal lesions were 
included in the study and underwent conventional US. For every patient 5 
measurements with Virtual Touch Quantification ROI were performed. In order 
to distinguish mucinous (potentially malignant) from serous cystic lesions 
(mainly benign) the result “XXXX/0” was considered meaning simple liquids 
(reportable to water), and the accuracy of Virtual Touch Tissue Quantification 
in differentiating cystic-pancreatic lesions was calculated. To consider the 
lesion as containing complex fluids, (potentially mucinous), two different 
reading methods were applied: at least two numerical values when performing 
five measurements; prevalence of numerical values irrespective of the number 
of measurements. Sensitivity, specificity, positive and negative predictive value 
and accuracy were calculated for the differential diagnosis between mucinous 
versus non-mucinous cystic lesions. .
Results: Sensitivity, specificity, PPV, NPV and accuracy in the group of cystic 
lesions by using the first reading method were respectively of: 68.8%, 77.3%, 
68.8%, 77.3%, 73.7%. Sensitivity, specificity, PPV, NPV and accuracy in the 
group of cystic lesions by using the second reading method were respectively 
of 37.5%, 100%, 100%, 68.8%, 73.3%..
Conclusion: ARFI can be useful in non-invasive characterization of pancreatic 
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SS 2.05
Apparent diffusion coefficient for discriminating 
metastatic from non-metastatic lymph nodes in primary 
rectal cancer
S.H. Kim, E.Y. Cho, J.H. Yoon, C.K. Eun; Busan/KR
Purpose: To investigate whether apparent diffusion coefficient (ADC) would be 
feasible to discriminate metastatic from non-metastatic lymph nodes (LNs) in 
patients with primary rectal cancer.
Material and Methods: 36 patients (male: 12, female: 24, mean age: 62.7, 
range: 37-82) who underwent 1.5-T MRI with DWI (b, 0 and 1000) and 
subsequent surgical resection were included. A blinded radiologist measured 
the ADC value in each regional LN on an ADC map after referring to T2-WI and 
DWI. The t-test was used to compare the mean ADC values of metastatic and 
non-metastatic LNs. ROC analysis was performed to calculate the diagnostic 
performance and to obtain the optimal cut-off value for the best accuracy for 
discriminating metastatic from non-metastatic LNs. Histopathologic results 
were used as the reference standard on a per-LN basis.
Results: 683 LNs were histopathologically identified. Of these, 116 LNs (46 
metastatic and 70 non-metastatic) were radiologic-pathologically matched and 
analyzed. The mean ADC of metastatic LNs (0.90 ± 0.15) was significantly lower 
than that of non-metastatic LNs (1.06 ± 0.22) (P<0.0001). The Az was 0.746 (95% 
CI, 0.655 to 0.822). When an ADC of 0.99×10-3 mm2/s was used as the cut-off, the 
accuracy of 72% was calculated for a sensitivity of 78% and a specificity of 67%.
Conclusion: ADC is feasible to discriminate metastatic from non-metastatic 
LNs in patients with primary rectal cancer, although the diagnostic accuracy is 
around 70%.
SS 2.06
Diffusion-weighted imaging in rectal cancer: 
comparison between 1.5 and 3T MR before, during and 
after neoadjuvant chemoradiotherapy
P. Lucchesi1, C.N. De Cecco1, M. Rengo1, M. Ciolina2, 
D. Caruso1, A. Laghi1; 1Latina/IT, 2Rome/IT
Purpose: To compare diffusion-weighted imaging (DWI) in patients with rectal 
cancer studied using 1.5 and 3T MRI in terms of DWI signal intensity (SI) and 
apparent diffusion coefficient (ADC) values.
Material and Methods: Twenty-two patients with rectal cancer consecutively 
underwent 1.5 and 3T MR examination before, during and after neoadjuvant 
therapy, which included DWI using a 1000 mm2/s b-values. DWI images were 
acquired using the following parameters: TR / TE, 667/70 ms, voxel size 2,3 x 
3 x 5 mm, 30 slices, gap 1 mm, acquisition time about 5 minutes. DWI SI and 
ADC values were evaluated by two expert readers in separate reading sessions 
placing a region of interest (ROI) within rectal cancer. Paired Wilcoxon tests 
were used to compare DWI values.
Results: No significant difference in ADC values was found before (3 T 0.83; 1.5 
T 0.84; p=0.16), during (3T 1.15; 1.5 T 1.17; p=0.16) and after (3T 1.24; 1.5 T 
1.25; p=0.48) neoadjuvant therapy. 1.5T rectal cancer SI was significantly lower 
(p<0.05) than SI values measured on 3T before (3T 325.14; 1.5 T 68.52) during 
(3T 207.30; 1.5T 58.24) and after (3T 130.77; 1.5 T 41.23) neoadjuvant therapy.
Conclusion: 3T DWI shows a significant increment in rectal cancer SI without 
difference in ADC measurement in comparison to 1.5T.
SS 2.03
High-resolution 3D T1-weighted imaging in nodal 
staging for locally advanced rectal carcinoma post 
chemoradiation – a lesion-by-lesion validation study
D. Mondal1, D.M. Lambregts2, L.A. Heijnen2, M.H. Martens2, 
R.G. Riedl2, G.L. Beets2, R. Beets-Tan2; 1Oxford/UK, 
2Maastricht/NL
Purpose: The aim of this study was to assess the advantage of 3D T1-
weighted gradient echo (3D-T1W GRE) imaging compared with routine 
multiplanar T2-weighted (T2W) imaging alone, for nodal re-staging following 
chemoradiation treatment in patients with locally advanced rectal cancer.
Material and Methods: Forty-one consecutive patients with locally advanced rectal 
cancer were retrospectively evaluated. An experienced reader scored each node as 
benign or malignant on T2W-MRI (1.5T) using a 5-point confidence level based on 
size, contour and signal heterogeneity. A week later, nodes were re-scored on 
3D-T1W GRE images with 1 mm2isotropic voxels. Each node was plotted on an 
anatomical map, ensuring exact lesion-by-lesion matching with histology.
Results: 609 nodes (39 N+, 570 N-) were harvested from the mesorectal fat, of 
which 195 (26 N+) could be identified on T2W-MRI versus 347 (31 N+) on 
3D-T1W-MRI. Sensitivity, specificity, positive and negative predictive values 
were 58%, 95%, 65% and 94% for T2W-MRI versus 39%, 97%, 60% and 
94% for 3D-T1W-MRI. Areas under the ROC-curve were 0.84 on T2W-MRI 
versus 0.75 for 3D-T1W-MRI (p=0.08).
Conclusion: Negative lymph nodes can be accurately predicted on MRI with 
a high NPV of >90%. Although it does not improve the diagnostic performance 
for differentiating between benign and malignant nodes, the benefit of 3D-T1W 
imaging compared with T2W MRI is that it increases the conspicuity and 
number of detected nodes.
SS 2.04
Diagnostic performance of semi-quantitative 
parameters of dynamic contrast-enhanced MRI for the 
selection of good responders after chemoradiation for 
rectal cancer
M.H. Martens, S. Subhani, M. Maas, L.A. Heijnen, 
D.M.J. Lambregts, A. Zur Hausen, G.L. Beets, E. Kluza, 
R.G.H. Beets-Tan; Maastricht/NL
Purpose: Response assessment after chemoradiotherapy (CRT) in rectal 
cancer remains difficult. Aim of this study was to investigate if semi-quantitative 
analysis of dynamic contrast-enhanced (DCE) MRI, using the blood-pool 
contrastagent gadofosveset, can identify good responders after CRT.
Material and Methods: Fifteen patients with locally advanced rectal cancer 
received DCE-MRI both before and 8 weeks after CRT. Kinetic parameters, i.e. 
initial slope, initial peak, time to peak, final slope, and area under the first 60, 
90, and 120s of the enhancement curve (IAUC60, IAUC90, IAUC120) were 
determined from relative signal enhancement-time curves. Receiver operating 
characteristics (ROC) curves were used to assess diagnostic performance. 
Good responders (n=8) were defined as patients with tumor regression grade 
(TRG) of 1 or 2 at histopathology. Poor responders showed a TRG of 3-5 (n=7).
Results: Significant differences between good and poor responders were found 
for post-CRT semi-quantitative parameters and also change in parameters. The 
initial slope, initial peak, ∆iAUC60, ∆iAUC90, and ∆iAUC120 were significant 
predictors for a good response after CRT. The most accurate parameter was the 
∆iAUC90 with the area under the ROC curve ranging from 0.88 to 0.91.
Conclusion: Semi-quantitative parameters of dynamic contrast-enhanced 
MRI are promising tools for predicting response after chemoradiotherapy in 
patients with rectal cancer. Best predictor for good response was the change 
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SS 2.09
Preoperative local staging of rectal cancer using 2D 
T2-weighted FSE sequence and diffusion-weighted MR 
imaging with b-multiple SE-EPI at 3T-device
F. Donati, P. Boraschi, E. Marciano, G. Gherarducci, 
F. Pacciardi, R. Gigoni, E. Neri, F. Falaschi, C. Bartolozzi; 
Pisa/IT
Purpose: To evaluate the image quality and diagnostic performance of two-
dimensional T2-weighted FSE sequence and diffusion-weighted imaging 
(DWI) in the local staging of rectal cancer at 3T-device.
Material and Methods: Phased-array MRI was performed in 26 consecutive 
patients with biopsy-proven rectal cancer. High-resolution two-dimensional 
T2-weighted FSE images in the sagittal, coronal, axial and axial oblique planes 
and DWI using an axial spin-echo echo-planar sequence with multiple b values 
(150, 500, 1000, 1500 s/mm2) were obtained at 3T-device (GE DISCOVERY 
MR750;GE Healthcare). A set of T2-weighted images and a combined set of 
T2-weighted and DW images were evaluated by two experienced radiologists 
in consensus with regard to local disease. A quality assessment of image 
datasets was also performed by the observers using a five-point scale. Total 
mesorectal excision surgery was used as the standard of reference.
Results: Twenty patients who underwent a total mesorectal excision were 
enrolled in this study. Image quality was considered excellent on T2-weighted 
images, and good on DWI. The sensitivity and diagnostic accuracy of DWI 
combined with T2-weighted imaging for prediction of extramural tumor spread 
(92% and 88%, respectively) were significantly higher than those of T2-
weighted imaging alone (67% and 65%). In particular, the measurement of the 
distance between the lesion and mesorectal fascia improved significantly after 
additional review of DWI (p<0.05).
Conclusion: DWI in addition to T2-weighted MR imaging can improve the 
local staging of rectal cancer at 3T.
SS 2.10
Does gadolinium improve accuracy of T4 diagnosis at 
MRI evaluation of rectal cancer?
M.J. Gollub1, Y. Lakhman1, K. McGinty2, M. Weiser1, 
A. Trakarnsanga1, J. Zheng1, M. Sohn1, C. Moskowitz1, 
J. Shia1, P.P. Paty1, J.G. Guillem1, G. Nash1, L. Temple1, 
K. Goodman1, L. Saltz1, D. Reidy1, N. Segal1, J. Garcia-
Aguilar1; 1New York, NY/US, 2Danville, PA/US
Purpose: To compare reader accuracy with and without gadolinium in the 
detection of T4 rectal cancer.
Material and Methods: From a rectal cancer surgical database (1998-2009), 
patients were randomly selected who had MRI scans with/without gadolinium 
prior to surgery and clinical T3/T4 disease or known recurrent rectal cancer. 
Three radiologists blinded to pathology and disease stage independently 
interpreted all MRI using either noncontrast images alone or combined with 
contrast images, with an interval between sessions of 4 weeks. Multiplanar 
views from a 1.5T magnet were observed. Readers evaluated involvement of 
surrounding structures on a 0-4 confidence scale. Pathology was the gold 
standard. Overall and site-specific sensitivity, specificity, NPV and PPV were 
calculated. ROC curves were constructed and AUC values derived.
Results: Ninety patients (mean age 59 years) included 4 T2, 49 T3 and 39 T4 
stage rectal cancers. 29 organs were invaded including (2 bladders, 10 
vaginas, 6 sidewall, 2 sphincters, 3 seminal vesicles and 6 prostates). Overall 
AUC without and with gadolinium were .74/.78, .85/.85, .80/.74 for readers 1, 
2, 3, respectively. The most experienced reader had overall se/sp/PPV/NPV 
.74/.70,.87/84, .65/.59, .91/.89 without and with gadolinium respectively. AUC 
pre- and post-gadolinium for global and site-specific readings were not 
statistically different.
Conclusion: Gadolinium did not improve accuracy of T4 diagnosis during MRI 
for rectal cancer.
SS 2.07
Evaluation for rectocele patients based on the 
defecographic findings. How is it useful for surgery by 
these results?
H.J. Jeon1, U.C. Park2, H.S. Park1, Y.J. Kim1, S.I. Jung1, 
S.J. Park3; 1Seoul/KR, 2Chungju/KR, 3Goheung-Gun 
Chollanamdo/KR
Purpose: Defecography and a dynamic imaging modality play an important 
role in the diagnosis of functional and morphologic abnormalities in patients 
with chronic constipation. Current study was designed to assess the 
physiologic characteristics and clinical significance of rectocele patients with 
functionally obstructed defecation. Moreover, outcome of treatment was 
analyzed based on the physiologic characteristics.
Material and Methods: 553 patients studied defecography and 
cinedefecography, anal manometry (n=237), colonic transit time study (n=85), 
155 female rectocele patients found to have significant rectocele. Diagnostic 
criteria of significant rectocele were a poor rectal emptying of barium paste 
from bulged outpocket of anterior rectum with a more than 3 cm, simultaneously, 
despite maximal trial of simulated defecation. The findings of defecography 
are as two types of anterior rectocele, “distension” of Type 1 (Group 1, n=102) 
and “displacement” or “deformity” of Type 2 (Group 2, n=53).
Results: In Group 1, clinical symptoms of obstructed defecation was not 
infrequently detected in comparison to Group 2 patients (p<0.01). In Group 2, 
patients showed a significantly higher frequency of the symptoms of pelvic 
outlet obstruction than in Group 1 patients (p<0.001). Current results showed 
improved outcome as compared with previous results of surgery before we 
had made these subclassification (97.0% vs. 85.7%, respectively, p<0.01).
Conclusion: We report defecographic features of rectocele findings. Careful 
selective surgical indications by using defecography are essential for the 
successful result.
SS 2.08
Is there a correlation between quantitative and 
qualitative parameters for dynamic contrast-enhanced 
MRI in rectal cancer?
M.H. Martens1, N. Papanikolaou2, E. Kluza1, L.A. Heijnen1, 
D.M. Lambregts1, M. Maas1, G.L. Beets1, R.G.H. Beets-Tan1; 
1Maastricht/NL, 2Heraklion/GR
Purpose: Recently several studies have been performed using dynamic 
contrast-enhanced MRI (DCE-MRI) in the response prediction for rectal cancer. 
However, both qualitative analyses (i.e. Wash in, wash out, peak enhancement) 
as quantitative analyses (i.e. Ktrans, Kep, Ve, Vp) are reported in current literature. 
The aim of this study was to compare the qualitative analysis method with the 
quantitative analysis method in rectal cancer patients.
Material and Methods: Twenty patients were included: 10 patients with DCE-
MRI of the primary tumor, and 10 after neoadjuvant chemoradiation (post-
CRT). Regions of interest were placed in the tumor and all parameters were 
measured. Pearson correlation test was used for comparison between the 
parameters. P-value <0.05 was considered statistically significant.
Results: Peak enhancement of the signal intensity curve showed strong 
correlation with Ktrans (r=0.74-0.80, p<0.01), moderate to strong correlation with 
Kep (r=0.62-0.75, p=0.04), and moderate correlation with Ve (r=0.62-0.70, 
p=0.04). Vp showed moderate to strong correlation with wash in (r=0.68-0.79, 
p=0.01).
Conclusion: There is a correlation between the quantitative and qualitative 
parameters derived from DCE-MRI. Of interest was the strong correlation that 
exists between Ktrans and peak enhancement of the signal intensity curve, 












SCIENTIFIC SESSIONS / WEDNESDAY, JUNE 5, 2013
 S480
SS 3.03
Withdrawn by the authors
SS 3.04
Increased flip angle for functional liver imaging with 
Gd-EOB after right sided portal venous embolization
T. Denecke, D. Geisel, M. Stockmann, B. Hamm, 
B. Gebauer; Berlin/DE
Purpose: To prospectively evaluate the effect of an increased flip angle (FA) of 
a T1- weighted fat saturated 3D-sequence for the measurement of hepatocyte 
uptake of Gd-EOB-DTPA MRI after right portal vein embolization (PVE).
Material and Methods: 10 patients who received a PVE prior to an extended 
hemihepatectomy were examined 14 days after PVE using Gd-EOB-DTPA-
enhanced MRI of the liver using the standard FA of 10° and the increased FA of 
30°.
Results: Relative enhancement of the right liver lobe (RLL) was 0.52 ± 0.12 for 
10° and 1.41 ± 0.39 for 30°, and the left liver lobe (LLL) was 0.58 ± 0.11 for 10° 
and 2.05 ± 0.61 for 30°. Relative enhancement of the RLL was significantly 
higher for 30° than for 10° (p = 0.009) and significantly higher in the 30° than in 
the 10° sequences (p = 0.005) for the LLL.
Conclusion: A flip angle of 30° increases the contrast between liver partitions 
with and without portal venous embolization. Thereby, the sensitivity for 
differences in uptake intensity is increased. This could be of value for a more 
exact determination of differences in regional liver function and, consequently, 
the estimation of the future remnant liver function.
SS 3.05
Diagnostic accuracy of dual energy CT in the evaluation 
of residual tumor within 24 h after RF ablation: ROC 
analysis
F. Vandenbroucke1, S. Van Hedent1, N. Buls1, K. Nieboer1, 
D. Belsack1, P. Ros2, J. De Mey1; 1Brussels/BE, 
2Cleveland, OH/US
Purpose: To evaluate the diagnostic accuracy of single source dual energy CT 
(DECT) within 24 h after RF ablation compared to the first follow-up imaging 
after 8-10 weeks.
Material and Methods: Thirty-three patients with 38 malignant lesions (20 
liver, 10 kidney, 8 lung) were scanned within 24 h after RF ablation with DECT 
technique to evaluate possible local tumor progression (LTP). The DECT data 
were reconstructed as monochromatic 70 keV images, grayscale iodine 
density and color-coded iodine density images. Two independent readers 
were asked to rate their confidence in the presence or absence of residual 
tumor. The results were compared with the follow-up imaging after 8-10 
weeks. Multireader multicase receiver operating characteristic (ROC) analysis 
was performed with the area under the curve and 95% confidence intervals 
(CI) as metric for diagnostic accuracy.
Results: Ten out of 38 (26.3%) lesions showed LTP at 8-10 weeks. The mean 
area under the curve was 0.84 (CI: 0.75-0.93) for 70keV, 0.80 (CI: 0.67-0.93) for 
grayscale iodine density and 0.78 (CI: 0.65-0.90) for color-coded images. 
There was no significant difference observed between the three reconstruction 
techniques (p=0.08).
Conclusion: DECT can be used to make an early evaluation within 24 h after 
RF ablation. Results for interpretation of LTP are equal to the reconstruction 
techniques used in DECT.
11:00 - 12:30 Room F
Scientific Session 3
Liver imaging: Technical performance
SS 3.01
High-resolution fat suppressed 3D T1-weighted imaging 
using a dual-echo Dixon technique and a high-
acceleration parallel acquisition for gadoxetic acid-
enhanced liver MR imaging at 3T
J.H. Yoon, J.M. Lee, M.H. Yu, E.J. Kim, J.K. Han, B.I. Choi; 
Seoul/KR
Purpose: To determine whether multi-echo Dixon (mDixon) 3D T1-weighted 
(T1W) gradient-recalled-echo (GRE) technique with a high-acceleration parallel 
acquisition can provide better image quality than conventional 3D-fat 
suppressed (FS)-T1W- GRE for gadoxetic acid-enhanced liver MRI at 3T.
Material and Methods: This retrospective study was approved by our 
institutional review board, and informed consent was waived. 138 patients 
with suspected hepatic focal lesions underwent gadoxetic acid-enhanced liver 
MRI at 3T, including dynamic imaging using either high-resolution mDixon 3D 
technique (n=70). Hepatobiliary phase (HBP) imaging was obtained using 
standard eTHRIVE with acceleration factor (AF) of 2.6, high-resolution eTHRIVE 
and mDixon with AF of 5. The image quality of the arterial, portal and HBP 
image sets of both groups was graded independently using a five-point scale 
by two radiologists and they reached a final consensus.
Results: High-resolution mDixon images with AF 5 provided better overall 
image quality than eTHRIVE with AF 2.6 and AF 5 (p<0.05). In addition, among 
the three HBP image sets, mDixon showed significantly less pixel graininess 
and better fat suppression than eTHRIVE with AF 5 (p<0.05), despite of similar 
performance in terms of lesion or anatomic structure conspicuity compared 
with eTHRIVE with AF 5.
Conclusion: Use of high-acceleration parallel acquisition factor and mDixon 
sequence can provide high-resolution T1WI with better image quality and fat 
suppression than that of conventional 3D-FS-T1GRE sequence.
SS 3.02
Inter and intra-observer reproducibility of MRI for the 
measurement of NET liver metastases
J. Arfi Rouche, C. Caramella, S. Foulon, A. Laplanche, 
E. Baudin, C. Dromain; Villejuif/FR
Purpose: Assessment of treatment is based on metastases size measurement. 
Our goal was to determine the intra and inter-observer reproducibility of each 
MRI sequence for the measurement of NET liver metastases.
Material and Methods: 32 patients with NET liver metastases underwent 1.5-
T MR imaging of the liver [T2W and T1W sequences before and after the 
injection of gadolinium on hepatic arterial (HAP) and portal venous phase 
(PVP)]. A maximum of 5 target lesions by patient was chosen by one reviewer 
on the MR sequence allowing the better depiction. Then measurements of 
target lesions diameter were performed by 3 reviewers blindly and 
independently in two sessions with a delay of one month.
Results: 3384 measurements were made (141 metastases, mean 4.4 per 
patient). The MR sequence allowing the better depiction of the target lesions 
was T2W in 81% of patients. Non-measurable lesions were significantly higher 
on HAP and PVP compared to unenhanced T1 and T2W (p<0.001). T2W 
sequence had the higher overall intra- and inter-observer inter-class correlation 
coefficient (0.99 and 0.98) but without significant difference compared to other 
sequences. No statistical difference was found between the senior and the 
junior radiologists.
Conclusion: MRI allows reproducible measurements with low inter and intra-
observer variability. Unenhanced T2W sequence should be considered as the 
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SS 3.08
Acoustic radiation force impulse imaging in pediatric 
population: normal liver values?
L.B. Barbosa, H. Matos, M.J. Noruegas; Coimbra/PT
Purpose: Until now, the range of shear wave values (SWV) of the normal liver, 
obtained using the ARFI technique, in a pediatric population were not defined. 
We aimed to define the range of normal values in different age groups and 
gender evaluating differences resulting from the methodological approach.
Material and Methods: Between July and December 2011, we prospectively 
evaluated 90 healthy children (54 girls, 36 boys), with an age range of 2 months 
to 17 years. All studies were performed using the Acuson S2000 equipped with 
ARFI and SWV quantification. Age, gender, ROI depth, liver lobe were analyzed 
using different methodological approaches.
Results: Mean SWV value was 1.09±0.18 m/s (0.57 - 1.50 m/s). Significant 
differences were found between different age groups, respectively: 1.10±0.09 
m/s to 0– 6 years; 1.09±0.09 m/s to 6– 12 years and 1.07±0.11 m/s to 12– 17 
years. The mean SWV for right lobe was 1.06±0.10 m/s and for left lobe 
1.18±0.15 m/s (p<0.05). Differences between superficial (1.17m/s) and deeper 
interrogation (1.10 m/s, 1.07 m/s and 1.02 m/s - with increasing depth) were 
significant (p<0.05).
Conclusion: We found a mean liver SWV value of 1.09±0.18 m/s in a normal 
pediatric population, ranging between 0.57 and 1.50 m/s. Depth of tissue 
interrogation and the ROI placement for SWV calculation (right/left lobe) may 
influence the results. For standardization, we propose that the SWV should be 
measured at right lobe, avoiding superficial and deep locations.
SS 3.09
Low-voltage CT of the abdomen: to identify cutoff 
patient diameters for patient selection through the 
analysis of the correlation between patient diameters 
and subjective image quality
M.C. Ambrosetti, G.A. Zamboni, F. Lombardo, R. Pozzi 
Mucelli; Verona/IT
Purpose: To identify cutoff patient diameters optimal for low-voltage scans 
through the correlation between patient diameters and subjective image 
quality in low-voltage and standard-voltage CT of the upper abdomen in the 
same patient population.
Material and Methods: 32 patients underwent MDCT of the abdomen with 
arterial phase at 80 kV with angular dose modulation on 64-row MDCT (test 
group). These examinations were compared with a previous 120kV scan on the 
same scanner. Patient transverse and sagittal diameters were measured at 
celiac axis level, and the mean was calculated. Two radiologists by consensus 
graded image quality on a 5-point scale (5=excellent; 1=non-diagnostic; 3 was 
the chosen cutoff quality). Image quality was correlated to the transverse, 
sagittal and mean diameter with ANOVA test.
Results: Patient diameters did not change across examinations (all p=ns). In 
low-voltage scans, image quality was significantly correlated to sagittal 
(p=0.034) and mean diameters (p=0.025), and only a trend to significance was 
observed for transverse diameter (p=0.053). In 120 kV scans, there was no 
significant correlation between image quality and patient diameters, and all 
patients received grade 4 or 5. In 80 kV scans, a subjective grade 3 
corresponded to a transverse diameter of 329 mm and a sagittal diameter of 
267 mm.
Conclusion: Patient size appears to influence subjective image quality more in 
low-voltage scans than in standard-voltage scans. For our protocol, cutoff 
diameters for diagnostic image quality are transverse 329 mm and sagittal 267 
mm.
SS 3.06
Depiction and characterization of liver metastases in 
18F-FDG PET/MRI: comparison to PET/CT
K. Beiderwellen1, B. Gomez1, V. Hartung-Knemeyer1, 
C. Buchbender2, F. Nensa1, H. Kuehl1, A. Bockisch1, 
T.C. Lauenstein1; 1Essen/DE, 2Düsseldorf/DE
Purpose: To evaluate the value of PET/MRI in the diagnosis of liver lesions in 
patients with solid malignancies.
Material and Methods: 70 patients (31 women, 39 men) with known solid 
tumors underwent full-dose contrast-enhanced PET/CT with 18F-FDG 
(Biograph mCT 128, Siemens). The patients subsequently underwent whole-
body contrast-enhanced PET/MRI (Biograph mMR, Siemens). The PET/MRI 
protocol comprised: 1) T1 FLASH pre-contrast, 2) T2 HASTE, 3) DWI, 4) T1 
FLASH post-contrast. The datasets were evaluated by two radiologists. Every 
depicted lesion was rated for conspicuity (4-point ordinal scale) and diagnostic 
confidence (5-point ordinal scale). Statistical analysis was performed using 
Wilcoxon’s signed rank test.
Results: A total of 97 lesions were detected (malignant n=26; benign n=71). 10 
patients had malignant liver lesions, whereas benign liver lesions were found in 
26 patients. Using PET/MRI, all lesions could be depicted, whereas 9 benign 
lesions were not detected in the PET/CT datasets. Lesion conspicuity was 
significantly higher for PET/MRI (PET/MRI: 2.91 ± 0.30 [95% CI: 2.87 - 2.95]; 
PET/CT: (2.36 ± 0.92 [95% CI: 2.23 - 2.49]; p < 0.0001). For malignant liver 
lesions diagnostic confidence was significantly higher (PET/MRI: 4.81 ± 0.45 
[95% CI: 4.64 - 4.98]; PET/CT: 4.52 ± 0.58 [95% CI: 4.30 to 4.74]; p < 0.0001).
Conclusion: PET/MRI provides significantly higher lesion conspicuity and 
diagnostic confidence for liver lesions, offering a high-potential alternative to 
PET/CT.
SS 3.07
Performance of shear wave elastography for 
assessment of liver fibrosis: correlation with histological 
staging and quantification
T. Lefort, G. Renosi, O. Guillaud, J. Dumortier, J. Scoazec, 
A. Guibal; Lyon/FR
Purpose: To evaluate the performance of shear wave elastography (SWE) for 
the quantification of liver fibrosis. Liver biopsy staging and quantification was 
used as the standard reference.
Material and Methods: Consecutive patients with various chronic liver 
diseases were prospectively included. On the same day, ultrasound SWE 
(Aixplorer, Supersonic Imagine, Aix-en-Provence, France), transient 
elastography (TE) using Fibroscan (Echosens, Paris, France), and subsequent 
liver biopsy were performed. Histologic analysis included staging according to 
the METAVIR score and digital quantification of the fibrosis area.
Results: Fifty-five patients were included for analysis. Chronic liver conditions 
included liver transplantation follow-up (n=21), non-alcoholic steatohepatitis 
(n=13), viral chronic hepatitis B or C (n=9), alcoholic liver disease (n=2), auto-
immune hepatitis (n=2), chronic biliary disease (n=2), and others (n=6). Area 
under the ROC curve (with 95% confidence interval) for SWE and TE, 
respectively, were: 0.92 (0.81-0.98) and 0.91 (0.80-0.97) for F score ≥2, 0.92 
(0.81-0.97) and 0.90 (0.79-0.96) for F≥3, 0.97 (0.88-0.99) and 0.97 (0.88-0.99) 
for F4. Liver stiffness measured with SWE and TE was significantly correlated 
with the fibrosis area: Spearman’s coefficient was 0.76 and 0.65 (p<0.0001), 
respectively.
Conclusion: SWE can be used as a non-invasive method for quantification of 
liver fibrosis. Liver stiffness was significantly correlated with histologic digital 
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Comparison of percutaneous portal vein embolization, 
portal vein ligation and portal vein occlusion combined 
with ipsilateral hepatic artery cannula implantation prior 
to major liver resection
P. Pajor, O. Hahn, I. Dudas, A. Zsirka-Klein, P.K. Kupcsulik; 
Budapest/HU
Purpose: To evaluate the results of percutaneous portal vein embolisation 
(PVE), portal vein ligation (PVL) and portal vein ligation combined with hepatic 
artery chemotherapy (PVL+can) prior to extended hepatectomy.
Material and Methods: Between 2004 and 2012, 140 patients presenting with 
multiple or large liver malignacies were included. Future liver remnant volume 
(FLR) of these patients after the planned extended hepatectomy was less than 
30% (normal liver), or 40% (cirrhotic liver). To increase the FLR, portal vein 
occlusion techniques (51 PVE, 89 PVL alone, or PVL combined with hepatic 
artery cannula implantation into the ipsilateral hepatic artery - PVL+can) were 
performed. They were evaluated with MDCT including volume assessment, 
before and 8 weeks after these procedures.
Results: 112/140 patients became resectable (PVE; PVL; PVL+can; 74.3%; 
80%; 88.5%). FLR increase 8 weeks after PVE, PVL or PVL+can was 17.6%, 
16.5%, 19%, the complication rate of the various portal occlusion techniques 
were 4.5%, 3.6%, 11.5%, respectively. At least 4 segments were resected 
during hepatectomy. Overall postoperative morbidity and mortality rates were 
13% and 2.5%, respectively. Postoperative complication and mortality rates 
did not differ significantly in the 3 groups.
Conclusion: Patients with previously unresectable liver tumors can benefit 
from resection after all kind of portal occlusion techniques. Although 
complication rate of portal occlusion combined with hepatic artery cannula 
implantion is higher, more patients become resectable due to higher increase 
rate of FLR in this group.
SS 4.02
Problem solving and aberrant anatomy in selective 
internal radiotherapy
D. Mullan, N. Kibriya, H. Laasch, P. Manoharan, 
J.A. Lawrance; Manchester/UK
Purpose: To discuss the incidence, consequences and outcomes of abnormal 
arterial anatomy in selective internal radiotherapy (SIRT) for liver metastases.
Material and Methods: 106 patients underwent SIRT work-up angiography 
between 21/9/5 and 14/6/12 at our institution. Angiograms and post-
angiography Tc-99 uptake scans were retrospectively reviewed to record 
arterial anatomical variants, radio-isotope uptake, and the effect these had on 
planning and performing treatment. Procedural and periprocedural 
complications were recorded.
Results: 57/106 patients had abnormal anatomy. 7/106 were deemed 
unsuitable for SIRT treatment following work-up angiography due to the 
effects of abnormal anatomy. Chronologically, 4 of these were within the first 
19/106 procedures at this institution, suggesting a learning curve when dealing 
with aberrant vasculature. 51/57 proceeded to treatment. 5/51 required an 
additional work-up and coil embolisation due to varied anatomy or initial extra-
hepatic uptake. 2 patients required a two stage treatment to right and left lobes 
due to hepatic tumour burden and the risk of radiation hepatitis. 1 patient died 
prior to treatment.
Conclusion: Abnormal is the new 'normal' when considering hepatic arterial 
anatomy. Vascular variants will directly influence all cases and can preclude 
treatment. There appears to be a learning curve involved when dealing with 
abnormal anatomy, and understanding the effects aberrant anatomy can have 
will increase the probability that a patient will be deemed suitable for SIRT.
SS 3.10
Controlled attenuation parameter compared with 1H-MR 
spectroscopy for liver fat content measurement: a pilot 
study
J.H. Runge, A.E. Bohte, A.J. Nederveen, U. Beuers, 
J. Stoker; Amsterdam/NL
Purpose: Recently, a new FibroScan device featuring the controlled 
attenuation parameter (CAP)-value has been introduced. The CAP-value is a 
quantitative measure of liver fat content, so far only compared with semi-
quantitative steatosis grade at biopsy, with a Spearman’s Correlation 
Coefficient of 0.51 (p<0.001). The purpose of this study was to compare CAP-
values with quantitative liver fat percentages (LF-%) measured with 1H-MR 
Spectroscopy (1H-MRS).
Material and Methods: Sixteen patients were included in a study investigating 
CAP-value and 1H-MRS in viral hepatitis. All patients had CAP and 1H-MRS 
performed on the same day. MR spectra were measured with a PRESS 
sequence (TE/TR: 38/3000ms) at 3T MRI and individual T2-correction was 
performed. Data were described as median (range). CAP-values and LF% 
were compared using Spearman’s correlation coefficient (rs).
Results: CAP-values and LF% were available in 15/16 patients whose median 
age and BMI were 51 (22-76) and 24.7 (22.3-31.6), respectively. Median CAP 
and LF% were 250 (123-328) and 1.6 (0-12.7). Correlation rs between CAP and 
LF% was 0.797 (p<0.001).
Conclusion: Our CAP results show a higher correlation with 1H-MRS-derived 
fat percentage as compared with current literature describing correlation of 
CAP with liver biopsy derived steatosis grade. If this is substantiated in a larger 
cohort comparing CAP with 1H-MRS, CAP-measurement could be established 
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SS 4.05
Trans-arterial embolization through intra-arterial 
injection of Ethiodol: results and follow up
F. Somma, R. D'Angelo, M. Marracino, R. Grassi, F. Fiore; 
Naples/IT
Purpose: Hepatocellular carcinoma is nowadays the third leading cause of cancer 
deaths worldwide, with over 500,000 people affected, while liver metastases are 
common in a wide range of malignancies, especially in patients with gastrointestinal 
cancers. A variety of treatment modalities have been reported including resection, 
transarterial chemoembolization, external irradiation, radiofrequency or ethanol 
ablation. Our aim is to retrospectively evaluate the efficacy and safety of 
transarterial embolization of hepatic malignancies using a 1:1 mixture of ethanol 
and lipiodol (Ethiodol), compared with other procedures.
Material and Methods: 39 patients (30.8% male; 69.2% female; range of age 
36-86 years) with documented hepatic lesions of size 1.4 to 5.4 cm were 
elected to transarterial chemoembolization using a mixture of 50 mg Epirubicin 
and 5 cc Lipiodol or transarterial embolization using Ethiodol, injected directly 
in the tumor-feeding arteries after super-selective catheterization, followed by 
the injection of 70-150 µ polyvinyl-alcohol solution.
Results: Chemoembolization and embolization therapies were performed, 
respectively, in 19 and 20 patients. 1 month after the procedure, a Multislice 
Computed Tomography (MSCT) showed in all patients at least partial 
response to RECIST1.1 and EASL criteria, while in 24 cases, a complete 
resolution was observed.
Conclusion: Compared to transarterial chemoembolization, the procedure using 
Ethiodol showed similar radiological outcomes at 1-month MSCT but less toxicity, 
which makes it useful in patients with more than one lesion or in case of relapse.
SS 4.06
Use of the Fong criteria to predict local recurrence after 
radiofrequency ablation of colorectal liver metastases: a 
retrospective review
A. Wale, J. McCall, N. Wijesekera, N. Khan, K. Shahabuddin, 
G. Brown; Surrey/UK
Purpose: The Fong criteria have been shown to predict outcomes after 
hepatic resection. We evaluated these criteria in the context of radiofrequency 
ablation (RFA) of colorectal liver metastases.
Material and Methods: 59 patients with colorectal liver metastases had RFA 
to 101 colorectal liver metastases between 2005 and 2011.
Results: 52% of lesions (53/101) developed local recurrence at the site of RFA. 
60% of local recurrence occurred within the first 3 months after RFA (32/53). 
On univariate binary logistic regression, the only significant factor which 
affected local recurrence was the disease-free interval from primary to liver 
metastases <12 months (OR 4.36, 95% CI 1.45-13.17, p=0.009). The disease 
free interval from primary to liver metastases <12 months was also the only 
significant factor which affected local recurrence on multivariate binary logistic 
regression (OR 3.8, 95% CI 1.21-11.88, p=0.022). The remaining factors 
(node-positive primary, number of hepatic tumours >1, largest hepatic tumour 
>5 cm, largest hepatic tumour >3 cm, carcinoembryonic antigen level >200 ng/
ml) did not significantly predict for local recurrence in this series. Cox 
proportional hazards model found no factors were significant predictors of 
time to progression.
Conclusion: In this small series, disease-free interval from primary to liver 
metastases <12 months was the only significant predictor of local recurrence. 
This has implications for patient counselling before RFA as it demonstrates 
that, as with hepatic resection, metachronous tumours have a better outcome 
after RFA.
SS 4.03
Hemorrhagic complications after percutaneous 
radiofrequency ablation of liver tumors: understanding 
of clinico-radiologic manifestation
J.Y. Lee, J.H. Kim, J.M. Lee, B.I. Choi; Seoul/KR
Purpose: To investigate hemorrhagic complications after percutaneous 
radiofrequency ablation (RFA) of liver tumors through understanding of its 
clinico-radiologic manifestation.
Material and Methods: From 2003 to 2012, 2218 patients underwent RFA in 
our institute. Among them, 19 patients (0.8%) had diverse hemorrhagic 
complications that were detected at immediate post-RFA 16-channel dynamic 
MDCT. Angiography was performed in 14 patients (74%) and embolization in 8 
patients (42%). Ten patients (53%) were cured with conservative management. 
The type, location, and CT findings of bleeding, interval between RFA and 
symptom onset, the relationship between laboratory findings and bleeding to 
be treated and clinical course were analyzed.
Results: Bleeding sites were intercostal artery (n=4), internal mammary artery 
(n=5), segmental hepatic artery (n=3), needle entry site of the liver (n=6), and 
unidentified vessel (n=1). Embolization was performed in 25% of free active 
leak (2/8), 83% of localized active leak (5/6), none of bleeding without active 
leak (0/4), and one patient with hemobilia (1/1). The shape of extravasations 
was curvilinear along the margin of diaphragm or chest wall or irregular in 
course. The mean interval between RFA and blood pressure drop was 94 
minutes (range, 64-165 minutes). All patients except one were successfully 
treated with embolization or conservative management.
Conclusion: The understanding of clinico-radiologic findings of post-RFA 
hemorrhagic complications may be helpful to easily detect it and accurately 
predict its clinical course.
SS 4.04
Safety and efficacy of percutaneous radiofrequency 
ablation of recurrent colo-rectal cancer liver metastases 
after hepatectomy
C. Valls, D. Leiva, S. Ruiz, L. Martinez Carnicero, L. Llado, 
A. Rafecas, E. Ramos; Barcelona/ES
Purpose: To assess the results, complications and clinical role of RFA in the 
treatment of recurrent colorectal liver metastases.
Material and Methods: Between 2005 and 2012, 59 patients (95 lesions) with 
colorectal metastases recurrence after surgery, were treated with RFA 
procedures if resection was not possible or the patient was not fit for surgery. 
Efficacy of ablation was assessed with CT at 1 month and every 6 months. The 
mean number of liver tumours per patient was 1.5 and mean tumour diameter 
was 2.3 cm (range, 0.6-5.8 cm). In 37.5% of the cases, lesions had a 
subcapsular location and 34% were close to a vascular structure.
Results: The morbidity rate was 18.7 %. Extrahepatic recurrence appeared in 
50% of the patients. Local recurrence at the site of ablation appeared in 18% 
of the lesions. Local recurrence rate was 7% in lesions less than 3 cm and 52% 
in lesions larger than 3 cm. Actuarial survival rates at 1, 3 and 5 years were 
94.5%, 65.3% and 21.7%.
Conclusion: Although our series include a selected population with poor 
prognosis, overall survival is comparable to surgical series. Local recurrence 
rate is higher than surgical resection, but it improves significantly in lesions 
less than 3 cm (7%). In our experience, RFA is an effective treatment in 
recurrent liver metastases of CRC and could be proposed as first-line treatment 
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SS 4.09
Intratumoral gas in hepatocellular carcinoma following 
transarterial chemoembolization: factors associated and 
clinical implications
M. Ronot, D. Bisseret, M. Abdel Rehim, A. Sibert, 
M. Bouattour, L. Castera, V. Vilgrain; Clichy/FR
Purpose: To determine the frequency and factors associated with the presence 
of intratumoral gas-containing areas in HCC on CT obtained 4-6 weeks after 
TACE.
Material and Methods: From June 2010 to December 2011, all patients 
undergoing TACE for HCC were included. Presence of intratumoral gas was 
assessed on CT obtained 4-6 weeks after TACE. Clinical and biological data as 
well as tumoral and TACE procedure characteristics were noted. Factors 
associated with the presence of intratumoral gas were tested. Tumor response 
was assessed using the EASL criteria. Comparison between tumors containing 
gas and no gas was performed by uni- and multivariate analysis.
Results: 201 patients (mean age: 66, M/F 171/30, BCLC A/B 18/82%, Child 
A/B 81/19%) with 497 tumors underwent 286 TACE procedures. Intratumoral 
gas was found in 26 tumors (5%) after 26 TACE procedures (9.1%) in 26 
patients (13%). Gas was related to abscess formation in only 3 of them 
(11.5%). On multivariate analysis, large tumor volume at baseline (P=0.003), 
TACE using drug eluting-Beads (P=0.033) and selective/superselective 
approach (P=0.024) were factors independently associated with the presence 
of gas. Tumors showing gas-containing areas at one month had a significantly 
higher response rate than those without (P<0.0001).
Conclusion: Intratumoral gas-containing areas after TACE are rarely related to 
abscess formation. Presence of intratumoral gas on CT obtained 4-6 weeks 
after TACE could be a surrogate marker for marked tumor necrosis.
SS 4.10
Interventional endovascular treatment of acute non-
variceal gastrointestinal bleeding through emergency 
transcatheter arterial embolization
E. Bozzi, P. Scalise, F. Calcagni, A. Mantarro, F. Turini, 
I. Bargellini, R. Cioni, C. Bartolozzi; Pisa/IT
Purpose: To retrospectively assess the efficacy and the incidence of ischemic 
complications in a series of patients who underwent transcatheter arterial 
embolization (TAE) for the management of acute non-variceal gastrointestinal 
(GI) bleeding.
Material and Methods: Between January 2009 and October 2012, 32 patients 
underwent emergency TAE for acute GI hemorrhage. Indications for 
endovascular management were massive bleeding, hemodynamic 
compromise, patient's unsuitability to surgery, bleeding refractory to 
endoscopic treatment or recurrent after surgery. In all cases, abdominal 
contrast-enhanced Computed Tomography (CT) examination was performed 
to precisely localize the source of bleeding. All patients underwent diagnostic 
angiography with 5Fr-catheter and superselective catheterism with 3Fr-
microcatheter to identify the presence of active bleeding.
Results: The commonest causes of bleeding were malignancies (n=10) and 
previous surgery (n=10); pancreaticoduodenal arteries were the culprit vessels 
in 71.8% of cases. The most commonly used embolic agents were metallic 
coils+gelatin sponge (n=13). Primary technical success rate was 78.1%; a 
second procedure was required in 7 cases (mean-time 3.1 days) with a total 
technical success rate of 30/32 patients (93.7%). Bowel ischemic complications 
occurred in 4 cases (mean-time 6.75 days).
Conclusion: In patients with both upper and lower acute non-variceal GI 
hemorrhage, TAE is a safe and effective procedure to obtain a rapid control of 
bleeding.
SS 4.07
Management of arterial ammonia level with various 
interventional approaches
S. Bhatnagar, D. Jain, A. Mukund, S. Thapar, S. Sarin;  
New Delhi/IN
Purpose: To describe various techniques for reduction/occlusion of the blood 
flow in gastro-renal/leino renal shunts for controlling the arterial ammonia level 
causing hepatic encephalopathy and suggesting the best technique according 
to individual patient needs.
Material and Methods: In 11 patients, different technique of blood flow 
reduction in shunt was used according to size, shape and position and origin 
of the shunt. Out of 11 patients, 8 underwent for shunt obliteration, 2 underwent 
for splenic artery embolisation and 1 underwent for leino renal shunt reduction. 
For leino renal shunt reduction, a stent (preformed hour glass shape) was 
deployed in shunt and multiple coils of varying sizes were deployed in the 
space between stent and shunt wall. For obliteration of shunts, Catheter was 
positioned deep inside the varix and after inflating the balloon sclerosing agent 
in the form of foam was infused with the goal of filling the full extent of varices. 
For reduction of flow in shunt, polyvinyl alcohol particles were infused in lower 
pole branches of spleen. It causes decrease blood in splenic vein.
Results: 7/8 shunt obliteration, 1/1 shunt reduction and 2/2 partial splenic 
artery embolisation showed significant reduction in arterial ammonia level.
Conclusion: Ammonia level can be controlled by controlling blood flow 
through the shunts. Various interventional methods are available and have to 
select according to the size, shape, and position of shunt.
SS 4.08
Improving outcomes in percutaneous transhepatic 
biliary intervention – a method for tract closure
S.D. Goode, A. Dale, R. Khan, N. Hersey, R. Peck, F. Lee; 
Sheffield/UK
Purpose: Percutaneous transhepatic cholangiography (PTC) is an established 
technique for biliary drainage and stent placement. Recent publication of the 
UK biliary drainage and stent registry identified very high mortality and 
complication rates for PTC. The aim of our work was to identify the incidence 
of post-procedural haemorrhagic complications in patients undergoing PTC 
and to further assess the impact of using a dedicated liver tract closure 
method on patient outcomes.
Material and Methods: Retrospective analysis of all patients undergoing PTC 
between 11/2010 and 06/2011 to identify rates of complications and death. 
Further analysis was also performed between 07/2011 and 06/2012 after the 
incorporation of a new dedicated liver tract closure method for PTC was 
initiated.
Results: Initial dataset included 84 patients between 11/2010 and 06/2011. 
There was an 9% (n=8) haemorrhage rate and a statistically significant 
decrease in mean Hb was demonstrated on comparing pre- and post-
procedure results (p<0.0001). Following this, we performed dedicated liver 
tract closure in 105 patients from 07/2011 to 08/2012. The technical success 
rate for closure was 98%. There was a significant decrease in the rate of 
haemorrhagic complications in this cohort (9% vs 3%, p=0.05).
Conclusion: Clinically significant post-procedure haemorrhage occurred in 
9% of the early cohort study. Following introduction of a dedicated method for 
liver tract closure following PTC, we had a significant decrease in haemorrhagic 
complications. We advocate the use of dedicated liver tract closure following 
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11:00 - 12:30 Room H2
Scientific Session 5
Challenging situations in abdominal 
imaging
SS 5.01
Diagnostic accuracy of MRI in diagnosing deep 
infiltrating endometriosis involving bowel, ureters and 
ligaments: comparison to laparoscopy
A. Murtaza1, S. Tirumani2, J. Ryan2, S. Singh2, M.A. Fraser-
Hill2, N. Fasih2; 1Lahore/PK, 2Ottawa, ON/CA
Purpose: To compare the diagnostic accuracy of MRI versus laparoscopy for 
identification of deep pelvic endometriosis, its involvement in urinary tract and 
bowel.
Material and Methods: This retrospective, HIPPA compliant study included 
100 patients with clinical suspicion of endometriosis who underwent 
laparoscopy between 2005 and 2011. Their randomized MRI scans were 
retrospectively evaluated by two radiologists blinded to previous imaging and 
clinical details. Imaging and surgical findings were correlated for concordance.
Results: For bowel involvement, MRI detected 54 patients (5 false positives). 
Specificity, sensitivity, negative and positive predictive values were calculated 
at 88.3%, 87.5%, 90.7% and 82.6%, respectively with accuracy of MRI in 
detecting presence or absence of bowel involvement being 87%. For ureteric 
involvement, MRI detected 23 cases (1 false positive). Specificity, sensitivity, 
PPV and NPV of 98.5%, 70.9%, 95.6% and 88.1%, respectively, with accuracy 
of 89%. For pelvic ligaments, MRI detected 62 patients (12 false positives). 
Specificity, sensitivity, PPV and NPV of 73.9%, 92.5%, 80.6% and 89.4% with 
accuracy of 84%. Using kappa statistics, inter-observer concordance was 
calculated. No statistically significant variation was observed between the two 
readers, with p values < 0.0001 for all three variables.
Conclusion: MRI is a useful tool for the evaluation of deep pelvic endometriosis 
and can potentially guide treatment planning and laparoscopy. Further 
prospective studies on a larger scale will be beneficial for evaluating individual 
site-specific involvement of endometriosis.
SS 5.02
Using oral contrast: is it really necessary for the 
diagnosis of acute appendicitis with MDCT?
K. Hekimoglu, M. Coskun, C. Tarhan, E. Akar, U.M. Yildirim, 
T. Tezcaner; Ankara/TR
Purpose: To compare the diagnostic performance of IV and oral contrast-
enhanced MDCT versus only IV contrast-enhanced MDCT in patients with 
acute appendicitis.
Material and Methods: 200 adult patients that suggested acute appendicitis 
were enrolled this research. Group 1 was composed of patients with combined 
oral and IV contrast-enhanced abdominal MDCT, and Group 2 was consisted 
of only IV contrast-enhanced MDCT patients. Images were evaluated by two 
radiologists. Acute appendicitis diagnosed with a five point Likert scale. Exact 
diagnosis of acute appendicitis was considered only when patients underwent 
surgical operation. For patients whom did not undergo an operation, medical 
follow-up data of patients were undertaken by another researcher. Kappa 
statistical analysis was planned for interobserver agreement. ROC curves were 
created for comparing two groups with the results of two radiologists. 
Sensitivity, specificity, positive predictive value, and negative predictive value 
were also evaluated.
Results: In ROC curves, AUCs were calculated for two readers, the values for 
Gp1 were 0.97 and 0.96. For Gp2, both were 0.99. There were no statistically 
significant differences between two readers in the AUC values in each group 
and no significant difference in sensitivity or specificity for the diagnosis of 
acute appendicitis.
Conclusion: Oral contrast do not contribute to the a better accuracy. However, 
in selected patients, oral contrast-added MDCT imaging may be helpful for the 
diagnosis of acute apendicitis.
SS 4.11
Outcomes following radiofrequency ablation of 
colorectal cancer liver metastases
A. Wale, J. McCall, N. Wijesekera, N. Khan, K. Shahabuddin, 
G. Brown; Surrey/UK
Purpose: The aim of this study was to determine survival outcomes according 
to radiofrequency ablation (RFA) treatment intent in patients with colorectal 
liver metastases.
Material and Methods: A total of 59 patients with colorectal liver metastases 
underwent their first RFA procedure between 2005 and 2010. 21 patients 
underwent RFA as a curative procedure, 16 patients underwent RFA as a 
holding procedure before hepatic resection and 22 patients underwent RFA as 
a palliative procedure.
Results: The median Kaplan-Meier survival for all patients was 25 months 
after first RFA treatment. Log Rank test showed survival was significantly 
different according to treatment intent; patients who underwent RFA as a 
holding procedure before hepatic resection had improved survival over those 
who underwent RFA with curative intent, who in turn had improved survival 
over those who underwent RFA with palliative intent (47 v 38 v 17 months, p 
<0.001).
Conclusion: Increasingly, RFA is performed as a holding procedure before 
resection and to reduce the burden of disease in patients with palliative 
disease. This study demonstrates that patients do best if RFA is used as an 
adjuvant treatment prior to hepatic resection, but demonstrates that patients 
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SS 5.05
Dynamic MRI pelvis for investigation of persistent groin 
pain and inguinal herniation: a promising new technique
A. Patel, M. Denunzio, M.K. Lingam, R. Singh; Derby/UK
Purpose: Historically, groin ultrasound and herniography have been performed 
to investigate persistent groin pain, often with variable sensitivity and 
specificity. Herniography is also associated with risks of infection and bowel 
injury. Dynamic MRI is a new technique which shows promising results.
Material and Methods: Retrospective review of dynamic MRI performed 
following equivocal clinical examination and/or indeterminate ultrasound and 
herniography. Imaging was acquired using 1.5T Philips Achieva in relaxed 
phases and during Valsalva manoeuvre. MRI protocol included T2 high-
resolution sagittal series, axial balanced fast field echo (BFFE) relaxed/
straining, oblique BFFE relaxed/straining on affected side. Dataset included 
patient demographics, clinical indication, correlation with prior imaging, 
characterisation of herniae and other significant findings.
Results: Sample size = 65 patients. Mean age was 49.6 years (95% CI 45.1 to 
54.2). Clinical indications included persistent groin pain, previous surgery and 
indeterminate swelling. 35 patients had prior ultrasound and/or herniography. 
Inguinal herniation was detected in 38/65 patients (58.4%), bilateral in 9 
patients. In 95%, the hernial sac contained intra-abdominal fat only. In all 
positive studies, herniation was more prominent during straining. 9 patients 
(24%) only demonstrated herniation on straining phases. 5 patients (7.7%) 
revealed femoral herniation and 4 patients (6.2%) demonstrated osteitis pubis 
and adductor longus muscle strain.
Conclusion: Dynamic MRI is a promising non-invasive alternative to standard 
ultrasound and herniography. High-resolution MRI can accurately diagnose 
osteitis pubis and adductor muscle strain, thereby avoiding unnecessary 
surgical exploration.
SS 5.06
Radiologist secretarial errors: nonclinical errors using 
voice recognition software for radiology reports in 
oncological abdominal CT
M. Twomey, J. Sammon, F. Moloney, M. Breen, M. Maher; 
Cork/IE
Purpose: The purpose of this study is to evaluate error rates when using a 
voice recognition (VR) dictation system, to identify if there is a reduction in 
error rates over time with familiarity, and to assess if dual reading reduces 
errors.
Material and Methods: A total of 350 finalised reports of CT studies for 
abdominal oncological follow up performed between June 2008 and December 
2012 were randomly selected for analysis in this study. Reports were 
individually scrutinized for errors which were divided into two categories: (1) 
significant but unlikely to alter patient management and (2) very significant with 
the meaning of the report affected, thus potentially negatively affecting patient 
management.
Results: 12% of the selected reports contained errors. In subgroup analysis, 
this fell from 14% in 2008 to 6% in 2012. 3% of reports contained errors that 
could significantly alter patient management. 60% of errors in reports occurred 
in dual reader studies. Two thirds of reports containing errors occurred when 
the report was finalised between 16:00 and 18:00 hrs.
Conclusion: Whilst there are many benefits to VR systems, there are also 
many pitfalls. By raising awareness of the learning curve related to error rates 
for radiology departments using VR lessons will be learnt. This is important in 
the context of ever-increasing demand on abdominal CT imaging workflow 
and for preventing potential detriment to our patients as a result of non-clinical 
errors.
SS 5.03
Intraoperative contrast-enhanced ultrasound and 
color-coded elastography for characterization of liver 
lesion before surgical resection
J. Rennert, C. Stroszczynski, E. Jung; Regensburg/DE
Purpose: To evaluate if IO-CEUS and CCE allow a differentiation between 
malignant and benign liver lesions in comparison to histopathology.
Material and Methods: Retrospective evaluation of digitally stored 
intraoperative CEUS and elastography. IO-CEUS and CCE of 49 liver lesions 
were compared to histopathology following surgical resection. Examinations 
were performed using a multifrequency linear probe (6-9 MHz). CEUS was 
evaluated during the arterial, the portal venous and the late-venous phase. 
Characterization of the CCE quality using cine-loops >10 s, based upon a 
color-coding system. Semi-quantitative evaluation of the lesions’ stiffness 
based upon a specified scaling of 0-6 (0 low up to 6 high) using 6 ROIs (1 
central, 5 peripheral).
Results: Lesion diameter from 7 to 54 mm. All 44 malignant lesions (13 HCCs, 
8 CCCs, 23 metastases) displayed a washout. 3 lesions that could not be 
characterized by IO-CEUS and CCE, a thrombosed hemangioma, a granuloma 
and a fibrosis. Two lesions were correctly diagnosed as complicated cysts 
using IO-CEUS. Sensitivity of IO-CEUS was 90%, PPV was 100%, NPV 40% 
and accuracy was 94%. Using CCE, malignant lesions were found to be 
inhomogenous, only partially indurated in 12 lesions, with a scaling of 5. In 
8/49 lesions, only central indurations were visible (scaling 4-6). Sensitivity of 
the CCE was 65%. PPV was 94%, NPV 20% and accuracy was 71%.
Conclusion: Only IO-CEUS offers clear benefits for characterization of liver 
lesions.
SS 5.04
Diagnostic value of CT enteroclysis in small bowel 
pathologies
L.M.F. Tee, K.C.H. Lau, A.Y.H. Tsang, S. Lau, S. Chiu; 
Hong Kong/HK
Purpose: To assess the diagnostic value of CT enteroclysis (CTE) in evaluating 
symptomatic patients for small bowel pathologies, using surgical, endoscopic, 
histological or clinical follow-up findings as reference standards.
Material and Methods: At our local institution, during 2010 Nov to 2012 Oct, 
104 consecutive patients underwent CT enteroclysis for evaluation of small 
bowel pathologies. The CTE findings were retrospectively reviewed and 
compared with surgical, endoscopic, histological or clinical follow-up 
outcomes as reference standards.
Results: CTE findings were positive in 17 patients and negative in 87 patients. 
3/17 positive cases were lost to follow up and thus excluded. Positive cases 
were compared with histologic proof after operation or endoscopy. Negative 
cases were followed up clinically and radiologically. Overall sensitivity, 
specificity, PPV, NPV were 100%, 98.9%, 92.9% and 100%, respectively. 
There were 7 cases of Crohn’s disease, 3 cases of gastrointestinal stromal 
tumour (GIST), 2 cases of Peutz-Jegher syndrome and 1 case of tuberculous 
ileitis. In addition, extra-enteric findings were found in 60 patients, a number of 
which may account for the symptoms or had an implication on management.
Conclusion: CT enteroclysis is an excellent diagnostic tool in the evaluation of 
small bowel pathologies, which, at the same time, can provide invaluable 
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SS 5.09
Withdrawn by the authors
SS 5.10
Mesenteric panniculitis is not a paraneoplastic 
phenomenon
Ö. Gögebakan, M.A. Osterhoff, A. Reimann, T. Albrecht; 
Berlin/DE
Purpose: Mesenteric panniculitis (MP) is an underdiagnosed inflammatory 
condition of mesenteric adipose tissue. Previous studies suggested that MP is 
associated with malignancy. In order to reassess this hypothesis, we performed 
the first-matched case-control study comparing the prevalence of malignancy 
and other disease in patients with PM versus controls.
Material and Methods: By keyword search from our RIS database, we 
identified patients with MP undergoing abdominal CT between 2010 and 2012. 
For each patient with a MP, two control patients matched for age, gender, 
abdominal diameter and CT protocol were chosen from the same database. 
The diagnosis MP was independently confirmed by two readers according to 
established criteria. Concomitant disease was recorded for MP patients and 
controls.
Results: A total of 13485 patients underwent abdominal CT in the study 
period; MP was diagnosed in 77 patients (prevalence 0.58%). There was a 
male predominance (3.3:1). 50.6% of the patients with MP had a malignancy, 
while the rate of malignancy was 60.2% in the control group (p ≤ 0.157; 
Fisher's exact test). There was also no difference in the rate of other frequently 
encountered concomitant diseases, such as arterial hypertension, diabetes, 
previous surgery, cholecystolithiasis or raised CRP between the two groups.
Conclusion: Contrary to previous reports, our matched case control study 
suggests that MP is not a paraneoplastic phenomenon and is also not 
associated with other disease.
SS 5.07
Value of cardiophrenic angle lymph nodes for the 
diagnosis of colorectal peritoneal carcinomatosis
C. Caramella, E. Pottier, I. Borget, D. Malka, D. Goere, 
M. Ducreux, D. Elias, C. Dromain; Villejuif/FR
Purpose: The radiological diagnosis of peritoneal carcinomatosis (PC) is 
challenging. Cardiophrenic angle lymph nodes (CPALN) have been reported in 
patients with abdominopelvic malignancies. We aimed to assess whether 
CPALN detected by computed tomography (CT) scan are associated with PC 
in patients with colorectal cancer (CRC).
Material and Methods: Between 2007 and 2011, 550 patients with CRC, 
including 165 (30%) with PC, underwent abdominal surgery. We retrospectively 
reviewed preoperative CT-scans for the presence of CPALN, and assessed the 
association of CPALN with surgically confirmed PC by univariate and 
multivariate analyses.
Results: CPALN were present in 123 (75%) of the 165 patients with PC, but 
absent in 263 (68%) of the 385 patients without PC (sensitivity, 0.72; specificity, 
0.68; PPV, 0.49; NPV, 0.85; odds ratio [OR], 3.3; p<0.001). PC was the only 
factor found independently associated with CPALN in multivariate analyses. 
The presence of CPALN was not correlated with liver or lung metastases. 
Among the 165 patients with PC, 99 (62%) had visible signs of PC on CT-scan; 
among the remaining 66 patients, CPALN were the only potential sign of CP in 
41 (62%), leading to Se, Sp, PPV, and NPV in patients with no signs of CP 
(other than CPALN) on CT of 0.62, 0.68, 0.24, and 0.92, respectively.
Conclusion: The detection of CPALN on CT may be of valuable help for the 
diagnosis of PC in patients with CRC.
SS 5.08
First in-human MR-visualisation of surgical mesh 
implants for inguinal hernia treatment
N.L. Hansen, A. Barabasch, M. Distelmaier, A. Ciritsis, 
N. Kuehnert, J. Otto, J. Conze, U. Klinge, C.K. Kuhl, N.A. 
Kraemer; Aachen/DE
Purpose: This study evaluates the MR-conspicuity of iron-loaded mesh 
implants in patients treated for inguinal hernia.
Material and Methods: A prospective study with thirteen patients receiving an 
iron-loaded mesh implant via laparoscopic (TAPP, n=8) or open (Lichtenstein, 
n=5) surgery was performed between March and September 2012. The study 
was approved by the local ethics committee. MRI was conducted on the first 
postoperative day at a 1.5T scanner using three conventional gradient echo 
(GRE1-3) and one T2-weighted turbospin echo (TSE) sequences. Three 
radiologists independently assessed the following criteria using a 4-point-
scale: visual contrast-to-noise ratio, conspicuity to air artifacts, and diagnostic 
quality rating with respect to the mesh and to the surrounding anatomy. In 
addition, mesh’s crease formation and localisation in relation to the hernia 
were rated. Wilcoxon signed-rank test was used for statistical analysis.
Results: All GRE sequences facilitated a good delineation of the mesh implant. 
GRE1 was rated best (3.6, p<0.05) for diagnostic quality with respect to the 
mesh whereas both GRE2 and GRE3 were suited best for evaluation of mesh 
localisation in respect to the hernia (3.3, p<0.05). TSE was preferred for 
evaluation of the anatomy (3.8, p<0.05) but insufficient in mesh delineation.
Conclusion: Using a combination of different MRI sequences, iron-loaded 
mesh implants can be clearly visualised for localization and configuration after 
hernia repair. Their use could help to identify mesh-related problems and 
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SS 6.03
Different lobar distribution of liver metastases based on 
the site of primary pancreatic carcinoma
M.C. Ambrosetti, G.A. Zamboni, F. Lombardo, R. Pozzi 
Mucelli; Verona/IT
Purpose: To investigate whether the different site of pancreatic adenocarcinoma 
affects the lobar distribution of metastases in the liver.
Material and Methods: From all the patients who underwent MDCT for first 
staging of pancreatic adenocarcinoma, we selected 51 consecutive patients 
(26 Males, 25 Females; mean age 60 years) with pathological proven liver 
metastases. 23 patients had a tumor in the head (Group A) and 28 in the body-
tail (Group B). We analyzed site, diameter and vascular invasion of the 
pancreatic adenocarcinoma and number of metastases in each lobe of the 
liver using Cantlie’s line. Total number of metastases was compared between 
the two groups with unpaired t-test while Fisher’s test was used to compare 
the number of metastases in the two lobes.
Results: As expected, the number of liver metastases was significantly higher 
in group B than in group A (p<0.05). The ratio of metastases in the right and left 
lobes was 6.5:1 for group A compared to 3.3:1 for group B (p=0.0018).
Conclusion: Although liver metastases are more numerous in the right than in 
the left lobe in both groups, there is a significant difference in the ratio of 
metastases between the right and the left hemiliver. This can support the 
existence of a “fast track” to the left liver lobe when the carcinoma invades the 
splenic vein, and may help in detection of liver metastases.
SS 6.04
Diagnostic performance of MRI for important prognostic 
factors in pancreatic cancer
J.H. Kim, H.W. Eun, J.M. Lee, J.K. Han, B.I. Choi; Seoul/KR
Purpose: Tumor size, T-stage, N-stage, vascular invasion, and cell 
differentiation are most important prognostic factors in pancreatic cancer. To 
investigate diagnostic accuracy of MR for determining these factors.
Material and Methods: 41 patients with resectable pancreatic cancer who 
underwent preoperative MR were included in this study. We measured tumor 
size on different MR sequences. Two radiologists retrospectively accessed 
T-stage, N-stage, vascular invasion. They also accessed MR findings including 
SI on T2WI, enhancement patterns, duct dilation, presence of diffusion 
restriction, and ADC values. Each MR finding was used to compare these 
prognostic factors. Statistical analyses were performed using ROC analysis, 
McNemar test, and paired t test.
Results: All pancreatic cancers were detected on FS GRE T1WI. Tumor size on 
FS GRE T1WI and DWI was closest to pathological size without difference 
(p>0.05). Diagnostic accuracy for T-stage was 92.6 and 95.1% with moderate 
agreement (Κ=0.41). Accuracy for N-stage was 70.7 and 65.8% with moderate 
agreement (Κ=0.576). Accuracy for peripancreatic invasion, bile duct invasion, 
and duodenal invasion were 88 and 93%, 90 and 93%, 83 and 83% with 
almost perfect agreement. Accuracy for determining vascular invasion was 
92%. MR findings were not different according to T-stage, N-stage, cell 
differentiation, and gross pattern.
Conclusion: MR is useful for preoperative evaluation of tumor size, T-stage, 
and vascular invasion, but it has limitation for N-metastasis. However, each 
MR finding is not different according to T-stage, N-stage, cell differentiation, 
and gross pattern.
11:00 - 12:30 Auditorium
Scientific Session 6
Imaging of pancreatic neoplams
SS 6.01
Radiopathological correlation in T4 pancreatic cancer: 
prognostic implications
C. Cappelli, R. Cervelli, S. Mazzeo, D. Campani, U. Boggi, 
C. Bartolozzi; Pisa/IT
Purpose: To discuss the correlation between CT and pathology in T4 
pancreatic cancer.
Material and Methods: 31 arteries (6 celiac axis, 10 hepatic arteries, 8 splenic 
arteries-SA, 7 superior mesenteric artery), resected in 17 patients were 
analyzed. The relationship between tumor and artery was graded as: 0, no 
contact; I, focal contiguity; II, tumor surrounding partially (a) or completely (b) 
the artery; III tumor surrounding (a) or (b) the vessel with lumen reduction. For 
each artery, the contact length with the tumor was reported. The neural plexus 
(NP) and celiac ganglia (CG) involvement was graded with a score between 1 
and 3.
Results: At CT, 1 resected artery was graded as 0, 2 as I, 17 as IIa, 3 as IIb, 5 
as IIIa and 3 as IIIb (all SA). At pathology, none of 0, I and IIa arteries was 
infiltrated, irrespective to the NP and CG score. Adventitial infiltration was 
identified in 2 IIb, 2IIIa and all IIIb arteries. Arterial infiltration was significantly 
related to CG involvement (p=0.014), while no correlation with NP grading was 
found (p=0.37). No correlation with survival existed considering arterial 
infiltration (p=0.66), while significance (p=0.0097) was reached considering CG 
involvement.
Conclusion: Radiological T4 poorly correlates with pathology. Current CT-
grading system should be revised because of the structural differences 
between arteries and veins, and the key role of CG involvement in predicting 
arterial infiltration and prognosis.
SS 6.02
Does arterial encasement on CT always mean vascular 
invasion at surgery in pancreatic cancer and what is the 
cause of false-positivity in assessment of 
unresectability?
V.I. Egorov, R.V. Petrov, E. Solodinina, G. Karmazanovsky, 
N. Starostina, N.M. Kurushkina; Moscow/RU
Purpose: Indication of pancreatic cancer (PC) unresectability is the superior 
mesenteric (SMA) and celiac artery (CA) encasement, signaling arterial 
invasion. Computed tomography (CT) is the gold standard for PC detection 
and its resectability evaluation.
Material and Methods: Preoperative radiology data were compared with 
findings at 51 standard, 58 extended, 17 total pancreaticoduodenectomies 
(PDs), 9 distal resections with CA excision (DPCA) and 28 palliative bypasses 
for PC. Survival of 11 patients with controversial data of CT and EUS in regard 
to arterial invasion, after R0/R1 procedures, was compared to survival of 8 
patients after R2 resection (Group B) and of 12 patients with locally advanced 
cancer after bypass surgery (Group C).
Results: CT showed peripancreatic arteries' encasement in 11 cases. In all 
cases an operative exploration was performed, basing on equivocal yield of 
endoUS, and no invasion of the arterial wall was revealed. The 1-year survival 
in Group A was 88.9%, 2-year – 26.7% with 22-month median follow-up. One-
year survival was not attained in Groups B and C. Survival difference between 
groups was significant (Pa-b = 0.0029,Pb-c = 0.003)
Conclusion: Peripancreatic arterial encasement on CT does not necessarily 
signify arterial wall invasion, which means that PC can still be radically 
removed. Whenever PC is considered unresectable endoUS should be used; 
without recourse to an extended pancreatectomy with skeletalisation of the 
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SS 6.07
MDCT features of pancreatic adenocarcinoma before 
and after chemotherapy: do they change? Do they affect 
interobserver agreement?
G.A. Zamboni, M.C. Ambrosetti, F. Lombardo, R. Pozzi 
Mucelli; Verona/IT
Purpose: To compare the MDCT features of pancreatic adenocarcinoma 
before and after chemotherapy, and to assess the effect on interobserver 
agreement.
Material and Methods: Two readers reviewed independently the MDCT scans 
performed before and after gemcitabine chemotherapy on 31 patients with 
advanced pancreatic cancer, assessing tumor margins, density, necrosis, 
infiltration of peripancreatic fat and vessels, liver metastases, ascites and 
carcinosis. Post-treatment tumor changes were analyzed with Student and 
Mann-Whitney tests, interobserver agreement was calculated with kappa 
statistics.
Results: 16/31 patients had stable disease, 15/31 disease progression. Tumor 
size, margins, homogeneity, necrosis, conspicuity, adipose tissue infiltration, 
presence of liver metastases, ascites or carcinosis were not significantly 
changed post-treatment (all p=n.s). A significant increase was observed post-
treatment in main duct caliber (7mm vs 6mm) and lymphnode size (16.8 mm vs 
12.6 mm). Post-treatment, venous invasion increased in 8/31, decreased in 
1/31 and remained stable in 22/31 patients. Arterial invasion increased in 9/31, 
decreased in 2/31 and was stable in 20/31 patients. Interobserver agreement 
did not change post-treatment for tumor homogeneity, presence of necrosis, 
adipose tissue infiltration or carcinosis (all good agreement), and ascites (very 
good agreement). Interobserver agreement decreased for tumor margins (from 
good to moderate) and liver metastases (from perfect to good).
Conclusion: Post-chemotherapy, the CT features of pancreatic 
adenocarcinoma do not appear to change significantly; interobserver 
agreement decreases for tumor margin evaluation and for liver metastases, 
possibly as an effect of treatment.
SS 6.08
Solid and pseudopapillary tumours of the pancreas: are 
the epidemiology and imaging features changing?
M.-P. Vullierme, G. Goujon, J. Cros, V. Vilgrain; Clichy/FR
Purpose: Solid and pseudopapillary tumours (SPT) are rare pancreatic 
tumours known to be large in size and affecting young women. Due to the 
trends in imaging methods, their presentation of may have changed over the 
past years, individualising new aspects. We retrospectively revisit the 
epidemiologic and radiological features in a series of patients with resected 
SPT.
Material and Methods: 36 patients (28 women, 8 men), median age 30 years 
(14-57) underwent surgery between 2002 and 2011. The diagnosis of 
pancreatic tumour was suspected following non-specific abdominal pain 
(n=24) or fortuitously (n=12). It was located in the head (n=19), the neck (n=10) 
or the body/tail (n=7). All patients underwent CT scan, MRI and EUS. In 
doubtful cases, EUS-biopsy or somatostatin-receptors scintigraphy (SRS) 
were performed in 12 and 6 patients, respectively.
Results: In 9 cases (25%), there was a differential diagnosis with a 
neuroendocrine tumour (NET) (n=6) or a mucinous cystadenoma (n=3), 
underlying two atypical patterns, a solid well-circumscribed lesion pattern, 
and a purely cystic pattern some with large shell-like calcifications. A peripheral 
fibrous capsule was present in 22 cases (61%) and this pattern was not 
described with other cystic and solid lesion.
Conclusion: This series suggests that the presentation of SPT has changed 
with half of patients aged >30 years and/or with small solid lesions (<3 cm), 1/3 
male. Atypical imaging features (entirely cystic or NET-like lesions) can be 
encountered as well.
SS 6.05
Value of MDCT angiography in predicting R0 
resectability of pancreatic adenocarcinoma
G.A. Zamboni, M.C. Ambrosetti, F. Lombardo, G. Malleo, 
R. Pozzi Mucelli; Verona/IT
Purpose: To assess the value of MDCT in the preoperative staging of 
pancreatic adenocarcinoma, with special regard to predicting R0 resectability.
Material and Methods: We reviewed in this retrospective study the images 
from the CT scans performed on 154 consecutive patients who underwent 
MDCT angiography at our institution for diagnosis and/or preoperative staging 
of pancreatic carcinoma. The diagnosis of pancreatic adenocarcinoma was 
confirmed at pathology in all patients. Imaging findings were compared with 
surgical reports, pathology reports and patient follow up. Sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value (NPV) for overall 
resectability and for R0 resectability were calculated with Fisher’s test.
Results: Patient population included 88 males and 66 females (mean age 63.8 
years, range 37-81). 52 patients underwent resection while 102 underwent 
palliative procedures because of unresectability. According to MDCT criteria, 
66 patients were potentially resectable and 88 nonresectable. When analyzing 
all the performed resections, CT for the prediction of resectability had 92.3% 
sensitivity, 82.4% specificity, 72.7% PPV and 95.5% NPV. When only R0 
resections were considered as true positives, CT had 93.1% sensitivity, 68.8% 
specificity, 40.9% PPV and 97.7% NPV.
Conclusion: The value of MDCT in predicting overall resectability is well 
known, and our results are in line with those presented in the literature. For 
patient outcome, however, R0 resectability might be a more important 
parameter: MDCT appears to be of value also in this assessment.
SS 6.06
MRI of pancreatic adenocarcinoma including diffusion-
weighted imaging: assessment of tumour conspicuity 
and pathologic correlation
L. Legrand, V. Duchatelle, V. Molinié, I. Boulay-Coletta, 
E. Sibileau, M. Zins; Paris/FR
Purpose: To identify the best MR sequences for pancreatic adenocarcinoma 
conspicuity and to determine whether MR signal and apparent diffusion 
coefficient (ADC) correlate with pathological findings.
Material and Methods: Twenty-two consecutive patients with pancreatic 
adenocarcinoma who underwent MRI (1.5 or 3T) before surgical resection were 
included. Fat-suppressed (FS) T1 and T2-weighted sequences, 3D FS dynamic 
T1-weighted gadolinium-enhanced gradient-echo (GRE) during arterial, portal 
and delayed phases, and diffusion-weighted imaging (DWI) with b values of 
600-800 s/mm2 were obtained. Lesion conspicuity was assessed on each 
sequence qualitatively (three-point rating scale) and quantitatively (tumour-to-
proximal and distal pancreas contrast), and compared using paired Wilcoxon 
tests. Histological characteristics were correlated with MRI features.
Results: 95% of pancreatic adenocarcinomas were hypointense on 3D FS T1 
GRE arterial phase, which was the best sequence for tumour conspicuity 
(p≤0.02). DWI was not useful for delineating 25% of tumours. Maximum 
diameter at pathological examination was 33±10 mm. It was best correlated 
with MR tumour size on DWI. Progressive enhancement curve was associated 
with extensive and dense fibrous stroma (p≤0.03). No correlation was found 
between ADC (mean value: 1.76x10-3 mm2/s) and differentiation, fibrosis or 
necrosis.
Conclusion: 3D FS T1 GRE arterial phase sequence is superior to DWI for 
pancreatic adenocarcinoma conspicuity but it underestimates the size of the 
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11:00 - 12:30 Room J
Scientific Session 7
Detection and management of focal liver 
lesions in the non-cirrhotic liver
SS 7.01
Preoperative evaluation of colorectal liver metastases 
after chemotherapy: a combined approach of diffusion-
weighted imaging with b-multiple SE-EPI and Gd-EOB-
DTPA MR sequences at 3T
F. Donati, P. Boraschi, L. Urbani, G. Gherarducci, 
F. Pacciardi, M.C. Della Pina, R. Gigoni, G. Masi, F. Falaschi, 
C. Bartolozzi; Pisa/IT
Purpose: To compare diffusion-weighted imaging (DWI) with b-multiple SE-
EPI and Gd-EOB-DTPA MR sequences alone and in combination at 3T-device 
for detecting colorectal liver metastases in patients previously undergone 
preoperative chemotherapy.
Material and Methods: Twenty patients with colorectal cancer and focal liver 
lesions underwent MR imaging at 3T-device (GE DISCOVERY MR750;GE 
Healthcare) after preoperative chemotherapy. Three images sets were 
reviewed by two observers in conference: (1) DWI using a spin-echo echo-
planar sequence with multiple b values (150, 500, 1000, 1500 s/mm2); (2) Gd-
EOB-DTPA Lava-flex sequence including both dynamic and hepato-biliary 
phase; (3) combined DWI and Gd-EOB-DTPA images. The MRI findings were 
correlated with surgery and histopathology, which was our gold standard. Only 
clear benign lesions at intraoperative ultrasound remained unresected. 
Statistical analysis was performed on a per-lesion basis.
Results: A total of 146 lesions were detected; of these, 106 were metastases 
(72.6%), whereas the remaining 40 (27.4%) were characterized as benign 
lesions (cysts and hemangiomas). Image set 1 correctly identified 92 out of 
106 metastases (sensitivity 86.7%, specificity 50%, diagnostic accuracy 
76.7%), image set 2 correctly detected 98 out of 106 metastases (sensitivity 
92.4%, specificity 70%, diagnostic accuracy 86.3%), and image set 3 correctly 
diagnosed 104 out of 106 metastases (sensitivity 98.1%, specificity 95%, 
diagnostic accuracy 97.2%). Differences were statistically significant 
(p<0.001).
Conclusion: DWI in combination with Gd-EOB-DTPA sequences at 3T-device 
significantly increases the diagnostic performance of MRI in detecting 
preoperative colorectal liver metastases.
SS 7.02
Growth of colorectal liver metastases in the embolized 
and non-embolized liver after portal vein embolization
M. Ronot, R. Pommier, F. Cauchy, S. Gaujoux, M. Abdel 
Rehim, A. Sibert, V. Paradis, S. Faivre, J. Belghiti, V. Vilgrain; 
Clichy/FR
Purpose: To compare tumor progression in both embolized and non-
embolized lobes after portal vein embolization (PVE) in patients with bilobar 
colorectal liver metastases (CLM).
Material and Methods: From 2002 to 2012, 42 consecutive patients displaying 
initially unresectable bilobar CLM and undergoing right PVE to achieve 
resectability after chemotherapy downstaging (median 12 cycles) were 
included. Before PVE, all patients had at least one lesion in the future non-
embolized lobe. Right and left livers tumoral and non-tumoral volumes as well 
as volume variations were measured on CT before and after PVE. Influence of 
neoadjuvant and post-PVE chemotherapy (n=26) on tumor growth was 
assessed.
Results: After a median of 34 days (28-37) following PVE, the median right liver 
volume decreased 17% (P<0.0001), while left liver volume increased 32% 
(P<0.0001). A tumoral volume increase was observed in both embolized and 
non-embolized lobes in 25 (60%) patients. Right and left tumoral volumes had 
a significant median increase of 48% (P<0.0001) and 31% (P<0.0001), 
respectively. After PVE, increases in right and left tumoral volume were 
correlated (r=0.54, p=0.0004). In both livers, tumor growth was not significantly 
reduced in patients who received chemotherapy after PVE (right liver, p=0.21; 
left liver, p=0.86).
Conclusion: Tumor growth after PVE can be observed in both embolized and 
non-embolized liver lobes and is not influenced by post-PVE chemotherapy.
SS 6.09
Complications after major pancreatic surgery: MDCT 
features
F. Lombardo, G.A. Zamboni, M.C. Ambrosetti, R. Pozzi 
Mucelli; Verona/IT
Purpose: To review the MDCT features of complications after major pancreatic 
surgery for pancreatic tumors.
Material and Methods: We reviewed 50 consecutive emergency MDCT scans 
performed after major pancreatic surgery. Patient population included 22 
Females and 28 Males, mean age 61.8 years. Surgeries included 37 
pancreatico-duodenectomies, 1 total pancreatectomy, 4 intermediate 
resections, 2 enucleations and 6 distal pancreatectomies. The resected tumors 
at pathology included 25 adenocarcinomas, 11 endocrine tumors, 2 mucinous 
tumors, 2 serous cystoadenomas, 6 intraductal papillary mucinous neoplasms, 
2 duodenal GISTs, 1 solid-pseudopapillary tumor and 1 mesenchimal tumor.
Results: Mean interval between surgery and CT was 6.8 days. The pancreatic 
remnant was normal in 39/50 cases and atrophic in 11/50 cases. The 
complications included 12 anastomotic leakages, 25 fluid collections, 5 
bleedings/hematomas, 8 free peritoneal fluid. 11/12 anastomotic leakages 
involved the pancreatic anastomosis. In 8/12 cases of leakage, the pancreatic 
remnant was normal while in 4 cases, it was atrophic. Fluid collections were 
hypoattenuating in 40 cases, hyperattenuating in 5 cases and mixed in 5 
cases. Free air was seen in all cases of anastomotic leakage and in 10/25 
cases with fluid collections.
Conclusion: Complications after major pancreatic surgery are not uncommon, 
even in high-volume referral centers, and range from small amounts of free fluid to 
anastomotic leakage or hemorrhage. Complications appear to be more common 
in patients with a normal pancreas than in those with atrophic parenchyma.
SS 6.10
Diagnostic performance of MR for pancreatic 
neuroendocrine tumor according to the WHO 
classification compared with the TNM stage
J.H. Kim, H.W. Eun, J.M. Lee, J.Y. Lee, J.K. Han, B.I. Choi; 
Seoul/KR
Purpose: According to WHO 2010 classification, pancreatic neuroendocrine 
tumor (PNET) was classified as NETG1, NETG2, and NEC. Our study 
investigates diagnostic performance of MR for PNET according to WHO 2010 
classification compared with TNM stage.
Material and Methods: Our study consisted of 39 patients with surgically 
proven PNET (NETG1; n=24, NETG2; n=12, NEC; n=3) who underwent 
preoperative MRI. Two radiologists retrospectively reviewed MR findings 
including margin, SI on T2WI, enhancement patterns, degenerative change, 
presence of diffusion restriction, duct dilation, and ADC value. They also 
assessed T-stage, N-stage, and tumor size. Statistical analyses were 
performed using Chi-square tests, ROC analysis, and Fisher’s exact test.
Results: Statistically specific findings for NEC were ill-defined borders 
(p=0.001) and hypo-SI on venous- and delayed-phase (p=0.016). ADC value 
showed significant difference between G1 and G2 (p=0.007). Az of ADC value 
for differentiating G1 from G2 was 0.743. Tumor size on MR was not different 
from pathologic size (p=0.452). Accuracy for T-staging was 77 and 85%, and 
for N-staging was 92 and 87% with substantial agreement (Κ=0.78, Κ=0.79). 
T-stage showed significant difference according to tumor grade (p<0.001), 
although there was no significant difference in tumor size (p=0.252) or N-stage 
(p=0.565).
Conclusion: Ill-defined borders and hypo-SI on venous- and delayed-phase 
are common findings of NEC, and ADC value is helpful for differentiating G1 
from G2. MR is useful for the evaluation of T-stage, N-stage, and tumor size, 
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SS 7.05
Detection of liver metastases in patients with 
adenocarcinomas of the gastrointestinal tract: 
comparison of [18F]FDG-PET-CT and MRI
C. Maegerlein, A.A. Fingerle, M. Souvatzoglou, 
E.J. Rummeny, K. Holzapfel; Munich/DE
Purpose: To compare the diagnostic performance of [18F]FDG-PET-CT and 
MRI in the detection of liver metastases in patients with adenocarcinomas of 
the gastrointestinal tract.
Material and Methods: Thirty-four patients with adenocarcinomas of the 
gastrointestinal tract who had undergone [18F]FDG-PET-CT and MRI of the 
liver within a maximum interval of 4 weeks were included in this study. The MRI 
protocol included diffusion-weighted imaging (DWI) and dynamic contrast-
enhanced imaging after intravenous application of Gd-DTPA using a VIBE 
(volume interpolated breathhold examination) sequence. Images were 
acquired in the arterial, portal venous and equilibrium phase. Two datasets 
(PET-CT and MRI) were analyzed by a blinded reader with a time interval of 4 
weeks between both datasets. Imaging results were correlated with 
histopathologic findings or results of follow-up imaging studies. Sensitivities of 
both modalities in the detection of liver metastases were compared using the 
Mann Whitney U-Test.
Results: A total of 94 metastases were confirmed in 34 patients. Sensitivity of 
MRI in detecting metastases was 91.2% and was significantly higher than that 
of PET-CT (77.0%; p<0.001). Regarding metastases with a diameter of ≤10 
mm, the difference was even more pronounced with sensitivities of 71.4% 
(MRI) and 16.7% (PET-CT; p<0.0001).
Conclusion: MRI including diffusion-weighted imaging and dynamic contrast-
enhanced imaging is significantly superior to PET-CT in detecting liver 
metastases in patients with adenocarcinomas of the gastrointestinal tract, 
especially in detecting metastases ≤10mm.
SS 7.06
Whole liver ADC histogram analysis in patients with liver 
metastases from rectal cancer
N. Papanikolaou1, D. Lambregts2, A. Nikiforaki1, 
M.H. Martens2, D. Mondal3, L.A. Heijnen2, G.L. Beets2, 
R. Beets-Tan2; 1Vasilika Vouton/GR, 2Maastricht/NL, 
3Oxford/UK
Purpose: ADC measurements have been proposed to characterize focal liver 
lesions in the basis of restricted diffusion pattern due to hypercellularity. The 
aim of this study was to explore whether whole liver ADC histogram metrics 
may be used to differentiate between patients with colorectal liver metastasis 
and controls with no liver disease.
Material and Methods: Ten patients with colorectal liver metastasis and 10 
controls with no focal or diffuse liver disease were included. Whole liver 
segmentation was performed on ADC maps and a corresponding histogram 
was generated. In addition, quantitative histogram metrics were calculated 
and compared between the patients and normal controls. P-value <0.05 was 
considered statistically significant.
Results: Mean ADC value of patient group was significantly lower than that of 
normal controls (0.958x10-3 and 1.22x10-3, respectively, p<0.05), while both 
skewness and kurtosis were not significantly different (p=0.176 and p=0.056, 
respectively). In the patient group mode, 5% percentile and 95% percentile 
were significantly lower to the normal controls (0.936x10-3 and 1.140x10-3, 
p<0.001, 0.475x10-3 and 0.7x10-3, p<0.05, 1.466x10-3 and 1.833x10-3, p<0.05).
Conclusion: Whole liver histogram ADC analysis revealed a significant shift 
towards lower ADC values in patients with colorectal liver metastasis compared 
to controls without liver disease. These results show that ADC histogram 
analysis could be a promising tool for detecting occult colorectal liver metastasis.
SS 7.03
Performance of gadoxetic acid-enhanced MRI for the 
differentiation of FNH and HCA: a single centre 
experience
C.M. Perez Fernandez, T. Denecke, I.G. Steffen, 
D. Seehofer, I. Kramme, B. Hamm, C. Grieser; Berlin/DE
Purpose: Evaluation of enhancement characteristics of focal nodular 
hyperplasia (FNHs) and hepatocellular adenomas (HCAs) with gadoxetic acid-
enhanced magnetic resonance imaging (MRI).
Material and Methods: Eighty-six patients who underwent MRI at 1.5 T were 
retrospectively included. Examination protocol contained: T1-in- and opposed 
phase; T2-weighted UTSE and fat-saturated T1-weighted (WATS; LAVA) with 
and without contrast media (Gd-EOB-DTPA; arterial, portal venous, venous 
and hepatobiliary phase. Standard of reference was surgical resection (n=53) 
or biopsy (n=15) available for 114 lesions. All cases were read by two 
independent radiologists in consensus. Lesion intensity was visually compared 
with the intensity of the surrounding liver parenchyma. Furthermore, relative 
signal intensity (SI) values (%) in contrast to native SI-values were recorded for 
the different contrast phases.
Results: 114 lesions (FNHs, n=44; HCAs, n=70) were evaluated. On 
unenhanced MRI, presence of fat (P<0.001; accuracy=54%), haemorrhage 
(P=0.071; accuracy=57%) and “wash-out'' were indicative for HCA (P<0.001; 
accuracy=63%), whereas presence of a central scar was indicative for FNH 
(P<0.001; accuracy=85%). Regarding signal intensities on hepatobiliary phase 
images, an iso-/hyperintense appearance of FNHs and hypointensity of HCAs 
were the best discriminators between both entities (P<0.001; acc=92%).
Conclusion: An iso-/hyperintensity of FNHs and hypointensity of HCAs on 
hepatobiliary phase images are highly accurate discriminators between both 
entities. In case of conclusive findings of FNH on gadoxetic-enhanced MRI, 
biopsy may be dispensable.
SS 7.04
Differentiating hepatic abscess from malignant 
mimickers: the value of diffusion-weighted imaging with 
an emphasis on the periphery of the lesion
H.J. Park, S.H. Kim, K.M. Jang, M.J. Park, S.J. Lee, D. Choi; 
Seoul/KR
Purpose: To evaluate the efficacy of diffusion-weighted imaging (DWI) in 
differentiating hepatic abscess from malignant mimickers with an emphasis on 
periphery of the lesions.
Material and Methods: 39 patients with hepatic abscess and 74 patients with 
malignant hepatic tumors were included. Patients underwent gadoxetic acid-
enhanced 3T conventional MRI and DWI. For qualitative and quantitative 
analysis, signal intensity and ADC values of periphery of the lesions on MRI 
and DWI with ADC maps were assessed. Two observers independently 
reviewed the DWI and ADC maps and rated them using 5-point scale. 
Diagnostic performance was evaluated using ROC curve analysis. Accuracy, 
sensitivity, specificity, PPV and NPV were calculated.
Results: Periphery of hepatic abscesses showed T1-hypointense, arterial 
hyperintense and hypointense on hepatobiliary phase less frequently than that 
of malignant tumors (P<0.05). No hepatic abscesses showed peripheral 
washout on 3-min late phase compared to malignant tumors (59.5%) 
(P<0.001). Both groups showed a hyperintense rim on DWI, but 37 (94.9%) 
abscesses revealed a hyperintense rim on the ADC map compared to one 
(1.4%) malignant tumor (P<0.001). Mean ADC value of abscesses was 
significantly higher than that of malignancies. Diagnostic performance (area 
under the ROC curve [Az]) of DWI in identifying hepatic abscess was 0.986 and 
0.982 in each observer. Interobserver agreement was excellent.
Conclusion: In addition to conventional MRI, DWI is helpful in differentiating 
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SS 7.09
Importance of arterial phase CT imaging for detection 
and management of liver metastasis
F. Willemssen, S. Van Koeverden, G. Krestin, R.S. 
Dwarkasing; Rotterdam/NL
Purpose: To evaluate the arterial phase imaging for detection of liver 
metastasis and the effect on therapeutic management.
Material and Methods: From January until December 2008, patients with 
histological proven colorectal or breast carcinoma, who underwent a CT 
examination in both arterial and portal-venous phase were included. Contrast 
material used was 120-150 ml iodixanol 320 mgI/ml (Visipaque, GE Healthcare 
Inc, Cork, Ireland), injection rate 3-3.5cc/s. Arterial phase was acquired at 30 
s, the portal-venous phase at 70 s. All CT examinations were evaluated in the 
portal-venous phase and compared to portal-venous and arterial phase. 
Difference in number of metastases was assessed. Follow-up CT examinations 
(3-30 months) were used to evaluate the aetiology of detected lesions. Change 
over time of a lesion was defined as metastasis.
Results: In this retrospective cohort follow-up study, 317 patients were 
included. 74 (23.5%) patients were excluded, because no follow-up was 
available. In 171 (54.3%) patients, there was neither difference in the number 
of metastases detected in both phases, nor new lesions developed. 72 (22.9%) 
patients developed new metastasis during follow-up. In 17 (23.6%) patients of 
this group, additional metastases were detected due to arterial phase imaging. 
Management would have changed in only 1 (1.4%) patient.
Conclusion: Combined arterial and portal-venous phase CT-imaging allows 
detection of additional metastases in patients with colorectal and breast 
carcinoma. However, therapeutic consequences related to higher number of 
detected liver metastases is extremely low.
SS 7.10
Differential findings between hepatic adenoma and focal 
nodular hyperplasia at DWI and hepatobiliary imaging
N. Al Ansari, V. De Marco, V. Buonocore, F. Mazzamurro, 
F. Maccioni; Rome/IT
Purpose: To characterize imaging features of hepatic adenoma (HA), 
confirmed at follow-up imaging, as well as radiologically proven focal nodular 
hyperplasia (FNH) using delayed hepatobiliary MR imaging with gadoxetic acid 
and DWI.
Material and Methods: 20 patients with radiologically proven HAs were 
retrospectively analyzed on liver MRI studies performed with gadoxetic acid 
and imaging acquired during the delayed hepatobiliary phase. 25 patients with 
radiologically diagnosed FNH lesions were identified. Only patients with non-
cirrhotic liver were evaluated. Two readers, blinded to the clinical information 
and the radiological diagnosis, reviewed all images in terms of signal intensity 
(SI) features on dynamic, and hepatobiliary phase images. Signal intensity 
ratios relative to adjacent liver were measured on selected imaging sequences. 
Agreement between the 2 observers was evaluated with kappa statistic.
Results: All 20 HA (100%) demonstrated hypointensity relative to adjacent 
liver on delayed imaging whereas FNH were either hyperintense (70%) or 
isointense (30%) relative to the adjacent liver on delayed imaging. None of the 
FNHs was hypointense relative to liver. Interobserver agreement was excellent 
(k=1). On the other hand, DWI signal was not significantly different between HA 
and FNH.
Conclusion: HA and FNH showed distinct imaging characteristics on delayed 
gadoxetic acid-enhanced MRI, whilst DWI was not effective in differentiating 
these lesions. The use of gadoxetic acid-enhanced MR imaging with 
hepatobiliary phase images plays a primary role in the differentiation of FNH 
from HA.
SS 7.07
Evaluation of radiological prognostic factors of hepatic 
metastases in patients with non-functional pancreatic 
neuroendocrine tumors
A.D.J. Baur, C.M. Perez Fernandez, C. Ihm, I.G. Steffen, 
E. Tischer, R. Arsenic, M. Pavel, T. Denecke; Berlin/DE
Purpose: In non-functional well to moderately differentiated (G1 and G2) 
pancreatic neuroendocrine tumors (pNET) with irresectable hepatic metastases, 
watchful waiting until tumor progression is a well-established approach. 
Treatment with somatostatin analogues (SSA) is optional. Goal of this study was 
to identify radiological prognostic factors predicting rapid tumor progression.
Material and Methods: In 44 patients, we retrospectively evaluated features 
of hepatic metastases on contrast-enhanced multiphase CT and MR imaging 
including contrast enhancement, presence of necrosis and macrovascular 
infiltration as well as number of metastases and tumor burden. These features 
were correlated with time to tumor progression (TTP) according to RECIST 1.0.
Results: In the initial patient cohort, none of the evaluated parameters was found to 
be a statistically significant predictor of TTP. This patient cohort included 14 patients 
who had received treatment with SSA. Since treatment with SSA was associated 
with an increased TTP (p=0.01), we also analyzed a subgroup of 30 patients without 
any antitumoral therapy. In this subgroup of patients, hypoenhancement of hepatic 
metastases during early contrast phases was found to be an independent prognostic 
factor predicting rapid tumor progression (p=0.018).
Conclusion: Hypovascularization of hepatic metastases from G1 and G2 
pNET reflected by hypoenhancement during the early contrast phases seems 
to be associated with rapid tumor progression. In patients with hypoenhancing 
metastases, early initiation of antitumoral therapy as well as repeated biopsy 
for grading of these metastases should be considered.
SS 7.08
The preoperative assessment of hepatic tumours: 
evaluation of UK regional multidisciplinary team 
performance
M.G. Wiggans, E.M. Armstrong, D.A. Stell, S. Jackson; 
Plymouth/UK
Purpose: In the UK, all patients where liver resection is contemplated are 
discussed at hepatobiliary multi-disciplinary team (MDT) meetings. The 
Peninsula HPB unit is a tertiary referral facility in the South-West of England. 
Our aim was to assess MDT performance by identification of patients where 
radiological and final pathological diagnoses differed.
Material and Methods: A prospective database of cases has been maintained 
since the inception of the unit. The presumed diagnosis as a result of 
radiological investigation and MDT discussion is recorded at the time of 
surgery. Imaging was reviewed by specialist gastrointestinal radiologists and 
results agreed by consensus. A review of patients undergoing surgery from 
Mar 2006 to Jan 2012 was performed.
Results: We identified 417 patients who underwent hepatic resection. There 
was a significant increase in the use of preoperative imaging modalities 
(p≤0.01) but no change in the rate of discrepant diagnosis over time. 42 
individuals were identified whose final histological diagnosis differed to the 
outcome of the MDT discussion (9.6%). These included 30% of patients 
diagnosed pre-operatively with hepatocellular carcinomas and 25% diagnosed 
with cholangiocarcinoma of a major hepatic duct.
Conclusion: The highest rate of discrepancies occurred in patients with focal 
liver lesions without a history of chronic liver disease or primary cancer, where 
hepatoma was over-diagnosed during MDT discussion and peripheral 
cholangiocarcinoma under-diagnosed. Additional care should be taken in 
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SS 8.03
Diffusion-weighted MRI enterography: assessment of 
Crohn's disease activity
A. Centola, E. Cleopazzo, C. Bristogiannis, P. Milillo, 
L.P. Stoppino, R. Vinci, L. Macarini; Foggia/IT
Purpose: To investigate the diagnostic accuracy of diffusion-weighted MRI 
(DW-MRI) in Crohn’s disease (CD) activity by differentiating acute, chronic and 
remission stage, evaluating the changes in apparent diffusion coefficient (ADC) 
values.
Material and Methods: 50 patients (mean age: 22-69) with histological 
diagnosis of CD underwent a magnetic resonance enterography (MR-E) 
including dynamic contrast-enhanced MRI on a 1.5T MR unit. Before i.v. 
contrast agent administration, we acquired DWI sequence with b values 0 and 
800 mm-2. We used 1.5 x 10-³ mm2/s as cut-off value to distinguish active 
from chronic disease and 2.0 x 10-³ mm2/s to distinguish chronic to inactive 
disease.
Results: We analysed a total of 298 segments. DWI identified active disease in 
54 bowel segments, chronic disease in 12, and inactive disease in the 
remaining 116. The sensitivity, specificity, accuracy, PPV, NPV were 84.3%, 
94,8%, 93%, 81,8%, 95,7%, respectively. In the quantitative assessment, 
ADC values in the disease-active area were lower than those in chronic-
disease and inactive areas (1.47 ± 0.34 x 10-³ mm2/s, 1.67 ± 0.42 x 10-³ mm2/s 
and 2.46 ± 0.47 x 10-³ mm2/s, respectively).
Conclusion: DWI allows the detection of CD active affected segments. 
Qualitative and quantitative analysis is a useful tool for follow-up and post-
treatment assessment. Further studies are necessary to assess the role of 
ADC values in long-term post-therapy follow-up.
SS 8.04
Automated evaluation of bowel motility in patients with 
Crohn's disease by development of a colour coding 
algorithm for cine MRI
M.L. Hahnemann, F. Nensa, S. Kinner, G. Gerken, 
T.C. Lauenstein; Essen/DE
Purpose: There are only few studies using cine MRI to consider bowel motion 
disorders in Crohn's disease. Furthermore, this method lacks an objective view 
and reproducible quantification of bowel motility. The aim of this study was to 
establish an automated algorithm for visualizing and quantifying bowel motion 
disorders in Crohn's disease by cine MRI.
Material and Methods: Twenty patients with suspected or diagnosed Crohn's 
disease underwent MR examination on a 1.5T scanner (Avanto, Siemens). In 
addition to the standard MRI bowel protocol, coronal T2-weighted cine MR 
images were acquired with a temporal resolution of 7.5s continuously over a 
time span of 150s. After affine 2D respiratory motion correction, bowel motility 
was estimated from cine MRI using an optical flow algorithm. The resulting 
motion vector magnitudes were color coded into bowel motility maps.
Results: Increased or decreased bowel movement visualized by intuitive heat 
mapping within the cine MRI allows for detecting segments of abnormal bowel 
motility. The different colors were defined by abnormally increased or 
decreased peristaltic motion compared with adjacent bowel. Particularly, 
inflamed bowel segments exhibited a decreased motility.
Conclusion: Bowel motilities highlighted by different colors within the T2w 
cine MRI is a feasible and promising new approach for detecting bowel motility 
disorders in Crohn's disease. In future, this method may be useful to identify 
pathological conditions or abnormalities of bowel segments with only subtle 
signs of inflammation on static images.
11:00 - 12:30 Room F
Scientific Session 8
Imaging of inflammatory small bowel 
diseases
SS 8.01
A technique for global small bowel motility assessment 
using dynamic MRI
A. Menys1, A. Plumb1, S.A. Taylor1, A. Ahmed1, A. Alam1, 
F. Odille2, A. Emmanuel1, S. Halligan1, D. Atkinson1; 
1London/UK, 2Nancy/FR
Purpose: To develop an MRI-based index of small-bowel motility, test its 
repeatability in human volunteers and to test its ability to detect changes 
induced by pharmacological challenge.
Material and Methods: 20 healthy volunteers (mean age 28, 13 male) 
underwent baseline cine MRI utilising 3D Balanced Turbo Field Echo to capture 
small bowel motility in 15 cm volume blocks over a 20-s breath hold. A 
randomised blinded, placebo-controlled cross-over study of either 0.5 mg 
Neostigmine or saline (n=10) or 20 mg IV Butylscopolamine or saline (n=10) 
was performed with motility MRI at baseline and repeated at mean 4 weeks 
(range 2-7). Two readers drew regions of interest around small bowel 
independently, and motility was quantified using a registration algorithm that 
provided a global motility metric in arbitrary units (AU). Repeatability of mean 
baseline AU was assessed using Bland Altman (BA) and within-subject 
coefficient of variation (wCV). Changes in mean AU following drug 
administration was compared to placebo using paired t-testing.
Results: Repeatability between baseline measurements of motility was high; 
BA mean difference -0.0025, range 0.28 to 0.4, 95% Limits of Agreement at 
±0.044AU and wCV of 4.9%. Measured motility following neostigmine (mean 
0.39AU) was significantly higher than placebo (mean 0.34AU), p<0.001, whilst 
that following Butylscopolamine (mean 0.13AU) was significantly less than 
placebo (mean 0.30AU) p<0.001.
Conclusion: MRI-generated software-quantified small bowel motility in 
healthy volunteers is repeatable and sensitive to changes induced by 
pharmacological manipulation.
SS 8.02
Validation of dynamic contrast-enhanced and diffusion-
weighted imaging for quantitative Crohn's disease 
assessment based on histologic characterization
J.A.W. Tielbeek1, M. Ziech1, Z. Li2, C. Lavini1, S. Bipat1, 
W. Bemelman1, J. Roelofs1, C.Y. Ponsioen1, F. Vos2, 
J. Stoker1; 1Amsterdam/NL, 2Delft/NL
Purpose: To prospectively compare conventional MRI, dynamic contrast-
enhanced (DCE)-MRI and diffusion-weighted imaging (DWI) sequences to 
histopathology of surgical specimens in Crohn’s disease (CD).
Material and Methods: 3T MR enterography was performed in 25 consecutive 
CD patients scheduled for surgery within 4 weeks. Features such as mural 
thickness, T1 signal ratio and T2 signal ratio were determined; ROI’s were 
drawn on DCE-MRI for maximum enhancement (ME), initial slope of increase 
(ISI), time to peak (TTP) and on DWI for apparent diffusion coefficient (ADC). All 
were compared with location matched-histopathologic grading of acute 
inflammation score (AIS) and fibrostenosis score (FS) by Spearman correlation, 
Kruskal Wallis and Mann-Whitney test.
Results: Twenty patients (mean age 38 years, range 21-73, 12 females) were 
included and 50 bowel locations were matched to AIS and FS. Mural thickness, 
T1 signal ratio, T2 signal ratio, ME and ISI correlated significantly to AIS (r = 
0.634, 0.392, 0.485, 0.520, 0.510, respectively, all p<0.05). Mural thickness, T1 
signal ratio, T2 signal ratio, ME and ISI differed significantly between the 
grades of FS (p<0.001, p=0.001, p=0.021, p=0.005 and p=0.020, respectively). 
ADC values differed significantly between the non-fibrotic sections and the 
fibrotic sections (p=0.023).
Conclusion: Quantitative parameters from conventional, DCE-MRI and DWI 
sequences correlate significantly to histopathologic scores of surgical 
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SS 8.07
The accuracy of CT enterography in the diagnosis of 
terminal ileal disease: a retrospective analysis
T. Mistry, G. Bhatnagar, E. Lemoniati, H.S. Sidhu, 
R. Ilangovan, S. Thomas-Gibson, M. Marshall; Harrow/UK
Purpose: CT enterography (CTE) is reported to have high sensitivity and 
specificity for diagnosing Crohn’s disease. Due at least in part to the lack of a 
gold standard examination for small bowel disease, there is little high-quality 
published data relating to the earliest signs of mucosal disease. We examine 
the accuracy of CTE for terminal ileitis in comparison to terminal ileoscopy (TI).
Material and Methods: CTE and TI findings were reviewed in patients attending 
St Mark’s hospital between June 2011 and May 2012. Discrepant cases were re-
evaluated by 3 independent GI radiologists blinded to the prior CTE and TI report.
Results: 36 patients underwent CTE and TI (mean interval 7 days). Prevalence, 
sensitivity, specificity, PPV and NPV for terminal ileitis on CTE were 36% 
(95%CI 21%-54%), 69% (95%CI 39-90%), 83% (95%CI 60-94%), 69% 
(95%CI 39-90%), 83% (95%CI 60-94%), respectively. Re-evaluation of 
discrepant cases demonstrated fair to moderate inter-observer correlation 
(kappa values 0.3-0.5 (Landis & Koch 1977)) between the three readers with 
mildly improved accuracy.
Conclusion: CTE is an important diagnostic tool in Crohn’s disease. However, 
identification of early inflammation is challenging. We demonstrate that not all 
radiographic signs reported to depict inflammation are reliable in accurately 
diagnosing terminal ileitis. Furthermore, we demonstrate significant variation in 
interpretation between expert readers. We recommend further studies to 
demonstrate correlation between radiological signs on CTE and pathology.
SS 8.08
Low-dose abdominopelvic CT in active Crohn's disease: 
image quality and diagnostic accuracy with model-
based iterative reconstruction
S.B. O'Neill, L. Crush, K.N. O'Regan, O.J. O'Connor, 
M. Maher; Cork/IE
Purpose: We designed a prospective, intra-individual study to determine the 
feasibility and diagnostic accuracy of low-dose CT (LD-CT) reconstructed with 
model-based iterative reconstruction (MBIR) in the setting of active Crohn's 
disease (CD). We compare the diagnostic performance of LD-CT with MBIR 
with synchronously acquired conventional dose CT (CD-CT).
Material and Methods: CD-CT and LD-CT datasets were acquired in 34 
consecutive patients with active CD. LD-CT images were reconstructed with 
MBIR, 40% and 70% adaptive statistical iterative reconstruction (ASIR). Image 
quality parameters were subjectively scored and image noise was objectively 
measured. LD-CT images were clinically interpreted by 2 radiologists in 
random order with interpretation of the CD-CT images after a 6-week delay.
Results: Mean ED was 1.27±0.87 mSv for LD-CT compared with 4.8±2.99 mSv 
for CD-CT. Reconstructing LD-CT images with MBIR resulted in a significant 
decrease in mean objective noise when compared with ASIR-40 and ASIR-70 
images (p<0.001). No acute complication of CD was missed on the LD-CT MBIR 
images with excellent statistical agreement between the findings identified on 
LD-CT MBIR and CD-CT images (k= 0.871). There was also substantial inter-
rater agreement with LD-CT MBIR interpretations (k=0.715).
Conclusion: Abdominopelvic CT at doses close to 1 mSv reconstructed with MBIR 
detected all acute complications in patients with active CD. This protocol has 
potential to effect substantial cumulative effective dose reductions in this cohort.
SS 8.05
MR enterography for planning fluoroscopically assisted 
endoscopic balloon dilatation in small bowel Crohn's 
strictures
E.M. Thomson, J. Hamlin, H. Lambie, N. Mohammed, 
F. Majeed, R. Hyland, D.J.M. Tolan; Leeds/UK
Purpose: Intestinal strictures are a complication of Crohn’s disease (CD). 
While surgical treatment was standard management, endoscopic dilatation 
offers an attractive alternative. We set out to (1) determine the correlation of 
MR enterography (MRE) with endoscopic findings in intestinal strictures 
complicating CD and whether MRE can select patients for dilatation treatment 
and (2) evaluate our experience and success of fluoroscopically assisted 
endoscopic dilatation.
Material and Methods: Retrospective review of patients undergoing balloon 
dilatation for CD-related strictures. All had undergone MRE prior to dilatation 
procedures. Outcomes evaluated were correlation of MRE and endoscopy 
findings; endoscopic success (able to traverse the stricture endoscopically 
after dilatation); clinical success (symptomatic improvement); and 
complications both immediate and longer term including the need for 
escalation of medical therapy, further dilatation or surgical intervention.
Results: 65 dilatations were performed in 37 patients with a median age of 47 
years. Median follow-up period was 21 months. MRE findings correlated with 
endoscopic findings in 30/37 (81%) of cases. Endoscopic success was seen 
in 34/37 (91%) and clinical success in 32/37(86%) of cases. 1 patient (3%) 
developed perforation following dilatation.
Conclusion: MRE findings correlate well with endoscopic findings and can be 
used effectively to help plan dilatation. Fluoroscopic screening helps to avoid 
surgery by facilitating safe and effective dilatation of CD-related strictures with 
good endoscopic and clinical success rates.
SS 8.06
Specific features of pediatric Crohn's disease detected 
at MRE
N. Al Ansari, F. Mazzamurro, R. Giovannone, V. De Marco, 
F. Maccioni; Rome/IT
Purpose: To retrospectively describe Crohn's disease (CD) in paediatric 
patients (PP) in terms of the location and activity of intestinal lesions.
Material and Methods: 70 children (mean age 15 years) with proven CD 
underwent magnetic resonance enterography (MRE), after the administration 
of negative or biphasic contrast agent, according to age and compliance of the 
patients, to localize lesions and to detect their activity in 9 segments of the 
small and large bowel. The results were analyzed on a per patient and per 
segment basis. Ileo-colonoscopy was performed in all patients.
Results: Involvement of terminal ileum was observed in 60% of PP. The colon 
was diseased in 87% of PP. In particular, left colonic segments were 
significantly involved in PP (descending colon 58%; rectum 68%, sigmoid 
colon 58%). The maximal disease activity was found in the left colonic 
segments.
Conclusion: MRE detected significant features of CD in PP, showing a more 
extensive and severe involvement of the left colon than distal ileum, differently 
from adult patients. The causes of the severe left colonic disease in children 
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Shear wave elastography for liver stiffness 
measurement in clinical ultrasound examination: 
evaluation of intraobserver reproducibility, technical 
failure and unreliable stiffness measurement
J.H. Yoon, J.M. Lee, J.K. Han, B.I. Choi; Seoul/KR
Purpose: To evaluate technical failure, unreliable stiffness measurement and 
intraobserver reproducibility of shear wave elastography (SWE) in assessing 
liver stiffness (LS) during clinical ultrasound (US) examinations.
Material and Methods: This retrospective study was approved by our 
institutional review board, and informed consent was waived. 423 patients 
who underwent abdominal US including SWE were enrolled in this study. SWE 
was performed by using a convex probe. In each patient, two sessions of SWE 
were carried in the liver right lobe, five times a session. Technical failure was 
defined when no or little signal was obtained in the SWE box for all acquisitions, 
and unreliable results of SWE was determined as coefficient of variant (CV) 
exceeds 25%. Intraobserver agreement was assessed by intraclass correlation 
coefficient (ICC) and 95% Bland-Altman limits of agreement.
Results: Technical failure occurred in 35 patients (8.3%). Unreliable 
measurements occurred in 58 patients (13.7%). Among the reliably measured 
330 cases, there was no significant difference of median LS values between 
the two sessions (6.8 kPa vs. 6.7 kPa; p >0.05). CVs of the 1st and 2nd 
sessions were 15.6±6% and 16±5.92%, respectively. The overall intraobserver 
reproducibility was excellent (ICC=0.97). The 95% limit of agreement between 
the repeated SWE measurements was 2.88 kPa and -2.56 kPa.
Conclusion: SWE using median LS value seems to be a reproducible 
noninvasive method, although relatively large CV of SWE necessitates multiple 
LS measurements.
SS 9.02
First intention-to-diagnose comparison of ARFI and 
Fibroscan in chronic liver diseases
V. Cartier, D. Bardou, J. Boursier, J. Lebigot, S. Michalak, 
I. Fouchard, C. Aube; Angers/FR
Purpose: To compare ARFI and Fibroscan in an intention-to-diagnose (ITD) 
basis for the non-invasive diagnosis of liver fibrosis.
Material and Methods: 219 consecutive patients with chronic liver disease 
and biopsy were included. Liver stiffness measurements were performed by 
ARFI (right lobe: ARFI-D, left lobe: ARFI-G) and Fibroscan (right lobe). ARFI-DG 
corresponded to the median value of all valid measurements obtained in both 
lobes. Reference for fibrosis was Metavir F staging. Diagnostic accuracy was 
evaluated using AUROC and Obuchowski index (adjusted AUROC). For ITD 
analysis, failures of elastographic measurement were replaced by the median 
value measured in the opposite group of the biopsy diagnosis.
Results: Fibrosis stage prevalence: F≥2: 50%, F≥3: 26%, F4: 9%. Rate of 
measurement failure: ARFI-D or ARFI-G: 0.5% versus Fibroscan: 5.9% 
(p=0.002). In per-protocol analysis, AUROCs of Fibroscan were significantly 
higher than those of ARFI-D for each diagnostic target (p<0.022), and those of 
ARFI-G or ARFI-DG for F4 (p<0.028). In ITD analysis, Fibroscan AUROCs 
decreased showing no significant difference with ARFI-D, ARFI-G, and ARFI-
DG for each diagnostic target. Comparison of Obuchowski indexes showed 
the same results.
Conclusion: ARFI and Fibroscan have close and high accuracy for liver 
fibrosis diagnosis. Due to a higher failure rate, accuracy of Fibroscan decreases 
in the ITD analysis but remains not significantly different from ARFI accuracy.
SS 8.09
Pilot study to assess the diagnostic performance of MRI 
in the identification of adhesions between the abdominal 
wall and small bowel loops, using a time efficient 
protocol
G. Bhatnagar, R. Tandon, A. Hansmann, P. Lung, H.S. Sidhu, 
R. Ilangovan, M. Marshall, A. Gupta; Harrow/UK
Purpose: Abdominal adhesions following surgery are the commonest cause 
of small bowel obstruction. Accurate identification of adhesions has been 
reported using MR fluoroscopy sequences. We report our results utilising a 
time efficient protocol.
Material and Methods: 10 patients scheduled for open colorectal surgery and 
who had undergone previous abdominal surgery were recruited over 4 months 
(mean age 44; range 29-59). The abdomen was divided into 9 segments prior 
to MR and surgery enabling accurate correlation. Using a 1.5T scanner 
(Siemens Avanto), T2 sagittal, axial, sagittal true-FISP 30s cine sequences 
were obtained in inspiration, expiration and abdominal strain within 8 min. 
Adhesions were identified by consensus following independent analysis from 
4 readers and compared to laparotomy (the gold standard).
Results: Of 90 abdominal segments, adhesions were identified in 44% at 
laparotomy and 34% on consensus MR opinion. 31 segments demonstrated 
adhesions on MR; 74% (95% CI 64%-83%) correlated at surgery, whilst the 
remainder was found in adjacent segments (26%). Sensitivity, specificity, PPV 
and NPV were 60% (95% CI 43%-75%), 86% (95% CI 73%-94%), 77% (95% 
CI 59%-90%) and 73% (95% CI 60%-84%), respectively.
Conclusion: Our results suggest utilisation of a time-efficient MR protocol in 
identifying adhesions between the bowel and anterior abdominal wall is 
feasible, and may represent a non-invasive application in the research of 
adhesion-preventative techniques. Reader performance rose during our study 
and further improvements may be realised in a larger trial.
SS 8.10
Comparison of magnetic resonance enterography and 
small bowel follow through in intestinal tuberculosis
N. Kalra, J.S. Krishna, P. Singh, R. Kochhar, R. Gupta, 
R. Singh, N. Khandelwal; Chandigarh/IN
Purpose: To compare magnetic resonance enterography (MRE) and small 
bowel follow through (SBFT) in intestinal tuberculosis.
Material and Methods: 30 consecutive patients who presented with clinical and 
radiologic suspicion of intestinal tuberculosis were enrolled in this prospective 
study. MRE and SBFT were done within 2 weeks of each other. The imaging 
findings were evaluated by two radiologists who were blinded to each other. 19 
of the 30 patients were finally diagnosed as tuberculosis. The remaining 11 
patients were either normal (n=6) or had alternate diagnoses (n=5).
Results: Out of the 19 patients with tuberculosis, 9 patients had ileocaecal 
junction involvement which was detected by both MRE and SBFT. Strictures in 
jejunum and ileum were seen in 7 of the 19 patients by both these imaging 
techniques. However, MRE detected more strictures (n=34) compared to SBFT 
(n=23). MRE also showed segmental mild mural thickening in 6 patients out of 
which only one could be demonstrated on SBFT. MRE detected extraenteric 
findings like lymphadenopathy (n=17), ascites (n=5), peritoneal involvement 
(n=6), splenic granuloma (n=1) and spondylodiscitis (n=1). Overall MRE had 
higher sensitivity and specificity for diagnosis of tuberculosis (100%, 95% 
confidence interval, CI: 1.000-1.000 and 72.73%, 95% CI: 0.464-0.990, 
respectively) compared to SBFT (88.23%, 95% CI: 0.729-1.036 and 70%, 95% 
CI: 0.416-0.984, respectively).
Conclusion: MRE is an alternative to SBFT and has the potential to become a 
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SS 9.05
MRI biomarkers on type-II diabetes mellitus patients: 
which role for multi-echo GRE and IVIM-DWI imaging?
S.I. Goncalves, F. Caseiro Alves, M. Castelo Branco; 
Coimbra/PT
Purpose: Evaluate the role of ME-GRE [2] and IVIM-DWI [3] as surrogate 
biomarkers of NAFLD [1] in patients with type-II diabetes mellitus (DM).
Material and Methods: Thirty-two asymptomatic patients (mean age 60±8) 
and 37 controls (mean age 49±7) were prospectively enrolled. IVIM-DWI and 
ME-GRE on a 3T scanner (Magnetom Trio, Siemens): FOV=400×400 mm, 1 
slice 10 mm thick; IVIM-DWI - TR/TE=3800/67 ms, 16 b-values, 3.12×3.12 mm 
in-plane resolution; ME-GRE - TR/TE=30/2.46, 3.69, …, 15.99 ms (12 echoes), 
2.08×2.08 mm in-plane resolution. Quantification for (a) liver fat fraction (FF) (b) 
T2* values as in [2]; (c) molecular diffusion (D (×10-3 mm2/s)), (d) pseudo-
diffusion (D*(×10-3 mm2/s)), and e) perfusion fraction (f) as in [3]. 
Results: 5% (31%) of controls (patients) showed FF values higher than 10%. 
D, D* and f of patients (1.17±0.27, 65±24, 0.26±0.09) and controls (1.22±0.27, 
66±28, 0.27±0.08) were not significantly different (p=0.05). However, D 
(1.04±0.13) and D* (54±10) for fatty liver (FL) patients (n=10) were significantly 
lower (p=0.05) compared to controls [4]. FF, D and D* differentiate FL patients 
from controls; T2* values not significantly different.
Conclusion: ME-GRE and IVIM-DWI are sensitive to NAFLD in the context of 
type II DM patients. References: [1] Neuschwander-Tetri et al., Hepatology, 
37(5), 1202-1219, 2003, [2] O’Reegan et al., Radiology, 247(2), 550-557, 2008; 
[3] Luciani et al., Radiology, 249 (3), 891-899, 2008; [4] Guiu et al., Radiology, 
265, 96-103, 2012.
SS 9.06
Diagnostic algorithm for high liver iron overload
J.M. Alústiza; San Sebastian/ES
Purpose: To develop and validate a diagnostic algorithm for high iron overload 
(HIO) based on laboratory and genetic variables.
Material and Methods: We collected a retrospective cohort with consecutive 
patients studied by MRI to determine liver iron concentration (LIC). We 
analyzed all variables using univariate statistics with the MRI acting as the gold 
standard. We validated the algorithm in a prospective cohort. HIO is considered 
if the hepatic iron index >1.9 (estimated by MRI).
Results: Retrospective cohort: 242 patients. 36 had HIO. 117 had both 
transferrin saturation index (TSI) and ferritin elevated and 28 (11.5%) were 
C282Y homozygous. Final algorithm: We consider a patient as having HIO with 
TSI and ferritin elevated and C282Y homozygosis. HIO is discarded if TSI or 
ferritin is normal. The rest should be studied by MRI. Prospective cohort: 177 
patients. 5 were TSI and ferritin elevated with C282Y homozygosis. Four of 
them proved to have HIO by MRI, PPV=80% (37.6-96.4) Specificity= 99.4% 
(96.8-99.9). 131 had TSI or ferritin within normal values. Two of them had HIO 
NPV=99.2% (95.8-99.9), Sensitivity=83.3% (43.6-97). 23% needed to have a 
diagnostic MRI for HIO.
Conclusion: MRI is not necessary in 77% of the patients for HIO diagnosis. 
MRI is indicated in patients who are C282Y non-homozygous with raised TSI 
and ferritin.
SS 9.03
CT texture as a novel biomarker of liver fibrosis
M.Y.S. Wan, B. Ganeshan, K. Miles, J. Karani; 
London/UK
Purpose: To determine if CT texture of liver and spleen is related to liver 
fibrosis severity.
Material and Methods: Histology and radiology databases (2009-2011) in a 
tertiary liver centre were reviewed. Patients with chronic viral hepatitis who had 
a contrast-enhanced CT and liver biopsy within 3 months of each other were 
selected. Severity of liver fibrosis was staged using modified histology activity 
index (HAI – Ischak). Patients whom had CT for other indications, without risk 
factor for liver disease were used as control. Regions of interests were drawn 
around the liver and spleen and analysed using a proprietary software (TexRad) 
which quantified Entropy, Uniformity, Kurtosis, Skewness, Standard-deviation 
on prefiltered CT images, using different filters (fine, medium, coarse).
Results: 29 patients (mean age 43.8) and 10 controls (mean age 42.8) were 
identified. Median for HAI was 3, standard deviation 1.8. Spearman’s rank 
correlation shows significant strong correlation between HAI and venous phase 
liver texture parameters: Kurtosis(medium) (r=-0.667, p≤0.001), Skewness(medium) (r= 
-0.725, p=<.0001) and Mean density(unfiltered) (r= -0.583, p<0.001). There is a 
significant strong correlation between HAI and the arterial phase spleen Mean 
density(unfiltered) (r=-0.589, p<0.001).
Conclusion: We have established the feasibility of CT texture as a novel 
biomarker for liver fibrosis. Kurtosis and skewness of the venous phase liver 
CT are strongest predictors of severity of liver fibrosis.
SS 9.04
Interobserver agreement for 3T magnetic resonance 
elastography and histological liver fibrosis stage
J.H. Runge1, A.E. Bohte1, J. Verheij1, V. Terpstra2, 
A.J. Nederveen1, C.M. Van Nieuwkerk1, R.J. De Knegt3, 
L.C. Baak1, P.L. Jansen1, R. Sinkus4, J. Stoker1; 
1Amsterdam/NL, 2The Hague/NL, 3Rotterdam/NL, 4Paris/FR
Purpose: To compare interobserver agreement for MR-Elastography (MRE) of 
the liver and histological fibrosis staging.
Material and Methods: 103 patients with viral hepatitis B or C who underwent 
liver biopsy were scanned with MRE at 3T. Mechanical waves were applied 
with a vibrating piston at 50Hz. Using a SE-EPI sequence, elasticity and 
displacement-amplitude maps were generated, voxel size: 4x4x4mm. Two 
readers independently selected a region of interest (ROI) in the liver, avoiding 
liver edges, large vessels and areas with displacement-amplitudes <4.5µm. 
Mean elasticity was derived from each ROI. Two pathologists independently 
scored biopsies for fibrosis using the Metavir scoring system (0-4). All were 
blinded to clinical data. Interobserver agreement for MRE and biopsy was 
assessed with intraclass correlation coefficients (ICC).
Results: MRE and biopsy data were available for 81/103 patients. Spearman’s 
correlation between MRE and fibrosis stage was 0.687. For histological 
grading, ICC of fibrosis stage was 0.905 (95%-CI:0.857-0.938). For MRE, ICC 
of elasticity was 0.992 (95%-CI:0.977-0.996) which was significantly higher 
(p=0.0001). Median difference in ROI-size between MRE readers was 135 
voxels [IQR:60-213].
Conclusion: Although interobserver agreement of fibrosis staging using 
histopathology was very good, interobserver agreement of MRE was even 
higher. This difference was statistically significant. Variation in ROI-size 
between MRE readers had a minor effect on the ICC of MRE. The high 
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SS 9.09
Fulminant hepatic failure: correlation among different 
aetiologies, MDCT findings and histopathology in adult 
transplanted patients
A. Pecchi, D. Corniani, M. De Santis, L. Maccio, L. Losi, 
N. De Ruvo, F. Di Benedetto, P. Torricelli; Modena/IT
Purpose: To describe the main features at MDCT of fulminant hepatic failure 
of different aetiologies, and correlating them with histopathological findings on 
explanted livers.
Material and Methods: The MDCT-exams of 11 patients transplanted 
between 2003 and 2011 were retrospectively evaluated and correlated with 
the histopathological examinations.
Results: MDCT revealed hepatomegaly in 6/11 patients, 5 confirmed by 
macroscopic evaluation. All patients showed smooth liver surface at MDCT 
imaging and at macroscopic examination. A diffuse hepatic parenchymal 
hypoattenuation was observed in 10/11 patients, correlating with the diffuse 
hepatocytes necrosis at histopathology. In all exams, we found periportal 
hypoattenuation and in 7 of them diffused peribiliary THADs corresponding to 
periportal inflammatory infiltration and ductular proliferation. All patients had 
thickened gall-bladder wall corresponding to inflammatory infiltration. Ascite 
was present in 9/11 patients, splenomegaly in 6/11 and thickened colon wall in 
3 patients.
Conclusion: A diffuse hepatocytes necrosis and an inflammatory cell 
infiltration were the main histopathological findings on explanted liver for 
fulminant hepatic failure. They were the pathological basis of the main features 
founded on MDCT imaging: diffuse parenchymal and periportal hypoattenuation 
and thickened gall bladder wall. The regenerative liver processes might be at 
the basis of parenchymal heterogeneous density, such as THAD.
SS 9.10
Opportunistic screening for hereditary 
hemochromatosis using unenhanced CT: determination 
of an optimal liver attenuation threshold
P.J. Pickhardt, B.D. Pooler, E. Lawrence; Madison, WI/US
Purpose: To evaluate for a liver attenuation threshold at unenhanced CT that 
might allow for sensitive and specific detection of unsuspected hereditary 
hemochromatosis.
Material and Methods: To establish normal distribution of liver attenuation 
and test-positive rates of various thresholds, hepatic attenuation was 
measured at unenhanced CT in 3,357 consecutive asymptomatic adults (mean 
age, 57.0 years) undergoing colorectal cancer screening. To assess sensitivity, 
hepatic attenuation was measured at unenhanced-CT in 12 patients (mean 
age, 48.3 years) with genetically confirmed hemochromatosis (homozygous 
for C282Y mutation of HFE gene), including three cases detected by screening 
CTC.
Results: Mean liver attenuation in asymptomatic adults was 59.4±12.7 HU, 
compared with 78.7±13.1 HU (range, 59-105 HU) in the hemochromatosis 
cohort (p<0.001). Test-positive rates for triggering iron/ferritin studies in the 
screening cohort was 30.6% (n=1,028) at 65 HU, 8.2% (n=275) at 70 HU, 1.2% 
(n=39) at 75 HU, and 0.2% (n=7) at 80 HU. Corresponding sensitivity for 
hemochromatosis at these thresholds was 83.3% at 65 HU, 83.3% at 70 HU, 
83.3% at 75 HU, and 50.0% at 80 HU.
Conclusion: An unenhanced-CT liver attenuation threshold of 75 HU would be 
both sensitive (83%) and specific (~99%) for the detection of clinically relevant 
hereditary hemochromatosis. Unexplained liver attenuation ≥75 HU (1% 
prevalence among asymptomatic adults) should trigger a blood draw, since 
early intervention with phlebotomy can prevent significant organ damage.
SS 9.07
Quantitative analysis of arterial enhancement fraction in 
Hepatitis C viral-related chronic liver diseases using 
dual energy multiphasic CT as objective index for 
assessment of hepatic hemodynamic alteration: initial 
experience
S. Kobayashi1, O. Matsui1, T. Gabata1, W. Koda1, T. Minami1, 
K. Kozaka1, A. Kitao1, K. Otani2, B. Krauss3; 1Kanazawa/JP, 
2Tokyo/JP, 3Forchheim/DE
Purpose: The purpose of this study was to clarify whether quantitative color 
map of arterial enhancement fraction (AEF) generated with arterial and portal 
phase images of contrast-enhanced dual energy CT (DECT) can reflect 
hemodynamic differences of hepatitis C viral (HCV)-related chronic liver 
diseases.
Material and Methods: 22 patients who underwent abdominal multiphasic 
DECT for closer examination of HCV positive hepatic disease (chronic 
hepatitis, CH-C n=12; cirrhosis without major portosystemic collateral, LC-C 
PS (-) n=7; cirrhosis with major portosystemic collateral, LC-C PS (+) n=5), and 
normal control liver (NL n=8) were included in this study. AEF color map was 
generated with prototype software. The mean AEF of each groups were 
compared with t-test. In addition, AEF of hepatic central zone (AEF-cz) and 
hepatic peripheral zone (AEF-pz) were also compared within each group.
Results: Average AEF in each groups were as follows; CH-C -57.0±11.4%, 
LC-C PS(-) -61.0±10.9%, LC-C PS(+) -44.9±18.8%, NL -44.7±10.3%. There 
were significance differences between CH-C and NL (P=0.02), LC-C PS (-) and 
NL (P=0.01). However, there were no significant differences between AEF-cz 
and AEF-pz within each group.
Conclusion: Quantitative AEF map generated with DECT might be useful as 
objective index to assess the hemodynamic differences of HCV-related chronic 
liver diseases.
SS 9.08
Gd-EOB-DTPA-enhanced MRI: estimation of liver 
function using T1 mapping
M. Haimerl, N. Verloh, C. Fellner, C. Niessen, A.G. Schreyer, 
C. Stroszczynski, P. Wiggermann; Regensburg/DE
Purpose: To determine the ability of T1 mapping of liver on Gd-EOB-DTPA-
enhanced MR imaging (MRI) for estimating liver function and to compare the 
estimated liver function to the Model for End-Stage Liver Disease (MELD) 
score.
Material and Methods: 75 patients underwent Gd-EOB-DTPA-enhanced MRI 
on a 3T system. Patients were classified into two groups: MELD-Score < 9 
(n=49) and MELD-Score ≥ 9 (n=26). Two TurboFLASH sequences (TI = 400 ms, 
1000 ms) were acquired before and 20 min after Gd-EOB-DTPA administration 
to obtain T1 maps. T1 relaxation times were determined indicating Gd-EOB-
DTPA liver-uptake and correlated to the MELD-Score.
Results: Significant changes between T1 relaxation times of non-enhanced 
MRI (778 ± 133 ms) and Gd-EOB-DTPA-enhanced MRI (339 ± 120 ms) were 
observed (p<0.001). T1 relaxation time for non-enhanced MRI showed no 
significant differences (p=0.526) between the group with MELD-Score < 9 (777 
± 150 ms) and the group with MELD-Score ≥ 9 (780 ± 97 ms). After 
administration of Gd-EOB-DTPA T1 relaxation time of patients with MELD-
Score < 9 (299 ± 103 ms) and patients with MELD-Score ≥ 9 (416 ± 112 ms) 
shows a significant difference (p<0.001).
Conclusion: Patients with advanced liver disease showed significantly lower 
changes in T1 mapping. Therefore, evaluation of changes in T1 mapping of the 
liver parenchyma may serve as a useful method to determine whole liver 
function, to improve the estimation of segmental liver function and finally to 
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SS 10.03
Diffusion-weighted imaging in the follow-up of patients 
after primary surgical and non-surgical treatment for 
rectal cancer
D.M.J. Lambregts, M.J. Lahaye, L.A. Heijnen, M.H. Martens, 
B.E. Heidemann, M. Maas, G.L. Beets, R.G.H. Beets-Tan; 
Maastricht/NL
Purpose: To evaluate the value of diffusion-weighted MRI (DWI) in the follow-
up of patients after primary surgical or non-surgical rectal cancer treatment.
Material and Methods: The study group (n=117) consisted of 36 patients who 
had previously undergone standard surgery (+/- neoadjuvant treatment), 40 a 
local excision (15 after chemoradiotherapy) and 41 a ‘wait-and-see’-policy. 
During clinical follow-up (FU), patients underwent ≥1 FU-MRIs (1.5T) including 
DWI, as a part of routine FU or because of a suspected local recurrence. Two 
readers in consensus evaluated each MRI and scored the (b1000) DWI-images 
as ‘no high signal/no recurrence’, ‘high signal suspected of recurrence’ or ‘not 
adequately assessable due to focal image artefacts’.
Results: Patients underwent a mean number of 3 FU-scans (range 1-11) with 
a mean FU-time of 44 months (4-144). 27/117 patients developed a local 
recurrence, of which 23 (85%) were accurately detected on DWI. The other 90 
patients together underwent a total of 261 FU scans, of which 194 (74%) 
remained negative (no high signal) on DWI. 57 DWI-scans (19%) could not 
adequately be assessed due to artefacts. 14 DWI-scans were false positive 
(mainly at the first FU after surgery/local excision) of which 50% again 
normalised during further FU.
Conclusion: DWI is a useful imaging tool in the follow-up of patients after 
primary rectal cancer treatment. False positives may occur immediately after 
surgery, but the DWI signal normalises again during follow-up.
SS 10.04
Structured reporting in rectal cancer staging: a proposal
R. Scandiffio, A. Mantarro, L. Faggioni, P. Vagli, R. Balestri, 
P. Buccianti, E. Neri, C. Bartolozzi; Pisa/IT
Purpose: To highlight the relevant information that should be included in a 
structured MRI report for rectal cancer (RC) staging.
Material and Methods: From March 2012 to January 2013, 100 patients with 
rectal cancer were prospectively evaluated at 3T MRI. A structured report was 
used by 3 experienced radiologists to describe relevant findings in 50 patients. 
Report included the following information: tumor location, longitudinal extent 
and maximum thickness parietal involvement; lumen stenosis; distance from 
the distal margin of the lesion and puborectal muscles; extent of extramural 
invasion; lesion morphology (infiltrative or nodular); distance from the 
mesorectal fascia; relationship with elevator muscles and extramural vessels; 
lymph node involvement. Diagnostic accuracy and mean reporting time was 
assessed.
Results: Diagnostic accuracy resulted superimposable in structured and non- 
structured reporting (75% and 77%); mean reporting time resulted in 15 and 
20 min, respectively.
Conclusion: The main advantages of a well-structured report include reduction 
of reporting time, the possibility of creating an easily accessible database and 
clearer description of imaging findings to clinicians, allowing for detailed 
comparison with previous MRI examinations.
11:00 - 12:30 Room H2
Scientific Session 10
GI Tract: From oesophagus to rectum
SS 10.01
CT colonography with rectal iodine tagging: evaluation 
of diagnostic accuracy and image quality
A. Mantarro, L. Faggioni, P. Bemi, R. Scandiffio, P. Vagli, 
E. Neri, C. Bartolozzi; Pisa/IT
Purpose: To evaluate diagnostic accuracy and image quality of CT-
colonography (CTC) examinations performed with rectal iodine tagging.
Material and Methods: Thirty-five patients (male:female=19:16, age 49-78 
years, mean 62 years) with a total of 44 lesions (37 sized between 6 and 9 mm, 
and 7 between 10 and 30 mm) were selected from a screening population for 
colorectal cancer (500 patients). Patients underwent CTC on a 64-row CT 
scanner following a 3-day low-residue diet plus a low dose of Macrogol 4000 
and bisacodyl after lunch, and immediately before CTC they were rectally 
administered 50 mL of diatrizoate dimeglumine (Gastrografin®, Bayer Schering) 
diluted in 300 mL warm tap water, followed by automatic insufflation of 3 L 
carbon dioxide. Patients were asked to turn themselves on the CT table to 
ensure homogeneous luminal enhancement. CTC findings were compared 
with optical colonoscopy, and per-segment image quality was assessed 
visually using a semiquantitative score (1=poor, 2=adequate, 3=excellent).
Results: Sensitivity and specificity of CTC in lesion detection were 94.6% 
(CI95% 80.5±99.1%) and 98.8% (CI95% 95.3±99.8%) for lesions between 6 and 
9 mm, and 100% (CI95% 56.1±100%) and 99.4% (CI95% 96.2±100%) for lesions 
between 10 and 30 mm, respectively. Mean image quality was adequate to 
excellent in all colonic segments (from 2.3 in the cecum to 3 in the sigmoid 
colon).
Conclusion: CTC performed with rectal tagging showed high sensitivity and 
specificity for all lesion sizes with overall good image quality.
SS 10.02
Technical feasibility of elastosonography in the 
assessment of bowel wall in inflammatory bowel 
disease and inter-observer variability
A. Colleoni1, L. Romanini1, M. Ravanelli1, V. Cantisani2, 
L. Grazioli1, P. Ricci2, R. Maroldi1; 1Brescia/IT, 2Rome/IT
Purpose: To investigate the feasibility of US-elastosonography to evaluate the 
abnormal bowel wall and the inter-observer variability as well.
Material and Methods: In this prospective study, we examined 35 consecutive 
patients who underwent US examination of the bowel and showed at least one 
segment with thickened wall underwent an additional elastosonography 
assessment. Overall, 39 abnormal thickened bowel segments were evaluated. 
GE E9 equipment was used, with a linear 6-15 MHz probe. In 39 segments, the 
elastosonography was acquired with 7.5 MHz in 30/39, with 5 MHz in 33/39, 
and in 24/39 with both frequencies. All studies were performed by the same 
operator. The images acquired were subsequently evaluated by two other 
radiologists, separately. Inter-observer variability was calculated by Cohen’s 
test (between two operators) and Randolph’s test (comparing three operators).
Results: All but 4 segments (35/39; 89.7%) were assessable by 
elastosonography. The elastosonography was considered adequate when the 
wall layers distinguished on standard ultrasound were equally detected in the 
color map (grading wall stiffness). The average thickness of the bowel 
segments was 6 mm. The Randolph test demonstrated a moderate agreement 
among the three operators (63%), while Cohen test provided a lesser 
agreement (k=0.39).
Conclusion: The preliminary results indicate the feasibility of US-
elastosonography assessment of abnormal bowel segments in inflammatory 
bowel disease. This could offer the possibility to differentiate fibrotic from 
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SS 10.07
Prognostic significance of novel 18F-FDG PET/CT 
defined tumour parameters in patients with 
oesophageal cancer
K.G. Foley, P. Fielding, W.G. Lewis, A. Karran, D. Chan, 
P. Blake, S.A. Roberts; Cardiff/UK
Purpose: Radiological staging of oesophageal cancer (OC) includes CT, 
endoscopic ultrasound (EUS), and 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) 
positron-emission tomography/computed tomography (PET/CT). The aim of 
this study was to determine the prognostic significance of radiologically 
defined OC tumour volume, including total lymph node metastasis volume, as 
measured by both EUS and PET/CT.
Material and Methods: 103 consecutive OC patients were staged using CT, 
EUS and PET/CT. PET/CT was used to measure tumour volume, including that 
of the primary tumour, nodal involvement and any metastases. Primary 
outcome measure was survival from diagnosis.
Results: 94% of patients had FDG-avid tumours on PET/CT. On multivariable 
analysis, 4 factors were found to be independently and significantly associated 
with survival; EUS T stage (HR 10.302 p=0.041); mean standardized uptake 
value (SUVmean, HR 0.797 p=0.025); PET/CT OC tumour and lymph node 
metastasis volume (HR 1.041 p=0.002); and PET/CT defined lymph node 
metastasis count (HR 3.271 p=0.007). EUS volume and PET/CT stage were 
not significant factors in the multivariate analysis.
Conclusion: PET/CT is an important predictor of survival and further research 
is needed to identify critical prognostic values. Current PET/CT reporting 
strategies should arguably include SUVmean, tumour and lymph node 
metastasis volume and count to enrich prognostic modelling.
SS 10.08
Role of preoperative imaging with MDCT in the 
management of patients with gastroesophageal reflux 
disease symptoms, candidate to sleeve surgical revision
M. Rengo, D. Caruso, F. Vecchietti, L. Bertana, A. Iossa, 
C.N. De Cecco, G. Silecchia, A. Laghi; Latina/IT
Purpose: To evaluate if multidetector computed tomography (MDCT) can be 
helpful and useful in the decision-making process in sleeve patients with 
gastroesophageal reflux disease (GERD) symptoms and to demonstrate the 
reproducibility and accuracy of the technique.
Material and Methods: Twenty-three patients submitted to LSG, complaining 
upper GI symptoms and/or weight regain and scheduled for a sleeve surgical 
revision were investigated. All patients underwent MDCT scan, upper GI barium 
swallow study and endoscopy. MDCT was compared to barium and endoscopy 
features as concern: esophageal dilatation, neo-fundus development and volume, 
hiatal hernia, sleeve size in toto and atrum dilatation. All patients underwent 
laparoscopic sleeve revision. Surgical findings were considered “as gold standard”.
Results: A total of 21 patients with hiatal hernia, neo-fundus or sleeve 
dilatation underwent surgical correction. All findings identified at MDCT were 
confirmed by intraoperative findings. The presence of hiatal hernia was 
significantly underestimated by both barium and endoscopy with a sensitivity 
of 57.1% and 50%, respectively (P=0.04, P=0.02).
Conclusion: MDCT is an accurate method for the detection of hiatal hernias 
and quantification of gastric volumes and can be considered as non-invasive 
method to guide surgery.
SS 10.05
MDCT evaluation of bowel obstruction: can the 
radiologist's experience make a difference?
R. Basilico, V. Calamita, A.R. Ferri, E. Rodolfino, 
N. Civitareale, A. Lella, A.R. Cotroneo; Chieti/IT
Purpose: To evaluate the diagnostic performance of MDCT in the detection of 
site and cause of bowel obstruction and in the diagnosis of bowel wall 
ischemia or infarction, by assessing the added value of the radiologist’s 
experience.
Material and Methods: The MDCT reports of 110 patients with surgical and 
istological diagnosis of bowel obstruction were retrospectively analyzed. We 
calculated the diagnostic accuracy of MDCT reports in the evaluation of the 
cause and the site of obstruction and the sensitivity, specificity, diagnostic 
accuracy values in the detection of bowel wall ischemia or infarction. The 
same MDCT examinations were then reviewed by an experienced abdominal 
radiologist, to compare her results with those of the original MDCT reports.
Results: The diagnostic accuracy in determining the cause of bowel 
obstruction and in defining the site of obstruction were respectively 89% and 
91% for MDCT reports and 92% and 94% for the experienced reader. The 
sensitivity, specificity and diagnostic accuracy of MDCT reports in identifying 
bowel wall ischemia or infarction were respectively 73%, 96% and 91%. The 
sensitivity value for bowel wall ischemia or infarction significantly increased to 
83% for the abdominal radiologist.
Conclusion: MDCT is very accurate in diagnosing the cause and the site of 
bowel obstruction. The radiologist’s experience in abdominal disease 
represents an added value in the diagnosis of bowel wall ischemia or infarction 
occurring in bowel obstruction.
SS 10.06
Morphological and functional evaluation of sleeve 
gastrectomy: MDTC and cMR imaging
M. Rengo, D. Caruso, D. Bellini, A. Iossa, M.M. Maceroni, 
C.N. De Cecco, G. Silecchia, A. Laghi; Latina/IT
Purpose: To evaluate morphological and functional changes after laparoscopic 
sleeve gastrectomy (LSG) using volumetric multidetector computer 
tomography (MDCT), for the evaluation of gastric volumes and thoracic 
migration, and cine magnetic resonance (cMR) of the esophagus, for the 
evaluation of motility anomalies and gastroesophageal reflux.
Material and Methods: Thirteen patients, presenting gastroesophageal reflux 
after LSG, underwent both volumetric MDCT of the stomach and cMR of the 
esophagus. All patients presented gastroesophageal reflux. Gastric volume, 
stomach length, sleeve length, antrum length thoracic migration and staple 
line length were evaluated on MDCT. Motility anomalies of the esophagus and 
the presence of gastroesophageal reflux were evaluated on cMR.
Results: Gastroesophageal reflux was detected by cMR in all patients. 
Thoracic migration was founded in 50% of patients. Mean gastric volume 
increase after surgery (initial volume 200 ml) was 105.3 ml. Antrum or proximal 
sleeve dilatation was found in all patients.
Conclusion: Volumetric MDCT and cMR can identify both morphological and 
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SS 10.09
N-staging of oesophageal carcinoma: is there still a role 
for EUS in patients staged N0 on PET/CT?
K.G. Foley, P. Fielding, W.G. Lewis, A. Karran, D. Chan, 
P. Blake, S.A. Roberts; Cardiff/UK
Purpose: Accurate exclusion of lymph node metastases in oesophageal 
cancer (OC) may prevent unnecessary preoperative chemotherapy. 
Endoscopic ultrasound (EUS) has been shown to be the most accurate 
method of assessing nodal status. However, with the increasing utilisation of 
2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/
computed tomography (PET/CT), our study aims to assess whether separate 
EUS N-staging is still of prognostic value in those staged N0 on PET/CT.
Material and Methods: Ninety-nine consecutive patients (median age 66, 72 
male, 80 ACA, 18 SCC, 1 other) staged as N0 on PET/CT were separated into 
two groups: EUS N0 (n=59) and EUS ≥N1 (n=40). Kaplan-Meier survival 
analysis was performed. Primary outcome was survival from diagnosis.
Results: There was a significant difference in survival between EUS N0 (mean 
survival 35.8 months, 95% CI 32.343 - 39.428) and EUS ≥N1 (mean survival 26.4 
months, 95% CI 20.727 – 32.106, p=0.002) in patients staged N0 on PET/CT.
Conclusion: EUS N-staging still has prognostic value in patients staged N0 on 
PET/CT. PET/CT and EUS continue to have complimentary roles in OC staging.
SS 10.10
Preoperative MDCT assessment for lymphatic gastric 
cancer spread in the era of neoadjuvant treatment
P. Mercuri, M.A. Mazzei, A.V. Parrinello, C. Pozzessere, 
S. Guerrini, N. Cioffi Squitieri, F.G. Mazzei, L. Volterrani; 
Siena/IT
Purpose: To validate the feasibility and accuracy of MDCT for the preoperative 
lymphatic gastric cancer spread.
Material and Methods: 104 patients with primary gastric cancer (mean age 
68.67 years) who consecutively underwent MDCT scan followed by radical 
surgical treatment were prospectively evaluated. Regional lymph nodes were 
considered involved when the short-axis diameter was >5mm for the lymph 
nodes of group 1 and >8mm for the lymph nodes of other group according to 
the Japanese Classification of Gastric Carcinoma. All patients underwent a 
radical lymph node dissection (D2-D3) according to Japanese Research 
Society for Gastric Cancer (JRSGC) guidelines. The removal of nodal stations 
was always preceded by Indian-ink injection in the lesser and greater curvature 
of the stomach; after operation, single lymph nodes were retrieved on the fresh 
specimen by the surgeon, and classified in JRSGC nodal stations for 
pathological examination.
Results: Lymph node invasion was found in 85 cases (81.73%) with a MDCT 
sensitivity and specificity of 89% and 85%, respectively. The rate of 
understaging was higher (15%) than that of overstaging (8%). Lymph node 
status of early forms was correctly staged in all cases. Furthermore, all N3 
cases were correctly staged.
Conclusion: MDCT is a useful technique in the preoperative assessment of 
lymphatic cancer spread and could have a positive impact in clinical decision 
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SS 11.03
HCC detection on CT: can multi-energy spectral CT 
improve lesion conspicuity?
F. Legou1, M. Chiaradia1, P. Richard2, M. Djabbari1, 
F. Pigneur1, C. Costentin1, J. Calderaro1, A. Laurent1, 
A. Rahmouni1, A. Luciani1; 1Creteil Cedex/FR, 2Buc/FR
Purpose: To determine the effect of spectral images obtained on multi-phasic 
spectral energy CT on HCC conspicuity.
Material and Methods: 14 patients with 35 advanced HCC (BCLC C, follow 
up under oral adjuvant therapy) underwent an abdominal contrast material-
enhanced spectral CT (Discovery CT 750HD; GE Healthcare, Wisconsin, USA), 
in liver-arterial phase, and portal venous phase, with final HCC diagnosis 
based on liver biopsy (n= 9) or AASLD imaging criteria with a median follow-up 
of 18 months (n=5). 140 kVp polychromatic images were compared to the 
monochromatic images datasets (40 to 140 keV, 1 keV step) derived from the 
spectral acquisition. Tumor-to-liver CNR and HCC signal intensity obtained on 
arterial phase whether using polychromatic (UH) or monochromatic images 
were compared (ANOVA, Post hoc Dunn). Effective radiation doses were 
estimated based on CTDIvol.
Results: 33 HCC were identified with polychromatic images vs 34 on spectral 
imaging (P=0.75). On monochromatic images obtained at the single energy 
optimal level of 49 keV, the mean HCC CNR was significantly higher than that 
obtained on polychromatic images (1.96 vs. 0.67; P<0.001). The HCC signal 
intensity was significantly higher on monochromatic images than on 
polychromatic images (4.45 vs 3.88; P=0.0099). Mean CTDIvol was 12.3 mGy.
Conclusion: Monochromatic energy levels at 49 keV can increase conspicuity 
of HCC in keeping with the usual standardized HCC enhancement profile, and 
with an acceptable radiation exposure.
SS 11.04
Small (≤1cm) hepatocellular carcinoma: diagnostic 
performance and imaging features of gadoxetic acid-
enhanced Liver MRI
M.H. Yu, J.H. Kim, Y.D. Cho, J. Yoon; Seoul/KR
Purpose: To investigate the diagnostic performance and imaging features of 
gadoxetic acid-enhanced MRI for detection of small (≤1cm) hepatocellular 
carcinoma (HCC) in patients with chronic liver disease.
Material and Methods: Sixty patients (M:F=56:4, 60.1 years) having HCCs 
(n=146; 70>1cm, 76≤1cm) underwent gadoxetic acid-enhanced MRI including 
DWI. HCCs were confirmed by surgical resection (n=72) or by showing interval 
growth with typical enhancement pattern on follow-up dynamic CT/MRI 
(n=74). Two radiologists graded the possibility of HCC on MRI using a 5-point 
confidence scale and assessed their MR imaging features. The jackknife free-
response receiver operating characteristic (JAFROC) method was used.
Results: The average JAFROC figure of merit (FOM) for small (≤1cm) HCC was 
0.717, meanwhile FOM for large HCC (>1cm) was 0.973 with substantial 
agreement (Κ=0.676). The sensitivity and specificity were as follows: 46% and 
42% in small HCC vs. 95% and 70% in large HCC. Eleven small HCCs (14.5%) 
were not demonstrated on MRI. MR imaging features of small HCC included 
arterial enhancement (n=60, 78.9%), hypointensity on hepatobiliary phase 
(n=52, 68.4%), washout on portal phase (n=38, 50%), T2 hyperintensity (n=33, 
43.4%), T1 hypointensity (n=24, 31.6%), and restriction on DWI (n=20, 26.3%).
Conclusion: The diagnostic performance of gadoxetic acid-enhanced MRI for 
small HCC detection is lower than that of large HCC. The arterial enhancement 
and hypointensity on hepatobiliary phase are the most common MR imaging 
features of small HCCs.
11:00 - 12:30 Auditorium
Scientific Session 11
Focal lesions in the cirrhotic liver 
SS 11.01
Diagnostic performance of multi-detector CT and 
magnetic resonance imaging for the detection of 
hepatocellular carcinoma: a systematic review and 
meta-analysis
Y.J. Lee1, J.M. Lee2, J.K. Han2, B.I. Choi2, J.S. Lee2; 
1Seongnam-Si, Gyeonggi-do/KR, 2Seoul/KR
Purpose: To perform a systematic review and meta-analysis of the diagnostic 
accuracy of CT and MRI for the detection of HCC and update previously 
summarized estimates.
Material and Methods: We searched MEDLINE, EMBASE, and Cochrane 
Library to identify studies providing per-patient or per-lesion diagnostic 
accuracy data of CT and MRI for the detection of HCC in patients with chronic 
liver disease. Studies published from January 2000 to December 2012, having 
a reference standard based on histopathology and/or follow-up, were included. 
Summary estimates of diagnostic accuracy were obtained using random-
effects model with further exploration using meta-regression and subgroup 
analyses.
Results: Forty-one studies (18 CT, 35 MRI) were included, evaluating 1135 
patients for CT and 2348 patients for MRI. Overall per-patient sensitivity of MRI 
was 87% with a specificity of 92%. Overall per-lesion sensitivity of MRI was 
higher than CT when pooling sensitivity data of all studies (MRI vs. CT: 78% vs. 
72%) and when pooling studies with cross-tabulation data only (79% vs. 
70%). Per-lesion specificity was not significantly different (91%). The use of 
Gd-EOB-DTPA for MRI showed a significantly higher per-lesion sensitivity than 
other contrast agents (P=0.01). There was a tendency of lower diagnostic 
accuracy for lesions smaller than 2 cm and for studies using explanted liver as 
the only reference standard.
Conclusion: MRI is more sensitive than CT for the detection of HCC with 
comparable specificity, in patients with chronic liver disease.
SS 11.02
Comparison of hepatobiliary phase Gd-EOB-DTPA-
enhanced magnetic resonance imaging and diffusion-
weighted imaging for detecting malignant focal liver 
lesions
D. Akata, I.C. Kose, M. Ozmen, M. Karcaaltincaba;  
Ankara/TR
Purpose: To compare the role of high-b-value diffusion-weighted imaging 
(DWI) and hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-
enhanced dynamic magnetic resonance imaging (MRI) to detect malignant 
focal liver lesions.
Material and Methods: 24 patients with 114 liver metastases and 17 patients 
with 50 hepatocellular carcinomas (HCC) underwent DWI and Gd-EOB-DTPA-
enhanced MRI for suspected or known malignant liver lesions according to 
previous imaging findings. Gd-EOB-DTPA-enhanced MRI included T(2) 
weighted TSE sequence, early dynamic T(1) weighted sequences and 20-min 
delayed hepatobiliary phase sequence. Each sequence was evaluated 
separately from other sequences. Lesions detected either at hepatobiliary 
phase or at DWI or detected in at least two other sequences were defined as 
true lesions. Sensitivity for detecting malignant focal liver lesions were 
compared among high-b-value diffusion weighted images and hepatobiliary 
phase images.
Results: Hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI yielded 
significantly higher sensitivity (87.8%) for detecting HCC than high-b-value 
diffusion weighted images (63,3%) (Mc Nemar test p<0.05). Hepatobiliary 
phase yielded equal sensitivity to DWI for detecting metastases (80% at both 
of them). For overall malign lesions, hepatobiliary phase had higher sensitivity 
(82.3%) than DWI (75%) but it was not significant at Mc Nemar test (p>0.05).
Conclusion: Hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI has 
highest sensitivity for detecting HCC among all sequences. However, 
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SS 11.08
Detection of hepatocellular carcinoma in gadoxetic 
acid-enhanced hepatobiliary phase MR imaging at 3T: 
comparison of high and low flip angle
H.J. Cho1, Y.K. Cho1, M.Y. Kim1, J.M. Lee2; 1Seoul/KR, 
2Bucheon, Gyounggi/KR
Purpose: To compare the detectability of hepatocellular carcinoma (HCC) on 
fat-suppressed 3D T1-weighted gradient echo sequences acquired with both 
low and high flip angle (FA) during hepatobiliary phase liver MRI using 
gadoxetic acid, quantitatively and qualitatively.
Material and Methods: Our institutional review board approved this 
retrospective study. 267 consecutive patients underwent 3T liver MR imaging 
with low and high FA (10° and 25°) sequences at hepatobiliary phase. Among 
125 patients diagnosed as HCC, 47 patients with 62 HCCs were enrolled in 
this retrospective study. To quantitative analysis, a radiologist measured signal 
intensities of the lesion, the liver and the spleen, and calculated liver-spleen 
contrast, lesion-to-liver contrast-to-noise ratios and SAR. To qualitative 
analysis, three reviewers independently reviewed the image sequences using 
a five-point rating scale, focused on hypointense lesion detection and the 
image qualities.
Results: The high FA sequence had significantly higher liver-spleen contrast 
and lesion-to-liver CNR compared to those of low FA (p<0.05, respectively). 
The per-lesion and per-person sensitivities of high FA were higher than those 
of low FA in all three reviewers (p<0.05, respectively). There was statistical 
differences for the detection of HCCs smaller than 1.5 cm in two of three 
reviewers (p<0.05, respectively). Interobserver agreements were more than 
moderate degree.
Conclusion: Increasing the FA in T1-weighted hepatobiliary phase liver MRI 
with gadoxetatic acid improves lesion detection and conspicuity for smaller 
lesions and helps the diagnosis of HCC.
SS 11.09
Imaging features of combined hepatocellular carcinoma 
and intrahepatic cholangiocarcinoma in patients 
undergoing liver surgery
N. Leo, L. Ricca, C. Balasa, S. Bivol, C. Guettier, E. Vibert, 
M. Lewin; Villejuif/FR
Purpose: To clarify imaging features of combined hepatocellular and 
intrahepatic cholangiocarcinoma (cHCC-CC).
Material and Methods: This retrospective study includes 10 patients (10 
males, mean age 65 years) who had either an hepatectomy (n=5) for HCC and 
CC, either a liver transplantation (LT) (n=5) for HCC. All the patients were 
evaluated with presurgical imaging study by US (n=10), MRI (n=6) and CT 
(n=10). All patients had a clinical history of chronic liver disease and 4/10 were 
treated with presurgical Transarterial Chemoembolization (TACE). After 
histologic and immunohistochemical stain confirmation, two radiologists 
analyzed the imaging features of cHCC-CC: size, shape, margins, signal 
intensity, components of tumor, enhancement pattern, satellite tumors, 
metastasis, lymphadenopathy, vascular invasion, biliary dilatation and findings 
of liver disease.
Results: The cHCC-CC was a single mass (8/10) with a mean size of 4 cm 
(range 1-10 cm), heterogeneous signal (6/10), hyperintensity on T2-weighted 
and hypointensity on T1-weighted images (6/10). On post-contrast imaging, 
cHCC-CC were divided in 3 enhanced patterns: HCC-like (early enhancement 
with wash-out on later phases, 4/10), CC-like (early ring-enhancement with 
progressive enhancement in central portions, 4/10) and hypovascular pattern 
(2/10). Other findings included chronic hepatopathy (10/10), late capsule 
enhancement (2/10), lymphadenopathies (2/10), portal venous invasion (1/10) 
and biliary dilatation (1/10).
Conclusion: In our study, cHCC-CC presents in male patient most commonly 
as a single mass, heterogeneous, hyperintensity on T2-weighted images with 
2 predominant enhanced patterns.
SS 11.05
Contrast-enhanced MDCT follow-up of HCC treated by 
TACE with iodized oil: correlation between oil deposition 
and residual enhancement, and effect on interobserver 
agreement
G.A. Zamboni, M.C. Ambrosetti, F. Lombardo, R. Pozzi 
Mucelli; Verona/IT
Purpose: To evaluate CT for follow-up HCC patients treated with TACE with 
oil, assessing the relationship between tumor sizes, complete filling with oil 
and residual enhancement. In addition, to assess how the presence of oil 
affects interobserver agreement in evaluating tumor filling with oil and presence 
of residual enhancement.
Material and Methods: The 64-row MDCTs performed 4 weeks after TACE on 
62 patients with HCC (52M, 10F; mean age 69 years) were reviewed: 
unenhanced, arterial, portal-venous and equilibrium phase images were 
available. Two readers reviewed independently the exams evaluating ≤3 
tumors/patient and assessed completeness of tumor filling with oil and 
presence of residual enhancement. Their relation with tumor size (t-test, 
Fisher’s test) and interobserver agreement (kappa-statistics) were calculated.
Results: 98 nodules were analyzed (mean diameter 31.7 mm). Tumors 
completely filled with oil were significantly smaller than those who were not 
(16.5±1.3 mm vs 42.2±4 mm; p<0.0001). Tumors with residual enhancement 
were significantly larger than those without (44.5±5.8 mm vs 21.7±1.8 mm; 
p<0.0001). Complete filling with oil was significantly associated with lack of 
residual enhancement (p<0.0001). Interobserver agreement was perfect for 
complete filling with oil (k=1) and very good for presence of residual 
enhancement (k=0.888).
Conclusion: Multiphasic CT is commonly used to follow-up HCC after TACE. 
Tumor size correlates directly with rate of complete filling with oil and inversely 
with presence of residual enhancement. Since interobserver agreement is very 
good/perfect, the technique can be safely used for treatment assessment.
SS 11.06
Withdrawn by the authors
SS 11.07
Italy meets Japan: comparison among Western and 
Eastern pathologists about histological classification of 
a series of nodules within cirrhosis showing atypical 
findings after Gd-EOB-DTPA contrast-enhanced MR
V. Battaglia1, U. Motosugi2, T. Ichikawa2, L.E. Pollina1, 
D. Campani1, M. Sakamoto3, M. Nakano3, C. Bartolozzi1; 
1Pisa/IT, 2Yamanashi/JP, 3Tokyo/JP
Purpose: Actually available guidelines for diagnosis and management of 
nodules in cirrhosis still focus on lesions with typical vascular pattern at 
dynamic imaging. MR with hepatospecific contrast agents can give additional 
clues for a more precise classification of atypical nodules, frequently detected 
in cirrhotic livers. Purpose of the study was to understand the pathological 
meaning of nodules' atypia at MR and to define a correspondence between 
Western and Eastern pathological interpretations.
Material and Methods: Thirty-one nodules on 15 explanted cirrhotic livers 
were retrospectively analysed. At MR examinations prior to OLT, performed 
after Gd-EOB-DTPA injection, all nodules did show atypical findings (hypo-
isointense on arterial phase; hypo-isointense on late phase). On HB phase, 
nodules were hypointense. All nodules were histologically analyzed both by 
Italian and Japanese expert pathologists. Results from blinded pathological 
assessments by two groups of experts were then compared.
Results: Complete agreement among pathologists was achieved in 12 
nodules (7 early HCCs, 4 overt HCCs, 1 characterized as regenerative nodule). 
Remnant 29 nodules were judged at first evaluation both as early HCC or as 
high-grade dysplastic nodules; agreement among pathologists about definite 
nodules’ diagnosis was achieved in a second time.
Conclusion: Despite different histological interpretations between Western 
and Eastern experts, MR atypical nodules should be considered as 
preneoplastic/early neoplastic lesions, thus giving a more accurate stratification 
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11:00 - 12:30 Room J
Scientific Session 12
CT Colonography: Implementation and 
technical performance
SS 12.01
Population screening with CT colonography: preliminary 
findings of a randomized multicenter trial
G. Iussich1, L. Correale2, C. Senore2, D. Campanella1, 
N. Segnan2, G. Galatola1, C. Laudi1, S. Montemezzi3, 
A. Bert2, D. Regge1; 1Candiolo/IT, 2Turin/IT, 3Verona/IT
Purpose: To report preliminary findings of a population-based screening CTC 
trial.
Material and Methods: Subjects aged 58-60 years without a personal history 
of cancer/adenomas were mailed a personal invitation. Respondents were 
randomized to either CTC or sigmoidoscopy. CTC bowel preparation consisted 
of a 3-day mild laxative (movicol) with same-day fecal tagging (gastrographin). 
Exams were read by experienced radiologists using a paradigm with first 
reader CAD. Patients with lesions ≥6 mm were referred for colonoscopy. 
Outcome measures included colonoscopy referral, reporting time, extracolonic 
findings (ECFs). Detection of advanced neoplasia (AN) was estimated on a 
subset of patients for which colonoscopy and histological data were available.
Results: Between December 2010 and September 2012, 1019 (521 men) 
subjects were randomly assigned to CTC screening. Exam quality was 
inadequate in 30 (2.9%) patients. A total of 121 lesions ≥6 mm, including 8 
masses, in 103 (10%) patients were found at CTC; 39 (3.8%) had lesions ≥10 
mm. On a subset of 917 patients, including 72 positive CTC results, detection 
rate for AN was 4.4% (95% CI: 3.1-5.9%) and the PPV was 55.6% (95% CI: 
43.4-67.3%). Forty-three (4.2%) patients had ECFs of any significance; only 8 
(0.9%) required further work-up. The mean reporting time was 239 s (range, 
60-1020).
Conclusion: As a primary colorectal screening tool, CTC has acceptable low 
referral rate, adequate reporting times and a high concordance of positive 
findings at colonoscopy.
SS 12.02
Use of CT colonography in the English national Bowel 
Cancer Screening Programme
A. Plumb1, S. Halligan1, C. Nickerson2, P. Bassett1, 
A. Goddard3, S.A. Taylor1, J. Patnick2, D. Burling4;  
1London/UK, 2Sheffield/UK, 3Derby/UK, 4Harrow/UK
Purpose: To examine use of CT colonography (CTC) in the English Bowel 
Cancer Screening Programme (BCSP) and investigate neoplasia detection 
rates and positive predictive value.
Material and Methods: Between June 2006 and July 2012, asymptomatic 
screenees undergoing CTC as their first-line colonic test following a positive 
faecal occult blood result were identified via the BCSP national database. 
Referral rates for further testing (usually endoscopy), neoplasia detection and 
positive predictive value for CTC were calculated. Variation between screening 
centres was assessed with risk-adjusted funnel plots. Multilevel logistic 
regression examined factors associated with variable neoplasia detection.
Results: 2753 CTC were performed over 6 years, spanning 3 rounds of 
biennial FOBt screening. Overall neoplasia detection rate was 24.4% (95%CI 
21.7, 27.0%). Referral rate for further testing after CTC was 40.6% (95%CI 
35.7, 45.6%). Positive predictive value (PPV) for neoplasia was 67.9% (95%CI 
64.6%, 74.4%) and was highly variable between screening centres. After 
adjusting for confounders, one centre had a significantly lower detection rate. 
Centres with highly experienced radiologists (1000+ lifetime total CTC cases 
interpreted) had higher neoplasia detection rates and PPV. 3D interpretation 
was associated with greater neoplasia detection.
Conclusion: Neoplasia detection following positive FOBt is highly variable 
across screening centres and is lower than colonoscopy. Radiologist 
experience and use of 3D visualisation are associated with greater detection 
rates. High yield centres also have high PPV.
SS 11.10
Diagnostic imaging after Yttrium 90 therapy in patients 
with hepatocellular carcinoma: comparison of magnetic 
resonance imaging with Gd-EOB-DTPA and gadobutrol
S. Kinner, C. Kloeters, J. Theysohn, J. Ertle, M. Forsting, 
T. Lauenstein; Essen/DE
Purpose: A precise evaluation of tumour response after Yttrium-90 therapy is 
essential for adequate clinical management. However, evaluation of imaging 
may be hampered as Y90 itself can lead to reactive liver changes with similar 
appearance to progress. We aimed to compare a liver specific agent (Gd-EOB-
DTPA) to gadobutrol MRI concerning therapy response evaluation.
Material and Methods: 20 patients with HCC underwent contrast-enhanced 
CT and gadobutrol-MRI on the day before and Gd-EOB-DTPA MRI directly 
before Y90 therapy. Follow-up images were performed 30, 90 and 180 days 
after therapy. Two radiologists reviewed gadobutrol and Gd-EOB-DTPA MRI in 
consensus using a 4-point-scale: 1=definitely response, 2=probably response, 
3=probably no response, 4=definitely no response. CT in combination with 
laboratory parameters served as reference standard.
Results: CT and laboratory parameters revealed progress in 5 patients after 
30, 3 patients after 90 and 7 patients after 180 days. With Gd-EOB-DTPA MRI 
radiologists were more determinate compared to gadobutrol-MRI (mean 
values day 30 for responders with Gd-EOB-DTPA=1.4; gadobutrol=1.9). In 
each patient, on day 90 and 180, radiologists rated gadobutrol-MRI as 
probable response while Gd-EOB-DTPA MRI revealed definite progress which 
was confirmed by AFP values.
Conclusion: Gd-EOB-DTPA MRI allows a more precise assessment of tumour 
response after Y90 therapy. The liver specific contrast-enabled earlier 
diagnosis of tumour progress compared to gadobutrol MR and also to CT and 
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SS 12.05
Colonic morphology at CTC in men versus women: 
quantitative assessment using novel software
C.N. Weber1, A.S. Lev-Toaff1, H.M. Zafar1, M.S. Levine1, 
A. Wilmot1, S. Sudarsky2, L. Guendel3, B. Geiger2; 
1Philadelphia, PA/US, 2Princeton, NJ/US, 3Forchheim/DE
Purpose: We developed novel CTC software for quantitative analysis of 
colonic morphology to determine if there are significant differences between 
genders which may explain higher rates of incomplete optical colonoscopy 
among women.
Material and Methods: 8CTC datasets from 20 men and 20 women with 
incomplete optical colonoscopies were compared using software to determine 
total/segmental colonic length, volume, tortuosity (number of 90° angles with 
8 cm limbs), compactness (volume containing colon/segments divided by 
length), and height of the sigmoid apex relative to the lumbosacral junction.
Results: Women had greater tortuosity (turns) of the total colon (10.60 vs 7.40, 
p<.001), rectum (0.85 vs 0.32, p<.001), sigmoid (4.40 vs 3.28, p=.005), and 
transverse colon (3.65 vs 2.20, p=.002). Women had greater compactness 
(mm2) of the total colon (6457 vs 8246, p<.001), sigmoid (2961 vs 3554, 
p=.032), descending (1534 vs 2165, p=.021) and transverse colon (3320 vs 
4132, p=.005). Men had greater volumes (liters) of the total colon (2.10 vs 1.65, 
p=.006), sigmoid (0.54 vs 0.31, p<.001) and ascending colon (0.28 vs 0.35, 
p=.029). Women had lower height (mm) of the sigmoid apex (46.47 vs 90.39, 
p=.004). There were no significant differences in total/segmental colonic length 
between genders.
Conclusion: Our novel CTC software enables quantitative analysis of colonic 
morphology. Significant differences between the genders in tortuosity, 
compactness, volumes, and sigmoid apex height may explain differences in 
optical colonoscopy performance. This software may have other beneficial 
applications.
SS 12.06
Withdrawn by the authors
SS 12.07
Low-dose CT colonography using model-based iterative 
reconstruction: findings in 65 patients
V. Vardhanabhuti, J. James, R.R. Nensey, E.M. Armstrong, 
C.A. Roobottom, B. Fox, S. Jackson; Plymouth/UK
Purpose: To compare image quality of CT images acquired at standard dose 
(SD) and low dose (LD) using adaptive statistical iterative reconstruction (ASIR) 
and model-based iterative reconstruction (MBIR) techniques.
Material and Methods: 65 patients were prospectively recruited with informed 
consent. They underwent SD and LD CT colonography. Both sets of scans 
were reconstructed with ASIR and MBIR. Objective and subjective image 
qualities were assessed as well as diagnostic accuracies for significant colonic 
and extra colonic lesions (e.g. polyps, colonic cancer, liver lesions, etc.). 
Effective doses for each scans were recorded.
Results: Objective image analysis supports significant noise reduction and 
superior contrast-to-noise ratio with low-dose scans using MBIR technique 
(p<0.05) compared to SD ASIR. Subjective image parameters were equivalent 
for LD MBIR and SD ASIR for both colonic and extra-colonic findings (p>0.05, 
overlapping 95% CI). Diagnostic accuracies for polyp detection were 
comparable although the numbers were too few to reach significance (p>0.05). 
Substantial dose reduction was achieved with LD scan (average 4.2 mSv) 
compared to SD scan (average 8.9 mSv) in our population group.
Conclusion: MBIR shows superior reduction in objective noise whilst 
maintaining subjective image quality and most importantly substantial dose 
reduction can be achieved. This small study confirms feasibility of using MBIR 
in performing low-dose CT colonography. A larger study is underway to assess 
diagnostic accuracies specifically for polyp detection.
SS 12.03
What did the barium enema teach us? Comparison of 
paired decubitus CT colonography to supine prone CT 
colonography
S.A. O'Connor, J.M. Hanson, A.D. Quinn; Drogheda/IE
Purpose: The purpose of the study was to assess the equivalence of paired 
decubitus imaging compared to supine prone imaging and to assess patient 
preference for positioning in CT colonography (CTC).
Material and Methods: Fifty consecutive symptomatic patients referred for 
CTC for failed colonoscopy were enrolled prospectively. Each patient was put 
into all four positions: prone, supine and both decubitus for the time taken to 
scan and were asked to grade the comfort on a linear scale. 50 supine/prone 
and 50 paired decubitus CTC were retrospectively scored by 2 experienced 
reporters for visual distension for each of 6 segments of the colon. 
1=inadequate distension of the segment. 2=inadequate distension of a part of 
the segment. 3=diagnostic distension of the entire segment. 4=optimal 
distension of the entire segment.
Results: The patient position survey showed the least comfortable position 
being prone 66% (p=0.001 Student t test). The most comfortable pair of 
positions was decubitus 78% (p=0.001 Student t test). On statistical input, 
comparison of equivalence of distension was made using two one-sided tests 
with equivalence shown at p=0.001 tcv=3.175.
Conclusion: Paired-decubitus imaging in CTC gives equivalent distension to 
supine prone. Paired-decubitus imaging is the preferred positioning and 
should be considered as an alternative strategy to conventional supine prone 
imaging.
SS 12.04
Natural history trial of small colorectal polyps: in vivo 
volumetric growth rates for assessing clinical behavior
P.J. Pickhardt1, D. Kim1, B.D. Pooler1, J.L. Hinshaw1, 
B. Cash2; 1Madison, WI/US, 2Bethesda, MD/US
Purpose: We report the results of a prospective natural history trial assessing 
behavior of small (6-9 mm) colorectal polyps at longitudinal CTC.
Material and Methods: In vivo CTC surveillance was performed on 306 small 
(6-9 mm) polyps initially detected at screening CTC in 243 consenting 
asymptomatic adults (mean interval, 2.3 years; range, 1-7 years). Volumetric 
and linear polyp measurements at initial and surveillance CTC were correlated 
with histologic subgroups.
Results: Applying a polyp volume threshold of ±20%/year to categorize 
growth, 22% progressed (n=68), 50% were stable (n=153), and 28% regressed 
(n=85), including complete resolution in 10% (n=32). 91% of advanced 
adenomas progressed, compared with 37% of non-advanced adenomas, and 
8% of all other lesions (p<0.0001). Mean polyp volume change was +77%/year 
for advanced adenomas (n=23), +16%/year for non-advanced adenomas 
(n=84), and -13%/year for all non-neoplastic or unresected polyps (p<0.0001). 
An absolute polyp volume >180 mm3 at surveillance CTC identified advanced 
neoplasia with 92% sensitivity, 94% specificity, 58% PPV, and 99% NPV. In 
general, volume assessment amplified small linear changes, as only sixteen 
6-9 mm polyps (6%) exceeded 10 mm at follow-up.
Conclusion: Volumetric growth assessment of small colorectal polyps 
represents a powerful biomarker for determining clinical relevance. Advanced 
adenomas demonstrate more rapid growth than non-advanced adenomas, 
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SS 12.10
Evaluation of two minimal-preparation iodine only 
regimes for CT colonography: implications for patient 
compliance and mucosal cleansing and correlation with 
bowel habit
H.S. Sidhu, G. Bhatnagar, R. Ilangovan, P. Shorvon, 
J. Muckian, R. Baldwin, K. Smith, M. Marshall, D. Burling, 
A. Gupta; Harrow/UK
Purpose: Minimal iodine-only preparations are increasingly established at 
CTC in optimising patient acceptability whilst producing diagnostic-quality 
studies. Debate exists concerning optimal regime and little is known regarding 
variation with bowel habit (BH). This study compares use of 2-day preparation 
with 1-day regime in compliance, mucosal cleansing and correlation with BH.
Material and Methods: Prospective study with 400 consecutive patients 
receiving Regime-1 (R1, N=200) two doses of 50 ml iodinated-contrast over 2 
days (with low residue diet; LRD) or Regime-2 (R2, N=200) two doses of 50 ml 
contrast over 1 day (LRD). Interview at CTC recorded compliance with contrast 
and LRD. BH recorded on four-point frequency scale. CTC mucosal cleansing 
adequacy scored by experienced GI-radiologists.
Results: R1 compliance with iodinated-contrast 97% and LRD 95.5% (non-
compliant excluded subsequently). Overall adequacy mucosal cleansing 
92.0%, by BH: 94.4% (134/142) BO>1/day, 88.9% (24/27) BO>1/two-days, 
80% (12/15) BO>1/five-days, 66% (2/3) BO<1/five-days. R2 compliance with 
iodinated-contrast 99.5% and LRD 96.2%. Overall adequacy mucosal 
cleansing 94.4%, by BH: 97.5% (157/161) BO>1/day, 92% (23/25) BO>1/two-
days, 77.8% (7/9) BO>1/five days, 50% (1/2) BO<1/five-days. Significantly 
greater compliance with iodinated-contrast in R2 (p<0.05) with improved LRD 
compliance. No statistical difference (p=0.34) in mucosal cleansing adequacy. 
Trend towards poorer mucosal cleansing with decreasing BO frequency in 
both regimes.
Conclusion: One-day minimal-regime results in significantly greater 
compliance with no statistical difference in mucosal cleansing. There is a trend 
towards suboptimal cleansing with decreasing frequency of bowel opening.
SS 12.08
CT colonography with adaptive statistical iterative 
reconstruction: estimation of dose radiation and 
diagnostic accuracy in a screening population
R. Scandiffio, A. Mantarro, L. Faggioni, E. Neri, 
C. Bartolozzi; Pisa/IT
Purpose: Dose reduction is a hot topic in imaging, especially for screening 
examination such as CTC. Aim of the paper is to evaluate and validate a 
method to reduce dose in CTC and control image noise using an adaptive 
statistical iterative reconstruction (ASiR).
Material and Methods: From March to December 2012, 253 patients 
underwent CTC for colorectal cancer screening on a 128-row CT scanner. 
Examination protocol included both supine and prone acquisition; a very low-
dose protocol was used, and static tube current was set at 30 mAs. ASiR was 
used to subtract noise. Three experienced radiologists reviewed examinations; 
in case of positive findings, endoscopy was performed and was considered 
the gold standard. DLP, CTDI were evaluated; per-segment image quality was 
assessed visually using a semiquantitative score (1=poor, 2=adequate, 
3=excellent). Sensitivity and specificity were assessed.
Results: Mean DLP and CTDI resulted significantly lower than in usual CTC 
protocol (mean value 45.35 mGy/cm and 0.90 mGy, respectively). Image 
quality was considered adequate (mean value: 2). Sensitivity and specificity in 
lesion detecting were 94.6% and 98.8% for lesions between 6 and 9 mm, and 
100% and 99.4% for lesions between 10 and 30 mm.
Conclusion: ASiR allows a significantly dose decreasing preserving image 
quality, anatomical details and technique efficacy.
SS 12.09
Review of CT colonography: real-life experience of one 
thousand cases in a tertiary referral centre
A.E. Smyth, C.F. Healy, P. Macmathuna, H.M. Fenlon; 
Dublin/IE
Purpose: The purpose of this study was to review the indications for and 
findings of 1000 most recent CT colonography examinations performed in a 
tertiary referral hospital campus.
Material and Methods: Data on patient demographics, indications and 
findings were analysed from a dedicated database.
Results: Over a 5-year period (January 2008 - December 2012), 1000 CT 
colonography studies were performed. The median age of patient was 70 
years (interquartile range 60-78). Patients were symptomatic in 86% of cases, 
while screening accounted for 8% and surveillance in patients with a history of 
polyps or colorectal cancer accounted for 6%. In 42% of patients, the study 
was performed following an incomplete optical colonoscopy. CT colonography 
was normal or had benign findings in 75% of patients. Neoplasia was observed 
in 19%: colorectal carcinoma 5.5%, polyps >1cm in 7.7% and smaller polyps 
<1cm in 5.7%. In this patient group, there was an extracolonic finding that 
required further evaluation in 18.5% with 5.5% found to have a potentially 
clinically significant finding. There was no significant procedure related 
complications.
Conclusion: This review describes the real life experience of CT colonography 
in a largely elderly, symptomatic patient group. In this patient group, CT 
colonography safely confirmed the need for no further bowel tests in 75%, 
identified colorectal cancer in 5.5% and clinically significant extracolonic 
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SS 13.03
Effects of liver cirrhosis on Gd-EOB-DTPA enhanced 3 T 
MRI
M. Haimerl, N. Verloh, J. Rennert, R. Müller-Wille, 
C. Fellner, P. Wiggermann, E.M. Jung, C. Stroszczynski; 
Regensburg/DE
Purpose: The purpose of this study was to assess differences in enhancement 
effects of liver parenchyma between normal and cirrhotic livers on dynamic, 
Gd-EOB-DTPA-enhanced 3 T MRI.
Material and Methods: 93 patients with cirrhotic liver (normal, n=54; Child-
Pugh class A, n=18; B, n=16; C, n=5) underwent contrast-enhanced 3 T MRI. 
T1-weighted volume interpolated GRE sequences with fat suppression were 
acquired before contrast injection in the arterial phase (AP), in the late arterial 
(LAP) phase, in the portal venous phase (PVP), and in the hepatobiliary phase 
(HBP) after 20 min. The relative enhancement (RE) of the signal intensity of the 
liver parenchyma was calculated for all phases.
Results: Mean RE for patients with normal liver and patients with a Child-Pugh 
score A increased significantly over time in all phases (p≤0.002-0.001). Child-
Pugh class B patients showed no increase between the PVP (0.50±0.22) and 
the HBP (0.46±0.17) (p=0.501). Patients with a Child-Pugh Score C showed a 
significant increase (p=0.043) between AP (0.15±0.11), LAP (0.45±0.12) and 
PVP (0.50±0.13) and a significant (p=0.043) decrease for HBP (0.29±0.04). RE 
in the hepatobiliary phase was significantly different among all evaluated 
groups and with increasing severity of liver cirrhosis, a constant reduction of 
RE could be shown (p≤0.021-0.001).
Conclusion: RE of liver parenchyma is negatively affected by increased 
severity of liver cirrhosis. Evaluation of RE might help to define the grade of 
liver disease.
SS 13.04
Assessment of liver perfusion by multi-parametric 
MR-DWI: correlation with phase-contrast portal venous 
flow measurements
F. Regini1, S. Colagrande1, L.N. Mazzoni1, S. Busoni1, 
B. Matteuzzi1, P. Santini2, R. Wyttenbach2; 1Florence/IT, 
2Bellinzona/CH
Purpose: To verify in vivo the bi-exponential model of signal decay in diffusion-
weighted imaging (DWI) in liver parenchyma by evaluation of related 
parameters: apparent diffusion coefficient (ADC), slow diffusion coefficient (D), 
fast diffusion coefficient (D*) and perfusion fraction (PF).
Material and Methods: Forty healthy volunteers (19 f, mean age 32 years; 
range 20-52 years), underwent MR imaging at 3.0 T including 2D-Phase-
Contrast (PC) acquisitions (Venc=40 cm/s) to measure portal venous flow, and 
DWI acquisitions (free breath, 14 b-values, b-range=0-800 s/mm2), repeated 
before and 30 min after a standard meal (600 Kcal). DWI parameters were 
calculated using signal intensities at every b value, measured with four different 
circular ROIs drawn on right liver lobe. Paired sample t-test and Pearson 
correlation coefficient test were performed to evaluate differences in various 
parameters when calculated before and after the meal and to detect possible 
correlation with portal flow.
Results: After the meal portal flow increased in all the subjects (mean 
increment±SD=887±281 ml/min; 96±33%). ADC, D, and PF did not show a 
statistically significant increment after meal at t-test, while D* did (mean 
increment±SD=34±46%, p<0.001). Pearson correlation coefficient did not 
show a significant correlation of portal flow and D* increment when calculated 
before and after the meal.
Conclusion: D* increases significantly with portal flow, confirming its 
dependence on perfusive phenomena, as hypothesized originally by Le Bihan. 
This observation underlines the possible role of D* evaluation in conditions 
involving perfusional changes.
11:00 - 12:30 Room F
Scientific Session 13
Liver functional imaging and response 
assessment
SS 13.01
Assessment of liver cirrhosis using T1 mapping on 
Gd-EOB-DTPA enhanced 3T MRI
M. Haimerl, N. Verloh, C. Niessen, C. Fellner, A.G. Schreyer, 
C. Stroszczynski, P. Wiggermann; Regensburg/DE
Purpose: To assess differences in T1 maps of liver parenchyma between 
normal and cirrhotic livers on contrast- enhanced MRI obtained with GD-EOB-
DTPA.
Material and Methods: A total of 71 patients with normal (n=36) and cirrhotic 
liver (n=35; Child-Pugh class A, n=16; B, n=14; C, n=5) underwent Gd-EOB-
DTPA-enhanced 3T MRI. To obtain T1 maps, two TurboFLASH sequences 
(TI=400ms, 1000ms) were acquired before and 20 min after Gd-EOB-DTPA 
administration. Region-of-interest measurements were used to define signal 
intensity of T1 maps in normal and cirrhotic liver parenchyma indicating Gd-
EOB-DTPA liver uptake and T1 relaxation time.
Results: T1 relaxation time of non-enhanced MRI (778±136ms) and Gd-EOB-
DTPA-enhanced MRI (339±121ms) were significantly different (p<0.001): mean 
decrease of T1 relaxation time was 56 ± 14%. T1 relaxation time for non-
enhanced MRI showed no significant differences between normal and cirrhotic 
livers (p= 0.59- 0.98). After administration of Gd-EOB-DTPA T1, relaxation time 
increased significantly between normal-liver and Child-Pugh class B and C 
patients, respectively (p<0.001). There was a constant, significant increase of 
T1 relaxation time from Child-Pugh class A up to class C patients (Child-Pugh 
class A, 311±84ms; B, 438±87ms; C, 545±71ms) coming along with a constant 
decrease of Gd-EOB-DTPA liver uptake (Child-Pugh class A, 60±9%; B, 
43±11%, C, 30±6%).
Conclusion: Evaluation of changes in T1 mapping of the liver parenchyma 
may serve as a useful method to determine severity of liver cirrhosis.
SS 13.02
Comparison between CT perfusion and indocyanine 
green retention test results in the assessment of hepatic 
function
R. De Robertis, M. D'Onofrio, S. Crosara, S. Canestrini, 
G. Puntel, R. Pozzi Mucelli; Verona/IT
Purpose: To assess the reliability of perfusion CT for the estimation of liver 
function in patients scheduled for hepatic resection, comparing these results 
with those obtained with the indocyanine green retention.
Material and Methods: 31 patients with hepato-biliary malignancies (13/31 
hepatocarcinomas; 5/31 peripheral cholangiocarcinomas; 12/31 hilar 
cholangiocarcinomas; 1/31 colonic adenocarcinoma metastases), scheduled 
for liver resection, were prospectively included in this study. In all cases, a pre-
operative perfusional CT and the indocyanine green retention test were 
performed. The results were compared using Pearson's correlation test.
Results: The comparison between single arterial input time to peak values and 
indocyanine green retention values at 15 min (ICGR15) and plasma 
disappearance rate (PDR) showed high correlation (R=0.84 and -0.80); the 
comparison between single portal input time to peak values, ICGR15 and PDR 
showed high correlation (R=0.88 and -0.83).
Conclusion: Perfusion CT may be a method to estimate liver function. Time to 
peak values obtained with single input analysis had shown good correlation 
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SS 13.07
Assessment of treatment response after selective 
internal radiation therapy using diffusion-weighted 
imaging
A. Barabasch, A. Ciritsis, N.A. Kraemer, C.K. Kuhl;  
Aachen/DE
Purpose: Fluorodeoxyglucose-uptake quantified by standardized uptake 
value (SUV) in positron-emission-tomography (PET)/CT-scans is an established 
parameter for tumour response following SIRT. Aim of the study was to 
compare the accuracy of liver-MRI to PET/CT for early treatment response 
assessment 8 weeks after SIRT.
Material and Methods: Between June 2010 and June 2012, 103 SIRTs in 57 
patients were performed for treatment of liver metastasis. 18 patients (12 
female; 10 colorectal, 7 breast and 1 cholangiocellular carcinoma) received 
contrast-enhanced liver-MRI and contrast-enhanced PET/CT-scans within 6 
weeks prior and 8 weeks after SIRT of the right liver lobe. Three target lesions 
per patient were defined. In both modalities, changes of tumour size, contrast-
enhancement, apparent diffusion coefficient (ADC)-values and SUV were 
compared before and after SIRT and validated by long-term follow up.
Results: After SIRT, average maximal SUV decreased from 7.86 to 5.34 (-32%; 
p<0.02) and average minimal ADC-value increased from 540×10-6 mm2/s to 
729×10-6 mm2/s (+35%; p<0.05). No significant changes in tumour size and 
contrast enhancement were observed on MRI or PET/CT scans. Follow-up 
imaging confirmed response to SIRT in patients with significant ADC changes.
Conclusion: These preliminary results indicate that changes of ADC-values in 
liver-MRI are useful to predict response to SIRT well before any change of 
tumor size or perfusion. Accordingly, liver-MRI with DWI can be used to 
evaluate treatment response just as PET/CT.
SS 13.08
Transient sinusoidal dilatation appearing as mosaic 
pattern on CT/MR imaging can be related to 
extrahepatic infectious or inflammatory states
M. Ronot, A. Kerbaol, M. Zappa, M.-P. Vullierme, 
P. Bedossa, V. Vilgrain; Clichy/FR
Purpose: To describe CT/MR findings of patients who had sinusoidal dilatation 
associated with extrahepatic infectious or inflammatory disease.
Material and Methods: From 2005 to 2012, patients who had extrahepatic 
infectious or inflammatory disease, and CT and/or MR of the liver showing 
mosaic enhancement pattern (MP) were selected. MP was defined as areas of 
high signal intensity of the liver on T2-weighted sequences and reticular 
enhancement on arterial and/or portal phases, which appear homogeneous on 
delayed phase. Clinical, biological, and imaging features were noted at the 
time of diagnosis and at follow-up.
Results: All (n=12) patients were women (median age: 30 years; 18-68) and 
among them 5 patients (42%) had OC intake. No patients had hepatic venous 
outflow impairment. Extrahepatic diseases were as follows: pyelonephritis 
(n=7), pancreatitis (n=2), pneumonia (n=1), septicaemia (n=1), and colitis (n=1). 
MP was seen on both arterial and portal phases in 7/12, 58% and on portal 
phase only in 2/12, 17%. MP was diffuse in all livers but more prominent in the 
sub-capsular areas. Four patients (33%) had liver biopsy, which showed 
sinusoidal dilatation. Nine patients (75%) had follow-up imaging with a median 
delay of 60 days, and abnormal liver enhancement disappeared in 7/9 cases 
(78%).
Conclusion: Extrahepatic infectious or inflammatory disease can be 
responsible for transient sinusoidal dilatation, which appears as mosaic 
pattern on CT/MR imaging.
SS 13.05
Quantitative evaluation of hepatocellular uptake 
function with use of gadolinium disodium-enhanced MR 
imaging: comparison of dynamic pharmacokinetic 
analysis and static signal intensity analysis
A. Yamada1, S. Yanagisawa1, M. Kurozumi1, Y. Fujinaga1, 
K. Ueda1, M. Kadoya1, S. Miyagawa1, K. Maruyama2; 
1Matsumoto/JP, 2Tokyo/JP
Purpose: The purpose of this study is to compare dynamic and static methods 
in the quantitative evaluation of hepatocellular uptake function with use of 
gadolinium disodium-enhanced MR imaging.
Material and Methods: We retrospectively evaluated 23 consecutive patients 
who underwent dynamic gadoxetate disodium-enhanced MR imaging and 
indocianine green (ICG) clearance test. T1-weighted images with fat 
suppression were obtained at pre-contrast and 25, 28, 31, 34, 37, 40, 43, 46, 
60, 120, 180, 1200 s after intra-venous administration of contrast agent using 
k-space weighted image contrast reconstruction (Radial-VIBE). Intracellular 
uptake rate (Ki) at the region of interest located in the part of the liver was 
determined applying obtained images into dual-inlet two-compartment uptake 
model. Hepatocellular uptake index (HUI) and volume (V) of the whole liver 
were determined from static contrast enhanced-images at hepatobiliary 
phase. The correlation coefficients for power regression between plasma 
disappearance rate of ICG (ICG-PDR) and parameters (V, Ki, Ki*V and HUI) 
were evaluated.
Results: The 95% confidence interval of correlation coefficient was 
significantly higher in HUI (0.76 to 0.78) than in the other parameters (0.10 to 
0.12 for V; 0.61 to 0.63 for Ki; 0.64 to 0.66 for Ki*V).
Conclusion: Hepatocellular uptake function can be evaluated quantitatively 
and efficiently with use of HUI determined from static gadoxetate disodium-
enhanced MR images at hepatobiliary phase.
SS 13.06
Prediction and monitoring of treatment effect using 
T1-weighted dynamic contrast-enhanced MRI in 
colorectal liver metastases: potential of whole tumour 
ROI and selective ROI analysis
K. Coenegrachts, A. Bols, M. Haspeslagh, H. Rigauts; 
Bruges/BE
Purpose: To evaluate dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) for prediction and early monitoring of treatment in 
colorectal liver metastases.
Material and Methods: Ten patients were included. Baseline and follow-up 
DCE-MRI examinations were evaluated by whole tumour and selected ROI 
placements calculating Kep-values. Selective ROIs, concentric-like and hot 
spot, were drawn on early arterial phase images. Monitoring of treatment was 
performed comparing RECIST1.1 criteria with whole tumour and selected ROI 
placement. To evaluate treatment effect between responders and non-
responders, independent samples t-test was used on Kep-values.
Results: In each patient, largest lesion was evaluated totalling 10 target 
lesions. At baseline, for whole tumour ROI placements mean Kep-values in 
responders were significantly higher than mean Kep-values in non-responders 
(t =7.481, p<0.001). Selective ROI placement comparison of mean Kep-values 
at baseline and after 6 weeks of treatment (first follow-up measurement) 
showed significant decrease in responding patients (t=4.706, p=0.003) 
whereas increase in Kep-values in non-responding patients was not statistically 
significant.
Conclusion: This preliminary study shows that baseline Kep for whole tumour 
ROI is a predictor for treatment outcome. Decrease of Kep using selective 











SCIENTIFIC SESSIONS / FRIDAY, JUNE 7, 2013
 S508
11:00 - 12:30 Room H3
Scientific Session 14
Imaging of the colon and rectum
SS 14.01
Does imaging of the pattern of relapse justify the 
hypothesis for benefit in more radical right colon 
surgery?
R. Balasubramaniam, A. Tan, D. Jayne, D.J.M. Tolan; 
Leeds/UK
Purpose: To evaluate the pattern of recurrence following elective right 
hemicolectomy for colon cancer and extrapolate potential benefit of D2 from 
more radical D3 resection in patients with right colon adenocarcinoma.
Material and Methods: Retrospective analysis was performed on patients 
undergoing D2 right hemicolectomy for adenocarcinoma in a tertiary referral 
centre over 6 years from 2005 to 2010. All post-operative imaging was 
independently reviewed by two radiologists blinded to histology to assess the 
pattern and form of relapse.
Results: Of 267 patients undergoing elective right hemicolectomy, 41 
developed disease recurrence. Of these 10.5% (28/41) presented first with 
haematogenous metastasis; in these, liver was the commonest site (36.6%) 
and earliest organ affected followed by pulmonary metastasis (24.4%). 
Isolated nodal recurrence was rare (1/41, 2.4% of metastases). Metastatic 
disease did not arise in any patients with node negative T2 or less primary 
tumours of the right colon.
Conclusion: Right colon cancers tend to first undergo haematogenous 
metastasis (28/41). The higher incidence of pulmonary metastasis reinforces 
the importance of pre- and post-operative CT thorax. The low incidence of 
nodal recurrence provides no evidence to justify a routine practice of a more 
radical D3 resection in elective curative right colon cancer surgery. The 
absence of recurrence in node negative T2 primary disease indicates a more 
customised post-operative follow-up protocol based on the histology could 
prove more efficient as early surveillance for low-grade tumours appears 
unnecessary.
SS 14.02
Regorafenib therapy effects on human colon carcinoma 
xenografts monitored by dynamic contrast-enhanced 
computed tomography with immunohistochemical 
validation
C.C. Cyran, P.M. Kazmierczak, H. Hirner, M. Moser, 
M. Ingrisch, L. Havla, R. Eschbach, E. Baloch, B. Schwarz, 
M.F. Reiser, C.J. Bruns, K. Nikolaou; Munich/DE
Purpose: To investigate dynamic contrast-enhanced computed tomography 
(DCE-CT) for monitoring the effects of regorafenib on experimental colon 
carcinomas in rats by quantitative assessments of tumor microcirculation 
parameters with immunohistochemical validation.
Material and Methods: Colon carcinoma xenografts (HT-29) implanted 
subcutaneously in athymic rats (n=15) were imaged at baseline and after a 
1-week treatment with regorafenib by DCE-CT (128-slice dual-source). The 
therapy group (n=7) received regorafenib daily (10 mg/kg bodyweight). 
Quantitative parameters of tumor microcirculation (plasma flow, mL/100mL/
min), endothelial permeability (PS, mL/100mL/min), and tumor vascularity 
(plasma volume, %) were calculated using a 2-compartment uptake model. 
DCE-CT parameters were validated with immunohistochemical assessments 
of tumor microvascular density (CD-31), tumor cell apoptosis (TUNEL), and 
proliferation (Ki-67).
Results: Regorafenib significantly (p<0.05) suppressed tumor perfusion 
(12.8±2.3 to 8.8±2.9 mL/100 mL/min) and tumor vascularity (15.7±5.3 to 
5.5±3.5%). Significantly lower microvascular density was observed in the 
therapy group (CD-31; 48±10 vs. 113±25, p<0.05). In regorafenib-treated 
tumors, significantly more apoptotic cells (TUNEL; 11,844±2,927 vs. 
5,097±3,463, p<0.05) were observed. DCE-CT tumor perfusion and vascularity 
correlated significantly (p<0.05) with microvascular density (CD-31; r=0.84 and 
0.66) and inversely with apoptosis (TUNEL; r=-0.66 and -0.71).
Conclusion: Regorafenib significantly suppressed tumor perfusion and 
vascularity quantified by DCE-CT in experimental colon carcinomas in rats 
with good to moderate correlations to an immunohistochemical gold standard. 
Tumor response biomarkers assessed by DCE-CT may be a promising future 
approach to a more personalized and targeted cancer therapy.
SS 13.09
Perfusion CT of hepatocellular carcinoma with the axial 
shuttle technique and iterative image reconstruction: 
preliminary experience
L. Faggioni, F. Pancrazi, I. Bargellini, P. Vagli, R. Sacco, 
G. Bresci, C. Bartolozzi; Pisa/IT
Purpose: To assess the feasibility of CT perfusion imaging (pCT) of 
hepatocellular carcinoma (HCC) on a 64-row scanner with extended lesion 
coverage and iterative image reconstruction.
Material and Methods: Thirteen patients (total 18 HCC) underwent pCT on a 
64-row CT scanner (Discovery CT750 HD, General Electric) with z-axis 
coverage of 8 cm obtained through continuous table toggling (axial shuttle) 
and an iterative image reconstruction algorithm (ASIRTM). Blood flow (BF), 
blood volume (BV), mean transit time (MTT), hepatic arterial fraction (HAF), and 
permeability-surface product (PS) parameters were computed in the HCC and 
the surrounding liver parenchyma (P). The rate of non-assessable HCC due to 
incomplete lesion coverage and dose-length product (DLP) values were 
compared with those achieved on 14 patients (total 23 HCC) previously 
evaluated on a 64-row scanner with 4 cm coverage and standard filtered 
backprojection (LightSpeed VCT).
Results: BF, BV, HAF, and PS were higher, and MTT lower in HCC than in P 
(p<0.01). The rate of non-assessable lesions was lower in the 8-cm coverage, 
ASIRTM group than in the 4-cm group (17% vs 26%, p=0.024). DLP was also 
lower in the 8-cm ASIRTM group (221.6±75.9 vs 598.2±135.4 mGy cm, p<0.01).
Conclusion: Compared with a standard pCT protocol, pCT of HCC lesions 
with extended lesion coverage and iterative image reconstruction is associated 
with a significantly higher rate of assessable lesions and lower radiation dose.
SS 13.10
Evaluation of T1rho as a potential MR biomarker for liver 
cirrhosis: comparison of healthy control subjects and 
patients with liver cirrhosis
I. Rauscher1, C. Ganter1, P. Martirosian2, E.J. Rummeny1, 
K. Holzapfel1; 1Munich/DE, 2Tübingen/DE
Purpose: To compare mean liver T1ρ values in patients with liver cirrhosis and 
healthy control subjects in order to evaluate T1ρ as a potential MR biomarker 
for liver cirrhosis.
Material and Methods: Ten healthy control subjects and 17 patients with 
clinically diagnosed and/or biopsy-proven liver cirrhosis were examined at 
1.5T. T1ρ-weighted images were acquired using a 2D Turbo FLASH sequence 
(TR/TE 3000/1.31 ms, FA 8°, FoV 309×380mm, resolution 2×2×6 mm, 
acquisition time 15 s) with Spin-Lock preparation. T1ρ maps were calculated 
from five breath-hold measurements, performed with different Spin-Lock-
times (4, 8, 16, 32, 48 ms). Mean liver T1ρ values were calculated and compared 
using two-tailed student-t-test. In addition, a receiver operating characteristic 
(ROC) curve analysis was performed to evaluate the utility of mean liver T1ρ for 
the prediction of liver cirrhosis.
Results: Mean liver T1ρ values in patients with liver cirrhosis (57.7 ± 8 ms) were 
significantly higher than those of healthy control subjects (48.6 ± 3.5 ms; 
p=0.006). According to the ROC analysis at a threshold value of 51.4 ms, the 
sensitivity and specificity of mean liver T1ρ in predicting liver cirrhosis were 86.7 
and 88.9%, respectively. The area under the ROC curve was 0.87.
Conclusion: Mean liver T1ρ values in patients with liver cirrhosis were 
significantly higher than those in healthy subjects suggesting a potential role of 
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SS 14.03
Is there a role for minimal preparation CT in bowel 
cancer screening?
D. Shetty, M. Strugnell, G.F. Maskell; Truro/UK
Purpose: The NHS Bowel Cancer Screening Programme (BCSP) offers 
screening every 2 years to all men and women in England aged 60– 69. An 
abnormal faecal occult blood test results in the patient undergoing 
colonoscopy. Patients unsuitable for colonoscopy or those with an incomplete 
colonoscopy are offered CT colonography (CTC). A small number of patients 
are considered unsuitable even for CTC, usually due to multiple co-morbidity 
or immobility. These have been referred for minimal preparation CT (MPCT) 
with oral contrast alone. These cases were retrospectively reviewed to 
determine what effect MPCT had on outcomes in this group of patients.
Material and Methods: Clinical, radiology and endoscopy records were 
reviewed for all patients referred for MPCT from the NHSBCSP in Cornwall, 
UK, from 2010 to 2012.
Results: 22 patients underwent MPCT. Indications were multiple co-morbidity 
in 11 (50%), severe immobility in 7 (32%) and mental incapacity in 4 (18%). 
Three patients (14%) had a positive result (suspected polyp or cancer). Only 
one patient (4.5%) had a polyp subsequently confirmed and treated by 
colonoscopy. One patient had a negative colonoscopy and one patient was 
considered unfit for further investigation.
Conclusion: The limited diagnostic value of MPCT makes it unsuitable for use 
in a screening programme. Patients in this group who are unfit for CTC are 
usually also unfit for subsequent therapeutic intervention even when pathology 
has been demonstrated.
SS 14.04
Role of perfusional MRI and DWI to predict pathological 
complete response to neoadjuvant chemoradiotherapy 
in rectal cancer
C.N. De Cecco1, M. Ciolina1, P. Lucchesi2, M.M. Maceroni2, 
F. Vecchietti2, F. Iafrate1, A. Laghi2; 1Rome/IT, 2Latina/IT
Purpose: To determine the ability of perfusional MRI (pMRI) and diffusion-
weighted imaging (DWI) to predict pathological complete response (pCR) in 
patient treated with chemoradiotherapy.
Material and Methods: Eleven consecutive patients underwent pre-, during 
and post-treatment dynamic contrast-enhanced MRI performed at 3T. 
Gadolinium 0.1 mmol/kg was injected at a rate of 3 mL/s. Treatment protocol 
consisted of neoadjuvant chemoradiotherapy with oxaliplatin and 5- 
fluorouracile. Ktrans, Kep, Ve and IAUGC90 were calculated. Tumoral 
dimension and apparent diffusion coefficient (ADC) were analysed. Surgical 
specimens were the gold standard. For variable comparison, Spearman’s rank 
correlation and Kruskal-Wallis test were used. P<0.05 was considered 
significant.
Results: Six patients showed cPR. Baseline Ktrans, IAUGC90 and Ve were 
significantly higher in non-responder (NR) patients (1.22±1.03 min-1, 1.36±1.07 
mM/s, 0.7±0.4) in comparison to cPR (0.92±0.91 min-1, 0.69±0.6 mM/s, 
0.37±0.15); Kep was significantly lower in NR (1.6±0.65 min-1 vs 2.93±2.71 
min-1). A significant reduction in Ktrans, IAUGC90 and Ve was observed in NR 
during (0.68±0.58, 0.62±0.33, 0.52±0.1) and after treatment (0.047±0.016, 
0.052±0.025, 0.19±0.28); instead in cPR patient a significant increase in 
perfusional values was reported (1.24±1.15, 1.21±0.96, 0.63±0.26 and 
1.13±1.36, 1.24±1.34, 0.59±0.34). No difference in baseline ADC value was 
observed between cPR (0.88±0.22x10-3 mm2/s) and NR (0.85±0.09x10-3mm2/s). 
In cPR mean tumour ADC significantly increase during treatment comparing to 
NR (1.22±0.6x10-3 mm2/s vs 0.98±0.12x10-3 mm2/s). No correlation was found 
between ADC values and pMRI parameters.
Conclusion: pMRI and ADC values are two independent parameters to predict 
rectal tumour response to chemoradiotherapy.
SS 14.05
Acceptability of oral iodinated contrast media: a head to 
head comparison of 4 agents
A. Pollentine, E. Ngan-Soo, R. Hunt, P. McCoubrie; 
Bristol/UK
Purpose: Patient compliance in ingestion of oral contrast can be crucial in 
obtaining a technically adequate study. We assessed the palatability and 
preference of four iodinated oral contrast agents commonly used in 
abdominopelvic CT and CT colonography (CTC).
Material and Methods: 80 volunteers sampled four common contrast agents, 
Omnipaque, Telebrix, Gastromiro and Gastrografin in a computer-generated 
random order. Each agent was anonymised and diluted to a standard 
concentration of 30 mg iodine/ml, the dilution used for faecal tagging in our 
institution. A 100 mm visual analogue scale and a 7-point Likert scale were 
used to rate palatability. Willingness to drink 3 aliquots of 200 ml of each of the 
contrast agents over a 48 h period was also assessed, as per our institution’s 
current bowel preparation protocol for CTC.
Results: Gastrografin was rated significantly less palatable than the remaining 
agents (p<0.005). Omnipaque and Telebrix were significantly more palatable 
than Gastromiro. No difference existed between Omnipaque and Telebrix. 
39% of participants would refuse to consume the quantities of Gastrografin 
required for a CTC examination compared to Telebrix (7%) and Omnipaque 
(9%) (p<0.05).
Conclusion: Omnipaque and Telebrix are significantly more palatable than 
both Gastromiro and Gastrografin with participants more willing to ingest them 
in larger quantities, thereby reiterating the influence of palatability on patient 
compliance. We feel that this will directly influence the technical adequacy of 
CTC studies.
SS 14.06
CT colonography: clinical evaluation of novel software 
to automatically co-register polyps between follow-up 
surveillance studies
E. Helbren1, H. Roth1, T. Hampshire1, P.J. Pickhardt2, 
D. Hawkes1, S. Halligan1; 1London/UK, 2Madison, WI/US
Purpose: To evaluate the software that aims to automatically identify and then 
register polyp location across sequential CTC acquisitions performed for polyp 
surveillance.
Material and Methods: We developed a registration algorithm to match 
endoluminal colonic surfaces between prone and supine CTC acquisitions. 
Haustral folds were automatically matched between scans to initialize a 
registration method that establishes correspondence over the entire colonic 
surface via non-rigid registration. Initial and follow-up CTC from 11 patients (14 
polyps) undergoing surveillance were selected and the algorithm was tested 
via two methods: “Direct” (the algorithm used polyp co-ordinates from the 
initial prone and supine acquisitions to automatically predict polyp location on 
follow-up CTC) and “loop” (polyp co-ordinates from initial supine acquisition 
were used to predict polyp location on the initial prone acquisition, then follow-
up prone, follow-up supine and back to initial supine, respectively). Registration 
accuracy was assessed by two observers via the Euclidean distance between 
true and predicted polyp locations.
Results: Successful polyp registration was achieved in all 11 cases for all 14 
polyps using both loop and direct methods. Mean Euclidean registration error 
for individual polyps was 2.0 cm (range 0.1 to 9 cm) for “direct” method and 
3.1 cm (range 0.3 to 8.5 cm) for “loop” method.
Conclusion: Our algorithm achieved automated registration of polyps across 
temporally separate CTC studies. This may facilitate rapid detection of known 
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SS 14.07
True- and false-positive diagnosis of extracolonic 
cancers by CT colonography: discrete choice 
experiment
A. Plumb1, S. Halligan1, D. Boone2, E. Helbren1, S. Zhu3, 
G.L. Yao3, N. Bell1, A. Ghanouni1, C. Von Wagner1, 
S.A. Taylor1, S. Mallett4, D. Altman4, R. Lilford3; 
1London/UK, 2Colchester/UK, 3Birmingham/UK, 4Oxford/UK
Purpose: To determine how healthcare professionals balance the potential 
benefits of detecting extracolonic cancer at screening CT colonography (CTC) 
versus risks of unnecessary investigations due to false-positives.
Material and Methods: 30 healthcare professionals underwent a discrete 
choice experiment. Participants chose between two hypothetical tests for 
colorectal cancer screening. One was unable to diagnose extracolonic cancer 
but generated no false positives (FP), whereas the other diagnosed a curable 
extracolonic cancer in 1 in 600 screenees, but generated FP. The FP rate was 
varied systematically to determine the ”tipping point” at which the rate was 
deemed sufficient to outweigh the benefit of detecting cancer. FP leading to 
follow-up imaging and those precipitating invasive tests were presented 
separately.
Results: 14/30 (47%) participants were prepared to tolerate any rate of follow-
up imaging to diagnose 1 extracolonic cancer in 600 screenees. Across all 
participants, the mean rate of further imaging deemed acceptable was 53.5%. 
Invasive tests were less acceptable: The mean ”tipping point” was an invasive 
test rate of 9.7% to diagnose 1 in 600 screenees with a curable extracolonic 
cancer.
Conclusion: Healthcare professionals will tolerate numerous extracolonic FP 
by CTC if the consequence is simply further imaging. Tolerance for invasive 
tests is lower. The specificity of CTC for clinically significant extracolonic 
findings is likely to be highly acceptable to healthcare professionals, including 
surgeons, gastroenterologists and radiologists.
SS 14.08
Diverticular disease severity score based on computed 
tomographic colonography
N. Flor1, P. Rigamonti1, S. Romagnoli1, A. Pisani Ceretti1, 
F. Balestra1, F. Sardanelli1, G.P. Cornalba1, P.J. Pickhardt2; 
1Milan/IT, 2Madison, WI/US
Purpose: We propose a diverticular disease severity score (DDSS) based on 
CT colonography (CTC) findings.
Material and Methods: Seventy-nine patients (62±14.5 years; 39 females, 40 
males) underwent CTC after acute diverticulitis. Two independent readers 
classified each case on 2D MPR using a 4-point DDSS, based on sigmoid 
colon wall thickness and lumen diameter: 1=wall thickness <3 mm, lumen 
diameter ≥15 mm; 2=wall thickness 3-8 mm, lumen diameter ≥15 mm; 3=wall 
thickness ≥8 mm, lumen diameter 5-15 mm; 4=wall thickness≥8 mm, lumen 
diameter <5 mm. Intra- and inter-observer reproducibility was evaluated. Of 79 
patients, 32 (40%) underwent surgery after CTC; maximum sigmoid wall 
thickness was measured on pathologic specimen. Cohen Κ, Χ2, Kruskall-
Wallis, and Jonckheere-Terpstra tests.
Results: Intra- and inter-observer reproducibility of DDSS was almost perfect 
(k=0.84-0.90). DDSS significantly correlated with patient age (p=0.017) and 
with the probability of surgical treatment (p=0.001). Pathology for the 32 
resected specimens revealed acute/chronic diverticular inflammation only in 
29 and superimposed sigmoid cancer (n=2) or Crohn’s disease (n=1) in three 
patients. All three patients with important coexisting pathology had a DDSS of 
4. Maximum wall thickness at pathology correlated with DDSS (p=0.008).
Conclusion: DDSS is highly reproducible and correlates with pathologic wall 
thickness, as well as the probability of surgery. Nearly one of three patients 
with DDSS of 4 had important superimposed sigmoid pathology. CTC with 
DDSS can provide valuable information for surgeons.
SS 14.09
Accuracy of CT colonography in detecting colorectal 
cancer at our District General Hospital in North Wales
S. Sinha, C. Corr; Wrexham/UK
Purpose: To assess accuracy of CTC in diagnosing colorectal cancer (CRC) at 
our hospital with respect to nationally and internationally agreed standards.
Material and Methods: A retrospective study analysing all CTC’s from 
November 2006 to May 2011 was performed. Radiology reports were reviewed 
and correlated with data of all patients with CRC diagnosed up to November 
2012, which was obtained from pathology and cancer services. The following 
were recorded from radiology reports: demographics; cancer diagnosis; 
equivocal findings and extra-colonic cancers.
Results: 841 CTC’s were performed of which 47 had confirmed CRC identified 
as cancer, suspicious for cancer, or suspicious polyp on CTC. Sensitivity and 
negative predictive value (NPV) were 100%. 40 cases were identified as 
definite CRC with no colonoscopy advised and 39 were proven to be cancer. 
Specificity was 97.5% for definitive CRC diagnosis. 16 cases were ‘suspicious 
but uncertain’ and colonoscopy advised – 6 of these were cancer. 18 cases 
diagnosed as benign were confirmed as benign. Combined specificity with 
CTC and colonoscopy for CRC diagnosis was 96%. 30 unexpected 
extracolonic malignancies were identified where 3 were concurrent with CRC.
Conclusion: CTC is very accurate for diagnosing CRC with high NPV and 
sensitivity. Specificity is also high and increases with the complementary use 
of colonoscopy in equivocal cases. CTC should be used as a first-line imaging 
investigation for diagnosis of CRC.
SS 14.10
Appendiceal length as an independent risk factor for 
acute appendicitis
P.J. Pickhardt, J. Suhonen, B.D. Pooler; Madison, WI/US
Purpose: To determine if appendiceal lengths differ among adults with proven 
acute appendicitis compared with normal adult controls.
Material and Methods: Preoperative MDCT in 321 consecutive adults with 
surgically proven appendicitis was compared with MDCT in 321 consecutive 
adult controls undergoing CTC screening. Appendiceal length at MDCT was 
obtained using curved reformatted images along the appendiceal long axis. 
For validation, MDCT length was compared with gross pathology length for the 
appendicitis group.
Results: Appendiceal length at MDCT correlated well with gross pathology 
(mean length, 6.76 vs 6.56 cm). Mean appendiceal length and standard 
deviation of length at MDCT were both significantly greater in controls 
compared with the acute appendicitis group (7.87±3.49 cm vs 6.76±1.94 cm; 
p<0.001). Appendicitis cases outnumbered controls at every 0.5-cm interval 
between 4.0 cm and 9.5 cm. The odds ratio (OR) for acute appendicitis within 
the 4.0-9.5 cm interval was 5.4 compared with controls, and increased to 37.9 
for the 2.25-13.75 cm interval. 88.5% (284/321) of appendicitis cases fell 
within the 4.0-9.5 cm range, compared with only 56.1% (180/321) of controls 
(p<0.001).
Conclusion: Appendiceal length strongly correlates with the likelihood of 
acute appendicitis. Specifically, ”intermediate” appendiceal lengths (4.0-9.5 
cm) are more frequently complicated by acute appendicitis, whereas both 
“long” (>9.5 cm) and “short” (<4.0 cm) appendiceal lengths are more frequently 
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HCC: From diagnosis to treatment
SS 15.01
Incidence and predictive factors for HCC recurrence 
after liver transplantation
A. Pecchi, G. Besutti, M. De Santis, C. Del Giovane, 
S. Nosseir, G. Tarantino, F. Di Benedetto, P. Torricelli;  
Modena/IT
Purpose: To estimate incidence of HCC recurrence after liver transplantation 
(LT) and to identify clinical, pathologic and imaging predictive factors for HCC 
recurrence after LT.
Material and Methods: 165 patients who underwent LT for HCC between 
October 2004 and November 2011 and survived more than 2 months were 
included. Clinical data as liver damage etiology, alphafetoprotein (AFP) before 
LT and type of immunosuppressive therapy undertaken after LT were collected. 
Imaging findings were retrospectively evaluated on pretransplantation 
contrast-enhanced MDCT/RM performed within 75 days before LT. 
Histopathological findings were obtained by a review of the pathologic reports. 
Incidence of recurrence was evaluated. Predictive factors for recurrence were 
estimated by using univariate analysis and Χ2 test.
Results: Recurrence was found in 24 (14.5%) patients. Univariate analysis 
revealed the following significant prognostic factors for recurrence(p<0.05): 
presence of viable tumor, more than three viable nodules, >3 cm diameter of 
largest nodule and >5 cm overall viable tumor size on both pathology and 
imaging; bilobar distribution, pathologic grade >1, capsule contact, vascular 
invasion, microsatellitosis on pathology; liver resection undertaken before LT, 
AFP level >10 ng/mL and cyclosporine alone as immunosuppressive therapy 
undertaken after LT among clinical and theraputic data.
Conclusion: Incidence of HCC recurrence after LT was 14.5%. Different imaging, 
pathologic and clinical data were predictive factors for HCC recurrence after LT.
SS 15.02
Hepatocellular carcinoma: comparison of enhancement 
patterns with gadoxetate disodium versus gadobenate 
dimeglumine
T. Tirkes, A. Aisen, K. Sandrasegaran, F. Akisik; 
Indianapolis, IN/US
Purpose: To determine if there is any difference in enhancement properties of 
hepatocellular carcinoma (HCC) during contrast-enhanced magnetic 
resonance imaging utilizing gadoxetic acid (Gd-EOB-DTPA, Eovist®, Bayer) 
versus gadobenate dimeglumine (Gd-BOPTA, MultiHance®, Bracco).
Material and Methods: 118 patients with HCC were scanned; 80 patients with 
Gd-BOPTA and 38 with Gd-EOB-DTPA using a 1.5T scanner. Breath-hold 
volumetric fat-suppressed sequences were performed at precontrast, arterial 
(20 s), portal (1 min) and equilibrium (2 min) phases. The GD-EOB-DTPA was 
administered at a dose of 0.025 mmol/kg body weight and at a rate of 1 mL/s. 
Gd-BOPTA was administered at a dose of 0.1 mmol/kg body weight and at 
rate of 2 mL/s. Bolus triggering software was utilized for both patient groups to 
optimize the contrast enhancement during the arterial phase. The contrast-to-
noise ratio (CNR) was calculated by (SIlesion – SIliver)/SDbackground (SD=standard 
deviation, SI= signal intensity).
Results: HCCs demonstrated peak enhancement during the arterial phase 
and continuing washout when scanned with either Gd-EOB-DTPA or Gd-
BOPTA. CNRs of Gd-EOB-DTPA and Gd-BOPTA were similar in arterial 
(p=0.67), portal (p=0.17) and equilibrium phases (p=0.53). HCCs demonstrated 
lower CNRs with Gd-EOB-DTPA compared to Gd-BOPTA in all three 
phases.Conclusion: 1. There was no statistically significant difference in 
CNRs of HCCs during arterial, portal and equilibrium phases scanned with 
Gd-EOB-DTPA compared to Gd-BOPTA. 2. Using approved doses of Gd-
EOB-DTPA, there was overall lower CNRs compared to Gd-BOPTA.
SS 15.03
Qualitative analysis of small (≤2 cm) regenerative 
nodules, dysplastic nodules and well-differentiated 
HCCs with gadoxetic acid MRI
M. Di Martino, V.C. Lombardo, R. Di Miscio, C. Catalano; 
Rome/IT
Purpose: To evaluate radiological findings and diagnostic accuracy of 
gadoxetic acid magnetic resonance imaging (MRI) in the evaluation of small 
(≤2cm) regenerative nodules (RN), dysplastic nodules (DN) and well-
differentiated hepatocellular carcinomas (HCCs).
Material and Methods: Forty-six cirrhotic patients, with 72 focal liver lesions 
were retrospectively recruited. The MRI study protocol included T1-weighted 
and T2-weighted pre-contrast sequences and 3D spoiled gradient-echo T1-
weighted post-contrast sequences Gd-EOB-DTPA-enhanced obtained during 
the arterial, portal-venous and equilibrium phases 25 s, 60 s 180 s and after 20 
m. All lesions (27 RN, 20 DN and 25 HCCs) were pathologically confirmed. One 
radiologist not involved in the datasets analysis reported the signal intensity 
characteristics of each lesion. Two radiologists blinded to clinical and 
pathological information evaluate radiological dataset images. Sensitivity, 
specificity and diagnostic accuracy were considered for statistical analysis.
Results: Regenerative nodules usually show enhancement during the arterial 
phase without wash-out sign during portal-venous and delayed phase. Dysplastic 
nodules tend to do not show enhancement during the arterial phase and present 
wash-out on delayed phase. Well-differentiated HCCs very often show typical 
vascular pattern and low signal intensity during the hepatobiliary phase. According 
to the AASLD radiological diagnosis the mean sensitivity, specificity and diagnostic 
accuracy in the diagnosis of HCC were, respectively (76.4%, 80%, 0.84).
Conclusion: Gadoxetic acid MR imaging is a reliable tool in the characterization 
of well-differentiated HCC from dysplastic and regenerative nodules.
SS 15.04
Dynamic enhancement pattern of Gd-EOB-DTPA 
compared to gadobutrol in patients with HCC
S. Kinner, C. Kloeters, T. Lauenstein, M. Forsting; Essen/DE
Purpose: The liver-specific contrast agent Gd-EOB-DTPA comprises high r1 
and r2 values and seems to be well suited for dynamic MR imaging in addition 
to liver specific characteristics. Aim of this study was to compare Gd-EOB-
DTPA to the extracellular agent gadobutrol at dynamic abdominal MRI.
Material and Methods: Dynamic contrast-enhanced liver imaging was 
performed in 42 patients with HCC with a T1-weighed volume interpolated 
breath hold examination. Gd-EOB-DTPA (0.25 mmol/ml) and gadobutrol (1 
mmol/ml) were injected body weight adapted using care bolus technique at 2 
ml/s on two consecutive days. SNR values of abdominal vessels and CNR 
values of HCC lesions during arterial phase were evaluated. For statistical 
evaluation, a Wilcoxon-signed-rank-test was used.
Results: SNR (aorta) with gadobutrol amounted to 106±15, with Gd-EOB-
DTPA to 77±14 (p=0.12). The portal vein (pv) and vena cava (vc) exhibited 
similar SNR values in portalvenous/venous contrast phase (SNR(pv) 
gadobutrol= 68±6, SNR(pv) Gd-EOB-DTPA= 63±3; p=0.6; SNR(vc) gadobutrol= 
59±4, SNR(vc) Gd-EOB-DTPA= 52±3; p=0.64). CNR values of HCC lesions 
amounted to 27±4 for Gd-EOB-DTPA, whereas with gadobutrol CNR = 41±6 
(p=0.14).
Conclusion: Despite the higher r1 value of Gd-EOB-DTPA, SNR and CNR 
values for gadobutrol were higher. This might be due to the higher gadolinium 
concentration. To achieve best image quality, the agent used in liver MR 
should be adapted to the clinical question: gadobutrol should be used for 
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SS 15.05
Accuracy of contrast-enhanced imaging in the 
pretransplantation staging of HCC
A. Pecchi, G. Besutti, M. De Santis, C. Del Giovane, 
S. Nosseir, G. Tarantino, F. Di Benedetto, P. Torricelli; 
Modena/IT
Purpose: To assess the accuracy of imaging in HCC pretransplantation 
staging, with pathologic evaluation of the explanted liver as reference standard.
Material and Methods: 165 patients who underwent liver transplantation (LT) 
for HCC between October 2004 and November 2011 and survived more than 2 
months were included, 146 of them (88.5%) having undergone pretransplantation 
treatment. Imaging findings were retrospectively evaluated on pretransplantation 
contrast-enhanced MDCT (n=130) or MR (n=35) performed within 75 days 
before LT. Histopathological findings were obtained by a review of the pathologic 
reports. Association between pretransplantation imaging and explanted liver 
pathology were estimated by using Χ2 test. Sensitivity, specificity and accuracy 
of imaging, MDCT and MR in the detection of viable tumor were calculated and 
compared with histopathology by using McNemar test.
Results: A significant association was found between imaging and pathology 
in the assessment of the presence of viable tumor (p≤0.001, also in patients 
who had undergone pretransplantation treatment), number of nodules 
(p≤0.001), diameter of the largest (p≤0.001), overall tumor size (p≤0.001) and 
lobar distribution (p=0.034). Sensitivity, specificity and accuracy of imaging in 
the detection of viable tumor were 81.4%, 59.6% and 75% (82.3%, 55.9% and 
75.4% for MDCT; 77.3%, 69.2% and 74.3% for MR), without significant 
difference between imaging and histopathology.
Conclusion: Contrast-enhanced imaging can be considered accurate in HCC 
pretransplantation staging, with a sensitivity of 81.4% and a specificity of 
59.6% in the detection of viable tumor.
SS 15.06
Y-90 microspheres radioembolization of unresectable 
HCC: is this safe in cases of portal vein thrombosis?
F. Somma, R. D'Angelo, L. Aloj, S. Limone, F. Fiore; 
Naples/IT
Purpose: Assessment of safety and effectiveness of trans-arterial 
radioembolization (TARE) using Y-90 microspheres in cases of unresectable 
HCC not responsive to other loco-regional treatments.
Material and Methods: Between November 2005 and January 2013, 74 TARE 
were performed in 68 patients with unresectable HCC and bilirubin values up 
to 2.5 mg/dl, 19 with portal vein thrombosis (PVT). Every patient was studied 
with multislice computed tomography (MSCT) scans and angiography while 
just some of them underwent the embolization of the gastro-duodenal artery. 
In these cases, a previous study was performed with the injection of TC-
99MAA through a 3F microcatheter. Proton-pump inhibitors (PPI) were 
administered to prevent gastritis and ulcers.
Results: The average dose administered was 1.7 GBq. After-treatment fevers 
and abdominal pain were found in 25 and 19 patients, respectively. No other 
side effect was observed. RECIST criteria were used to evaluate the response: 
at least a partial response was found in 71% of patient three months after the 
procedure and in 91% at 9 months. The mean survival of patients with PVT 
was similar to those without thrombosis. Moreover, a regression of PVT was 
registered in more than 50% of patients.
Conclusion: Among the loco-regional treatments of HCC, TARE using Y-90 
microspheres is a safe and effective technique, even in patients with PVT. 
Furthermore, TARE showed to be useful in case of relapse after trans-arterial 
embolization or chemoembolization, improving the survival of these patients.
SS 15.07
Limits of CT scan in the evaluation of sarcopenia in 
cirrhotic patients
M. Giusto, M. Di Martino, R. Di Miscio, V.C. Lombardo, 
B. Lattanzi, M. Merli, C. Catalano; Rome/IT
Purpose: To evaluate the relationship between CT, dual-energy X-ray 
absorptiometry (DEXA) and anthropometry to assess sarcopenia in cirrhotic 
patients.
Material and Methods: Adult patients eligible for elective LT for whom CT was 
available were considered. Skeletal muscle cross-sectional area was measured 
by CT and sarcopenia was defined using previously published gender-specific 
cutoffs. Mid-arm muscle circumference (MAMC,cm) was calculated according 
to standard methods. Fat-Free Mass Index (FFMI, kg/m2) and Appendicular 
Skeletal Muscle Index (ASMI, kg/m2) were calculated using DEXA. Agreement 
was assessed through Kendall's tau statistic. We used multi-state-models to 
model survival taking into account the possible intermediate transplant event.
Results: Fifty-nine patients (78% males, median age 59 years, 56% post-viral, 
41% with HCC) were included. Median MELD was 16 in patients without HCC 
and 12 in patients with HCC. CT sarcopenia was diagnosed in 45 patients 
(76%) with similar prevalence in males and females. A reduction of FFMI and 
ASMI was observed in 42-52% of the patients while 52% showed a 
MAMC≤10thpercentile. A significant but slight correlation between FFMI, 
ASMI and CT was observed while MAMC significantly correlate with CT only in 
males. Eight patients died before LT and 7 within 12 months after LT. CT 
sarcopenia did not correlate with mortality, while MAMC and FFMI (only in 
males) were associated with higher mortality (p≤0.005).
Conclusion: CT and others techniques of muscle evaluation are not good 
predictive modalities in the evaluation of mortality post-OLT.
SS 15.09
Withdrawn by the authors
SS 15.10
Radiofrequency ablation of HCC: impact of size of the 
lesion, Child-Pugh score and technical parameters on 
outcome
P. Shriduth, S. Moorthy, P.V. Ramachandran, K.P. Sreekumar, 
R. Rajesh Kannan; Kochi/IN
Purpose: To correlate the pre-procedural tumor morphology (size of the lesion 
on contrast imaging), Child-Pugh score and technical parameters with the 
outcome of radiofrequency ablation (successful ablation or local tumor 
progression).
Material and Methods: This prospective study involved 40 HCC patients 
treated over a period from June 2010 to June 2012. We used Cool-tip 
radiofrequency ablation system (Covidien). The patients were then followed up 
by contrast imaging. The modified RECIST (mRECIST) assessment for HCC 
was applied to define the treatment response to RFA and tumor progression. 
The median follow- up period was 5 months.
Results: (1) Overall complete response (CR) was noted in 72.5% of cases. 
Less than 3 cm tumors showed CR of 88.5%. Even >3 cm tumors also showed 
CR of 42.9%. (2) Overall local tumour progression (LTP) was seen in 27.5% of 
lesions. More than 3 cm tumors showed LTP of 57.1%. (3) The median 
recurrence free survival was 6 months. (4) The 1-year survival rate of Child-
Pugh A and B patients was 61 and 50%, respectively.
Conclusion: (1) Preprocedural tumor morphology showed statistically 
significant association with the outcome. Less than 3 cm lesions showed good 
response; larger lesions require multiple needle placements, longer procedure 
time and reablation. (2) Child-Pugh score and technical parameters did not 
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Civitareale N.: SS 10.05
Cleopazzo E.: SS 8.03
Coenegrachts K.: SS 13.06
Colagrande S.: SS 13.04
Colleoni A.: SS 10.02
Conze J.: SS 5.08
Cornalba G.P.: SS 14.08
Corniani D.: SS 9.09
Corr C.: SS 14.09
Correale L.: SS 12.01
Coskun M.: SS 5.02
Costentin C.: SS 11.03
Cotroneo A.R.: SS 10.05
Cros J.: SS 6.08
Crosara S.: SS 1.10, SS 13.02
Crush L.: SS 8.08
Cyran C.C.: SS 14.02
D
D’Angelo R.: SS 4.05, SS 15.06
D’Onofrio M.: SS 13.02
D’Onofrio M.: SS 1.10
Dale A.: SS 4.08
De Cecco C.N.: SS 2.06, SS 10.06, 
SS 10.08, SS 14.04
De Knegt R.J.: SS 9.04
De Leo F.: SS 1.07
De Marco V.: SS 2.01, SS 7.10, SS 8.06
De Mey J.: SS 3.05
De Robertis R.: SS 1.10, SS 13.02
De Ruvo N.: SS 9.09
De Santis M.: SS 9.09, SS 15.01, 
SS 15.05, SS 15.09
Del Giovane C.: SS 15.01, SS 15.05, 
SS 15.09
Della Pina M.: SS 7.01
Demozzi E.: SS 1.10
Denecke T.: SS 1.05, SS 3.04, SS 7.03, 
SS 7.07
Denunzio M.: SS 5.05
Di Benedetto F.: SS 9.09, SS 15.01, 
SS 15.05, SS 15.09
Di Martino M.: SS 15.03, SS 15.07
Di Miscio R.: SS 15.03, SS 15.07
Distelmaier M.: SS 5.08
Djabbari M.: SS 11.03
Donati F.: SS 1.03, SS 2.09, SS 7.01
Dorigo A.: SS 1.07
Dromain C.: SS 3.02, SS 5.07
Duchatelle V.: SS 6.06
Ducreux M.: SS 5.07
Dudas I.: SS 4.01
Dumortier J.: SS 3.07
Dwarkasing R.: S.: SS 7.09
E
Egorov V.I.: SS 6.02
Eiber M.: SS 1.08
Elias D.: SS 5.07
Emmanuel A.: SS 8.01
Ertle J.: SS 11.10
Eschbach R.: SS 14.02
Eun C.: SS 2.05














Faggioni L.: SS 10.01, SS 10.04, 
SS 12.08, SS 13.09
Faivre S.: SS 7.02
Falaschi F.: SS 1.03, SS 2.09, SS 7.01
Fasih N.: SS 5.01
Fellner C.: SS 9.08, SS 13.01, SS 13.03
Fenlon H.M.: SS 12.09
Ferri A.: SS 10.05
Fielding P.: SS 10.07, SS 10.09
Fingerle A.A.: SS 7.05
Fiore F.: SS 4.05, SS 15.06
Flor N.: SS 14.08
Foley K.G.: SS 10.07, SS 10.09
Forsting M.: SS 11.10, SS 15.04
Fouchard I.: SS 9.02
Foulon S.: SS 3.02
Fox B.: SS 12.07
Fraser-Hill M.A.: SS 5.01
Fujinaga Y.: SS 13.05
G
Gögebakan Ö.: SS 5.10
Gaa J.: SS 1.08
Gabata T.: SS 9.07
Galatola G.: SS 12.01
Ganeshan B.: SS 9.03
Ganter C.: SS 13.10
Garcia-Aguilar J.: SS 2.10
Garcia Bennett J.: SS 2.02
Gaujoux S.: SS 7.02
Gebauer B.: SS 3.04
Geiger B.: SS 12.05
Geisel D.: SS 3.04
Gerken G.: SS 8.04
Ghanouni A.: SS 14.07
Gherarducci G.: SS 1.03, SS 2.09, 
SS 7.01
Gigoni R.: SS 1.03, SS 2.09, SS 7.01
Giovannone R.: SS 8.06
Giusto M.: SS 15.07
Goddard A.: SS 12.02
Goere D.: SS 5.07
Gollub M.J.: SS 2.10
Gomez B.: SS 3.06
Goncalves S.I.: SS 9.05
Goode S.D.: SS 4.08
Goodman K.: SS 2.10
Goujon G.: SS 6.08
Grassi R.: SS 4.05
Grazioli L.: SS 10.02
Grieser C.: SS 1.05, SS 7.03
Guendel L.: SS 12.05
Guerrini S.: SS 10.10
Guettier C.: SS 11.09
Guibal A.: SS 3.07
Guillaud O.: SS 3.07
Guillem J.G.: SS 2.10
Gupta A.: SS 8.09, SS 12.10
Gupta R.: SS 8.10
H
Hahn O.: SS 4.01
Hahnemann M.L.: SS 8.04
Haimerl M.: SS 9.08, SS 13.01, SS 13.03
Halligan S.: SS 8.01, SS 12.02, SS 14.06, 
SS 14.07
Hamlin J.: SS 8.05
Hamm B.: SS 1.05, SS 3.04, SS 7.03
Hampshire T.: SS 14.06
Han J.: SS 3.01, SS 6.04, SS 6.10, 
SS 9.01, SS 11.01
Hansen N.L.: SS 5.08
Hansmann A.: SS 8.09
Hanson J.M.: SS 12.03
Hartung-Knemeyer V.: SS 3.06
Haspeslagh M.: SS 13.06
Havla L.: SS 14.02
Hawkes D.: SS 14.06
Healy C.F.: SS 12.09
Heidemann B.E.: SS 10.03
Heijnen L.A.: SS 2.03, SS 2.04, SS 2.08, 
SS 7.06, SS 10.03
Hekimoglu K.: SS 5.02
Helbren E.: SS 14.06, SS 14.07
Hersey N.: SS 4.08
Hinshaw J.L.: SS 12.04
Hirner H.: SS 14.02
Holzapfel K.: SS 1.08, SS 7.05, SS 13.10
Hunt R.: SS 14.05
Hyland R.: SS 8.05
I
Iafrate F.: SS 14.04
Ichikawa T.: SS 11.07
Ihm C.: SS 7.07
Ilangovan R.: SS 8.07, SS 8.09, SS 12.10
Ingrisch M.: SS 14.02
Iossa A.: SS 10.06, SS 10.08
Iussich G.: SS 12.01
J
Jackson S.: SS 7.08, SS 12.07
Jain D.: SS 4.07
James J.: SS 12.07
Jang K.: SS 1.04, SS 7.04
Jansen P.L.: SS 9.04
Jayne D.: SS 14.01
Jeon H.: SS 2.07
Jung E.M.: SS 5.03, SS 13.03
Jung S.: SS 2.07
K
Kadoya M.: SS 13.05
Kalra N.: SS 8.10
Karani J.: SS 9.03
Karcaaltincaba M.: SS 11.02
Karmazanovsky G.: SS 6.02
Karran A.: SS 10.07, SS 10.09
Kasatkina E.: SS 1.02
Kazmierczak P.M.: SS 14.02
Kerbaol A.: SS 13.08
Khan N.: SS 4.06, SS 4.11
Khan R.: SS 4.08
Khandelwal N.: SS 8.10
Kibriya N.: SS 1.01, SS 4.02
Kim D.: SS 12.04
Kim E.: SS 3.01
Kim J.: SS 4.03, SS 6.04, SS 6.10, 
SS 11.04
Kim M.H.: SS 11.08
Kim S.: SS 1.04, SS 2.05, SS 7.04
Kim Y.: SS 2.07
Kinner S.: SS 8.04, SS 11.10, SS 15.04
Kitao A.: SS 9.07
Klinge U.: SS 5.08
Kloeters C.: SS 11.10, SS 15.04
Kluza E.: SS 2.04, SS 2.08
Kobayashi S.: SS 9.07
Kochhar R.: SS 8.10
Koda W.: SS 9.07
Kolderman S.: SS 1.09
Kose I.C.: SS 11.02
Kozaka K.: SS 9.07
Kraemer N.A.: SS 5.08, SS 13.07
Kramme I.: SS 7.03
Krauss B.: SS 9.07
Krestin G.: SS 7.09
Krishna J.: S.: SS 8.10
Kuehl H.: SS 3.06
Kuehnert N.: SS 5.08
Kuhl C.K.: SS 5.08, SS 13.07
Kupcsulik P.K.: SS 4.01
Kurozumi M.: SS 13.05
Kurushkina N.M.: SS 6.02
L
Laasch H.: SS 1.01, SS 4.02
Laghi A.: SS 2.06, SS 10.06, SS 10.08, 
SS 14.04
Lahaye M.J.: SS 10.03
Lakhman Y.: SS 2.10
Lambie H.: SS 8.05
Lambregts D.M.: SS 2.03, SS 2.04, 
SS 2.08, SS 7.06, SS 10.03
Laplanche A.: SS 3.02
Lattanzi B.: SS 15.07
Lau K.C.: SS 5.04
Lau S.: SS 5.04
Laudi C.: SS 12.01
Lauenstein T.C.: SS 3.06, SS 8.04, 
SS 11.10, SS 15.04
Laurent A.: SS 11.03
Lavini C.: SS 8.02
Lawrance J.A.: SS 1.01, SS 4.02
Lawrence E.: SS 9.10
Lebigot J.: SS 9.02
Lee F.: SS 4.08
Lee J.: SS 3.01, SS 4.03, SS 4.03, 
SS 6.04, SS 6.10, SS 6.10, SS 9.01, 
SS 11.01, SS 11.01, SS 11.08
Lee S.H.: SS 7.04
Lee Y.: SS 11.01
Lefort T.: SS 3.07
Legou F.: SS 11.03













Leiva D.: SS 4.04
Lella A.: SS 10.05
Lemoniati E.: SS 8.07
Leo N.: SS 11.09
Lev-Toaff A.: S.: SS 12.05
Levine M.: S.: SS 12.05
Lewin M.: SS 11.09
Lewis W.G.: SS 10.07, SS 10.09
Li Z.: SS 8.02
Lilford R.: SS 14.07
Lim S.: SS 1.04
Limone S.: SS 15.06
Lingam M.: SS 5.05
Llado L.: SS 4.04
Lombardo F.: SS 3.09, SS 6.03, SS 6.05, 
SS 6.07, SS 6.09, SS 11.05
Lombardo V.: SS 15.03, SS 15.07
Loos M.: SS 1.08
Losi L.: SS 9.09
Lucchesi P.: SS 2.06, SS 14.04
Luciani A.: SS 11.03
Lung P.: SS 8.09
Lyadov V.: SS 1.02
M
Müller-Wille R.: SS 13.03
Maas M.: SS 2.04, SS 2.08, SS 10.03
Macarini L.: SS 8.03
Maccio L.: SS 9.09
Maccioni F.: SS 2.01, SS 7.10, SS 8.06
Maceroni M.: SS 10.06, SS 14.04
Macmathuna P.: SS 12.09
Maegerlein C.: SS 7.05
Maher M.: SS 5.06, SS 8.08
Majeed F.: SS 8.05
Malka D.: SS 5.07
Malleo G.: SS 6.05
Mallett S.: SS 14.07
Manoharan P.: SS 4.02
Mantarro A.: SS 4.10, SS 10.01, 
SS 10.04, SS 12.08
Marciano E.: SS 2.09
Maroldi R.: SS 10.02
Marracino M.: SS 4.05
Marshall M.: SS 8.07, SS 8.09, SS 12.10
Martens M.H.: SS 2.03, SS 2.04, SS 2.08, 
SS 7.06, SS 10.03
Martinez Carnicero L.: SS 4.04
Martirosian P.: SS 13.10
Maruyama K.: SS 13.05
Masi G.: SS 7.01
Maskell G.F.: SS 14.03
Matos H.: SS 3.08
Matsui O.: SS 9.07
Matteuzzi B.: SS 13.04
Mazzamurro F.: SS 2.01, SS 7.10, SS 8.06
Mazzei F.: SS 10.10
Mazzei M.: SS 10.10
Mazzeo S.: SS 6.01
Mazzoni L.N.: SS 13.04
McCall J.: SS 4.06, SS 4.11
McCoubrie P.: SS 14.05
McGinty K.: SS 2.10
Menys A.: SS 8.01
Mercuri P.: SS 10.10
Meric K.: SS 1.06
Merli M.: SS 15.07
Michalak S.: SS 9.02
Miles K.: SS 9.03
Milillo P.: SS 8.03
Minami T.: SS 9.07
Mistry T.: SS 8.07
Miyagawa S.: SS 13.05
Mohammed N.: SS 8.05
Molinié V.: SS 6.06
Moloney F.: SS 5.06
Mondal D.: SS 2.03, SS 7.06
Montemezzi S.: SS 12.01
Moorthy S.: SS 15.10
Morana G.: SS 1.07
Moser M.: SS 14.02
Moskowitz C.: SS 2.10
Motosugi U.: SS 11.07
Muckian J.: SS 12.10
Mukund A.: SS 4.07
Mullan D.: SS 1.01, SS 4.02
Murtaza A.: SS 5.01
N
Nakano M.: SS 11.07
Nash G.: SS 2.10
Nederveen A.J.: SS 3.10, SS 9.04
Nensa F.: SS 3.06, SS 8.04
Nensey R.R.: SS 12.07
Neri E.: SS 2.09, SS 10.01, SS 10.04, 
SS 12.08
Ngan-Soo E.: SS 14.05
Nickerson C.: SS 12.02
Nieboer K.: SS 3.05
Niessen C.: SS 9.08, SS 13.01
Nikiforaki A.: SS 7.06
Nikolaou K.: SS 14.02
Noruegas M.J.: SS 3.08
Nosseir S.: SS 15.01, SS 15.05, SS 15.09
O
O’Connor O.J.: SS 8.08
O’Connor S.A.: SS 12.03
O’ Neill S.B.: SS 8.08
O’Regan K.N.: SS 8.08
Odille F.: SS 8.01
Osterhoff M.A.: SS 5.10
Otani K.: SS 9.07
Otto J.: SS 5.08
Ozgur A.: SS 1.06
Ozmen M.: SS 11.02
P
Pacciardi F.: SS 1.03, SS 2.09, SS 7.01
Pajor P.: SS 4.01
Pancrazi F.: SS 13.09
Papanikolaou N.: SS 2.08, SS 7.06
Paradis V.: SS 7.02
Park H.: SS 1.04, SS 2.07, SS 7.04
Park M.: SS 1.04, SS 7.04
Park S.J.: SS 2.07
Park U.: SS 2.07
Parrinello A.V.: SS 10.10
Patel A.: SS 5.05
Patnick J.: SS 12.02
Paty P.P.: SS 2.10
Pavel M.: SS 7.07
Pecchi A.: SS 9.09, SS 15.01, SS 15.05, 
SS 15.09
Peck R.: SS 4.08
Perez Fernandez C.: SS 1.05, SS 7.03, 
SS 7.07
Peters R.: SS 1.09
Petralia G.: SS 2.02
Petrov R.V.: SS 6.02
Pickhardt P.J.: SS 9.10, SS 12.04, 
SS 14.06, SS 14.08, SS 14.10
Pigneur F.: SS 11.03
Pisani Ceretti A.: SS 14.08
Plumb A.: SS 8.01, SS 12.02, SS 14.07
Pollentine A.: SS 14.05
Pollina L.: SS 11.07
Pommier R.: SS 7.02
Ponsioen C.Y.: SS 8.02
Pooler B.D.: SS 9.10, SS 12.04, SS 14.10
Pottier E.: SS 5.07
Pozzessere C.: SS 10.10
Pozzi Mucelli R.: SS 1.10, SS 3.09, 
SS 6.03, SS 6.05, SS 6.07, SS 6.09, 
SS 11.05, SS 13.02
Puntel G.: SS 13.02
Puro P.: SS 1.01
Q
Quinn A.D.: SS 12.03
R
Rafecas A.: SS 4.04
Rahmouni A.: SS 11.03
Rajesh Kannan R.: SS 15.10
Rakic S.: SS 1.09
Ramachandran P.V.: SS 15.10
Ramos E.: SS 4.04
Rauscher I.: SS 13.10
Ravanelli M.: SS 10.02
Regge D.: SS 12.01
Regini F.: SS 13.04
Reidy D.: SS 2.10
Reimann A.: SS 5.10
Reiser M.F.: SS 14.02
Rengo M.: SS 2.06, SS 10.06, SS 10.08
Rennert J.: SS 5.03, SS 13.03
Renosi G.: SS 3.07
Ricca L.: SS 11.09
Ricci P.: SS 10.02
Richard P.: SS 11.03
Riedl R.G.: SS 2.03
Rigamonti P.: SS 14.08
Rigauts H.: SS 13.06
Roberts S.A.: SS 10.07, SS 10.09
Rodolfino E.: SS 10.05
Roelofs J.: SS 8.02
Romagnoli S.: SS 14.08













Ronot M.: SS 4.09, SS 7.02, SS 13.08
Roobottom C.A.: SS 12.07
Ros P.: SS 3.05
Roth H.: SS 14.06
Ruiz S.: SS 4.04
Rummeny E.: SS 1.08, SS 7.05, SS 13.10
Runge J.H.: SS 3.10, SS 9.04
Ryan J.: SS 5.01
S
Sımsek M.: SS 1.06
Sacco R.: SS 13.09
Sakamoto M.: SS 11.07
Saltz L.: SS 2.10
Sammon J.: SS 5.06
Sandrasegaran K.: SS 15.02
Santini P.: SS 13.04
Sardanelli F.: SS 14.08
Sarin S.K.: SS 4.07
Scalise P.: SS 4.10
Scandiffio R.: SS 10.01, SS 10.04, 
SS 12.08
Schreyer A.G.: SS 9.08, SS 13.01
Schwarz B.: SS 14.02
Scoazec J.: SS 3.07
Seehofer D.: SS 7.03
Segal N.: SS 2.10
Segnan N.: SS 12.01
Senore C.: SS 12.01
Shahabuddin K.: SS 4.06, SS 4.11
Shetty D.: SS 14.03
Shia J.: SS 2.10
Shorvon P.: SS 12.10
Shriduth P.: SS 15.10
Sibert A.: SS 4.09, SS 7.02
Sibileau E.: SS 6.06
Sidhu H.S.: SS 8.07, SS 8.09, SS 12.10
Silecchia G.: SS 10.06, SS 10.08
Simoens M.: SS 1.09
Singh P.: SS 8.10
Singh R.: SS 5.05, SS 8.10
Singh S.: SS 5.01
Sinha S.: SS 14.09
Sinitsyn V.: SS 1.02
Sinkus R.: SS 9.04
Smith K.: SS 12.10
Smyth A.E.: SS 12.09
Sohn M.: SS 2.10
Solodinina E.: SS 6.02
Somma F.: SS 4.05, SS 15.06
Sosnovskikh I.: SS 2.02
Souvatzoglou M.: SS 7.05
Sreekumar K.: SS 15.10
Starostina N.: SS 6.02
Steffen I.G.: SS 1.05, SS 7.03, SS 7.07
Stell D.A.: SS 7.08
Stelter L.: SS 1.05
Stivaros S.M.: SS 1.01
Stockmann M.: SS 3.04
Stoker J.: SS 3.10, SS 8.02, SS 9.04
Stoppino L.P.: SS 8.03
Stroszczynski C.: SS 5.03, SS 9.08, 
SS 13.01, SS 13.03
Strugnell M.: SS 14.03
Subhani S.: SS 2.04
Sudarsky S.: SS 12.05
Suhonen J.: SS 14.10
Summers P.: SS 2.02
T
Tan A.: SS 14.01
Tandon R.: SS 8.09
Tarantino G.: SS 15.01, SS 15.05, 
SS 15.09
Tarhan C.: SS 5.02
Tavano V.: SS 1.07
Taylor S.A.: SS 8.01, SS 12.02, SS 14.07
Tee L.M.: SS 5.04
Telli S.: SS 1.06
Temple L.: SS 2.10
Terpstra V.: SS 9.04
Tezcaner T.: SS 5.02
Thapar S.: SS 4.07
Theysohn J.: SS 11.10
Thomas-Gibson S.: SS 8.07
Thomson E.M.: SS 8.05
Tielbeek J.A.: SS 8.02
Tirkes T.: SS 15.02
Tirumani S.: SS 5.01
Tischer E.: SS 7.07
Tolan D.J.: SS 8.05, SS 14.01
Torricelli P.: SS 9.09, SS 15.01, SS 15.05, 
SS 15.09
Trakarnsanga A.: SS 2.10
Tsang A.Y.: SS 5.04
Turini F.: SS 4.10
Twomey M.: SS 5.06
U
Ueda K.: SS 13.05
Urbani L.: SS 7.01
V
Vagli P.: SS 10.01, SS 10.04, SS 13.09
Valls C.: SS 4.04
Van Hedent S.: SS 3.05
Van Koeverden S.: SS 7.09
Van Nieuwkerk C.M.: SS 9.04
Vandenbroucke F.: SS 3.05
Vardhanabhuti V.: SS 12.07
Vasileuskaya S.: SS 1.01
Vecchietti F.: SS 10.08, SS 14.04
Verheij J.: SS 9.04
Verloh N.: SS 9.08, SS 13.01, SS 13.03
Vibert E.: SS 11.09
Vilgrain V.: SS 4.09, SS 6.08, SS 7.02, 
SS 13.08
Vinci R.: SS 8.03
Volterrani L.: SS 10.10
Von Wagner C.: SS 14.07
Vos F.: SS 8.02
Vullierme M.-P.: SS 6.08, SS 13.06
W
Wale A.: SS 4.06, SS 4.11
Walter T.C.: SS 1.05
Wan M.: SS 9.03
Weber C.N.: SS 12.05
Weiser M.: SS 2.10
Wiggans M.G.: SS 7.08
Wiggermann P.: SS 9.08, SS 13.01, 
SS 13.03
Wijesekera N.: SS 4.06, SS 4.11
Willemssen F.: SS 7.09
Wilmot A.: SS 12.05
Wyttenbach R.: SS 13.04
Y
Yamada A.: SS 13.05
Yanagisawa S.: SS 13.05
Yao G.L.: SS 14.07
Yencilek E.: SS 1.06
Yildirim U.M.: SS 5.02
Yoon J.: SS 2.05, SS 3.01, SS 9.01, 
SS 11.04
Yu M.: SS 3.01, SS 11.04
Z
Zafar H.M.: SS 12.05
Zamboni G.A.: SS 3.09, SS 6.03, SS 6.05, 
SS 6.07, SS 6.09, SS 11.05
Zappa M.: SS 13.08
Zheng J.: SS 2.10
Zhu S.: SS 14.07
Ziech M.: SS 8.02
Zins M.: SS 6.06
Zsirka-Klein A.: SS 4.01
Zur Hausen A.: SS 2.04
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